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Abstract 
Mass spectrometry (MS) is an essential detection tool in bioanalytical chemistry 
owing to its exceptional selectivity and sensitivity, paired with rapid analyte identification 
and quantification. In this thesis, two classical MS and a newly developed ionization method 
are employed, including matrix-assisted laser desorption/ionization (MALDI) MS, 
electrospray ionization (ESI) MS and electrostatic spray ionization (ESTASI) MS.  
To meet the emerging challenges in bioanalytical chemistry, from disease diagnosis to 
drug development, new MS-based analytical methods ought to be developed with respect to 
high sensitivity, throughput, speed, as well as sample consumption and experimental 
simplification. For these purposes, this thesis presents four analytical strategies combined 
with MS detection for improved analytical performance in different research fields.  
Two classical analytical tools, thin layer chromatography (TLC) and 384-well plate, 
were coupled with ESTASI-MS respectively. In ESTASI-TLC-MS, ESTASI was applied to 
extract and identify a wide range of molecules of different polarities and chemical structures 
from both hydrophilic or hydrophobic silica plates with high sensitivity and minimal sample 
consumption in the femtomole range. In 384-well plate ESTASI-MS, the commercial 384-
well plate could work as a container and an emitter for sample spray ionization, without any 
liquid delivery system or any additional interface. This approach provides fast and high 
throughput analyses for the large batches of reactions, such as enzyme assay and drug 
metabolism. Tyrosinase-catalyzed tyrosine oxidation in the presence or absence of inhibitors 
and cytochrome P450-catalyzed metabolic reactions of two drugs were studied respectively. 
To improve analysis sensitivity, two strategies, mass barcoded gold nanoparticles 
(Mb-AuNPs) for MALDI-MS signal amplification and microfabricated on-chip spyhole (Ø 
10-12 μm) emitter for nanoelectrospray (spyhole-nanoESI), were developed, leading to a low 
sample consumption and high analysis efficiency. Mb-AuNPs combined with magnetic 
separation were applied for multiplex cow’s milk allergy diagnosis in a component-resolved 
manner. IgE antibodies (Abs) could be extracted from a patient’s blood serum by the 
formation of a sandwich structure between allergenic proteins-coated Mb-AuNPs and anti-
human IgE Abs-functionalized magnetic beads (MBs). Detection of Mb-AuNPs by MALDI-
MS provides a limit of detection (LOD) down to picograms per milliliter level for specific 
IgE Abs from only 1 μL of patient’s blood serum. To take advantages of microfluidics in low 
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sample consumption and easy integration, a novel interface of spyhole-nanoESI was designed 
for coupling microfluidics with MS and showed an improved sensitivity than standard ESI. 
This disposable microchip coupled with MS/MS shows potential application in cancer 
diagnosis by the successful detection of a small cell lung cancer biomarker in 1 μL of human 
serum at the extensive stage, without any complicated sample preparation steps.  
 
Key words: matrix-assisted laser desorption ionization, electrospray ionization, electrostatic 
spray ionization, nanoelectrospray ionization, mass spectrometry, thin layer chromatography, 
signal amplification, gold nanoparticles, 384-well plate, microfluidic chip, allergy, cancer 
biomarker, drug metabolism. 
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Résumé 
La spectrométrie de masse (MS) est un outil de détection essentiel en chimie 
bioanalytique en raison de sa sélectivité et de sa sensibilité exceptionnelle, avec une 
identification et une quantification rapides des analytes. Dans cette thèse, on utilise trois 
types de spectromètre de masse avec une source désorption/ionisation laser assistée par 
matrice (MALDI), une source d'ionisation par électronébulisation (ESI) et une source 
d'ionisation par nébulisation électrostatique (ESTASI). 
Pour répondre aux défis émergents dans les applications de la chimie bioanalytique, 
du diagnostic médical au développement de médicaments, les méthodes de spectrométrie 
tirent avantage de la sensibilité, du débit, et de la vitesse, ainsi que de la faible consommation 
d'échantillons et de la simplification expérimentale. Cette thèse présente diverses stratégies 
analytiques utilisant la MS comme méthode de détection pour améliorer les performances 
analytiques dans différents domaines de recherche. 
Deux outils analytiques classiques, une chromatographie en couche mince (TLC) et 
une plaque de 384 puits ont été couplés avec ESTASI-MS respectivement. Dans ESTASI-
TLC-MS, ESTASI a été appliqué pour extraire et identifier une large gamme de molécules de 
différentes polarités et structures chimiques à partir de plaques de silice hydrophiles ou 
hydrophobes avec une sensibilité élevée et une consommation minimale d'échantillon dans la 
gamme de la femtomole. Dans l’approche plaque-ESTASI-MS, une plaque commerciale de 
384 puits plaque a été utilisée comme récipient et comme émetteur pour l'ionisation par 
électronébulisation d'échantillons, sans système de fluidique ni aucune interface 
supplémentaire. L'approche fournit des analyses rapides et à haut débit pour les nombreux 
lots de réactions, tels que le dosage enzymatique et le métabolisme médicamenteux. 
L'oxydation de la tyrosine catalysée par la tyrosinase en présence ou en l'absence 
d'inhibiteurs et les réactions métaboliques catalysées par la cytochrome P450 de deux 
médicaments ont été étudiées respectivement. 
Pour améliorer la sensibilité à l'analyse, deux stratégies, les nanoparticules d'or 
modifiées avec des code-barres massiques (Mb-AuNPs) pour l'amplification du signal de 
MALDI-MS et l'émetteur sur puce (spyhole, Ø 10-12 μm) pour la nanoélectronébulisation 
(spyhole-nanoESI), ont été développées pour une faible consommation d'échantillons et une 
efficacité élevée d'analyse. Les Mb-AuNPs combinées avec la séparation magnétique ont été 
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appliqués pour le diagnostic multiplex de l'allergie au lait de vache d'une manière résolue par 
les composants. Les anticorps (Abs) IgE ont été extraits du sérum sanguin d'un patient par la 
formation d'une structure en sandwich entre les Mb-AuNPs recouvertes de protéines 
allergènes et les billes magnétiques (MBs) fonctionnalisées avec des anticorps IgE. La 
détection de Mb-AuNPs par MALDI-MS fournit une limite de détection (LOD) de l’ordre de 
picogrammes par millilitre pour des IgE Abs spécifiques dans seulement 1 μL de sérum 
sanguin du patient. Pour profiter des avantages de la microfluidique dans une faible 
consommation d'échantillons et une intégration facile, une nouvelle interface de spyhole-
nanoESI a été conçue pour coupler la microfluidique avec la MS et a montré une sensibilité 
améliorée par rapport à l'ESI standard. Ce microchip jetable couplée à la MS/MS montre une 
application potentielle dans le diagnostic du cancer par la détection réussie d'un biomarqueur 
de cancer du poumon en petites cellules dans 1 μL de sérum humain au stade étendu, sans 
étapes de préparation d'échantillon compliquées. 
 
Mots-clés: désorption/ionisation laser assistée par matrice, ionisation par électronébulisation, 
ionisation par nébuliseur électrostatique, ionisation par nanoélectronébulisation, 
spectrométrie de masse, chromatographie sur couche mince, amplification du signal, 
nanoparticules d'or, plaque de 384 puits, microfluidique, allergie, biomarqueur du cancer, 
métabolisme médicamenteux. 
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Chapter Ⅰ: Introduction 
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CHAPTER I. 
Introduction 
1.1. Mass spectrometry ion source  
1.1.1. General introduction 
Since the observation of anode rays by Goldstein in 1886,1 mass spectrometry (MS) 
research started and progressed continuously. The progress has led to advent of new 
instruments and expanded the applications from isotope research and organic molecule 
detection to solving biochemical issues.2,3 A typical MS instrument contains three main parts: 
ion source, mass analyzer and detector. The masses within a sample could be simultaneously 
determined by ionizing the chemical species with an ion source, separating them according to 
their mass-to-charge ratios (m/z) with a mass analyzer, and detecting them with a detector. 
From a mass spectrum, the elemental, isotopic composition and chemical structures could be 
elucidated.  
It is critical to choose a proper ion source for a MS depending on what types of 
samples to be analyzed and various ion sources have been introduced consecutively for 
different purposes. In 1918, Dumpster introduced the first ion source of electron ionization 
(EI) by bombarding salts with electrons.4 As a hard ionization technique, EI is predominantly 
coupled with gas chromatography (GC) for the gas analysis and gives an extensive 
fragmentation. 50 years later, a complimentary technique of chemical ionization (CI) was 
discovered by Munson and Field with less fragmentation, through colliding the gas phase 
analytes with reagent gas ions coexisting in the source for proton transfer, adduct formation 
or charge transfer.5  
To analyze liquid samples, atmospheric pressure chemical ionization (APCI) was 
firstly introduced by Horning and collaborators in 19746 and has become a popular interface 
for coupling liquid chromatography (LC) with MS.7 Later on, fast atom bombardment 
(FAB),8 liquid secondary ion (LSI)9 and thermospray (TSP)10 were successively described. 
Both FAB and TSP were widely applied as interfaces for LC-MS until the beginning of 
1990s, when it began to be replaced by atmospheric pressure ionization methods, especially 
Chapter Ⅰ: Introduction 
 
2 
with the advent of electrospray ionization (ESI) technique.11,12 Fenn and Aleksandrov 
established ESI as a powerful ion source in 1980s and Fenn received the Nobel Prize in 
Chemistry for ionizing large biological molecules with ESI.13,14 Since then, ESI has become 
an essential technique for the proteomics studies mainly due to its soft character and easy 
coupling with separation methods.  
For analyzing solid samples, the ion source usually combines both desorption and 
ionization (DI) processes. Currently, there are more than 25 described DI techniques, each 
with their own advantages and disadvantages for specific classes of samples and mainly 
classified into two catalogues. One type is under vacuum and another type, known as ambient 
ionization techniques, operates at atmospheric pressure with minimal sample preparation. As 
one of the two most widely used soft ionization techniques together with ESI, matrix-assisted 
laser desorption/ionization (MALDI) was developed by Franz Hillenkamp, Michael Karas 
and co-workers in 1985.23 Tanaka shared the Nobel Prize of Chemistry in 2002 with Fenn for 
his contribution in ionizing intact biomolecules as large as 34 kDa with MALDI.16,17 
In analytical chemistry, the most recent applications are oriented towards biochemical 
studies, such as proteome, metabolome, drug discovery and metabolism, with the two 
primary ion sources of ESI and MALDI. In this thesis, different analytical methods are 
developed based on ESI and MALDI MS, and therefore the detailed introductions of ESI and 
MALDI will be given in the following parts. 
1.1.2. Matrix-assisted laser desorption ionization 
Since MALDI was introduced in 1988,17 it has become a powerful and widely used 
ion source for analyses of a broad range of large, non-volatile and thermally labile 
compounds such as proteins, oligonucleotides, polymers and large inorganic molecules. This 
method is characterized by high throughput, easy sample preparation, high tolerance to 
contaminations, soft ionization of intact molecules with little fragmentation, and giving 
mainly singly charged ions. Therefore, it has been widely applied for polymer science, 
biochemistry, microbiology, and medicine development.  
1.1.2.1 Principle  
The MALDI process involves two steps, co-crystallization of sample and matrix, laser 
irritation induced sample desorption and ionization. The sample to be analyzed is deposited 
on a conductive plate together with proper matrix solutions for crystallization. To obtain a 
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homogeneous sample distribution and geometry, the most commonly used methods for 
sample preparation include the dried droplet method, thin layer method, and sandwich 
method with a matrix to analyte ratio of 1000:1 or larger.18 The analyte molecules are 
embedded throughout the matrix so that they are mostly isolated from one another. The 
matrix plays an important role in sample co-crystallization and strong optical absorption in 
ultraviolet (UV) or infrared radiation (IR) range.19 Matrices employed for MALDI are 
normally small organic species and suitable matrix is determined to some extent by trial and 
error. Some common matrices such as 2,5-dihydroxybenzoic acid (DHB), α-cyano-4-
hydroxy-transcinnamic acid (CHCA), and sinapic acid (SA) are particularly suited to nitrogen 
(337 nm) and Nd-YAG lasers (355 nm).20 
 
Figure 1.1. Schematic representation of a MALDI source in positive ionization mode. Figure adapted 
from “ Mass Spectrometry: Principles and Applications”, 3rd edition, de Hoffmann et al., John Wiley 
& Sons Ltd. © 2007. 
The second step occurs under vacuum conditions in the MALDI source and combines 
photo-ablation and photo-ionization, as shown in Figure 1.1. Upon intense laser irradiation 
over a short duration, a photochemical process takes place and its exact mechanism is not 
completely elucidated.21,22 The rapid heating of sample crystals through laser irradiation-
induced excitation of matrix molecules causes localized sublimation of matrix crystals 
entraining intact analytes into the gas phase.23 During this process, when and how the ions are 
produced are still not fully understood.19,24 The most widely accepted mechanism suggested 
that the ionization happened through proton transfer from matrix molecules in solid sample 
crystals before desorption or from photo-ionized matrix molecules in the gas-phase plume.   
MALDI is a high frequency pulsed ion source and produces mainly singly charged 
Red 
Ox 
V 
M
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Chapter Ⅰ: Introduction 
 
4 
ions with large values of m/z. The analyzer of time of flight (TOF) is fast, theoretically not 
limited by m/z values and thereby very suitable for MALDI.25 The gas phase ions in MALDI 
are extracted and accelerated towards the field-free TOF tube under a constant electric field 
between the plate and the detector. The counter ions are driven back to the target plate under 
the electrostatic field. The initially obtained velocities of ions are reversely related with m/z 
values and determine the total time taken to reach the detector after passing through a known 
length of TOF tube. By measuring the time of flight, m/z values of ions could be easily 
obtained. The most important drawback of a TOF analyzer is poor resolution, which is 
proportional to the flight path and time. To improve the mass resolution, two important 
strategies were developed by reducing the kinetic energy spread with delayed pulsed 
extraction26 or an electrostatic reflector27 to increase the path length. In a delayed pulsed 
extraction mode, the ions with same m/z values but different energies could be separated in 
the field-free region. The initially less energetic ions receive more kinetic energy and join the 
initially more energetic ions at the detectors. While with a reflectron TOF, the kinetic energy 
spread could be reduced by creating a retarding field behind the field-free region. The ions 
with more kinetic energy will penetrate the reflectron more deeply for a longer time inside 
and thereby reach the detector at the same time as slower ions with the same m/z. 
1.1.2.2 Quantification  
Quantitative analysis with MALDI was considered as improbable due to the low shot-
to-shot reproducibility and strong dependence on sample preparation process. There is a poor 
correlation between uncorrected signal intensity and analyte amount. But, there are still 
several ways to optimize the experiment conditions and design experiments that allow for 
meaningful quantitative comparisons by MALDI.28 For relative quantification, a fixed 
amount of internal standard with similar chemical or physical properties as the analyte of 
interest was added into samples and the relative peak intensity or area of an individual 
analyte to the internal standard is calculated. To obtain the absolute amount of analyte in a 
sample, a calibration curve requires to be constructed with a constant amount of the internal 
standard and varying amounts of a single specific analyte of interest. Consequently, the 
constant of proportionality for one analyte can be deduced to convert the ion intensity ratios 
to absolute amounts of analytes. When the matrix is rather complex or highly variable 
between samples and the analyte exists in a low abundance, known amounts of the standard 
analytes are added to assist the establishment of the calibration curve. The utility of an 
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internal standard is not necessary for a sample giving a mass spectrum with quite constant 
relative signal intensities. In this case, a method called profile analysis is utilized to obtain 
useful information from the changes of relative signal intensities between similar samples. 
The differences of mass spectra between distinct populations could be examined reproducibly 
by using classification algorithms and this method has been commonly applied for MALDI 
protein profiling.29–31 
1.1.2.3 LDI-MS signal amplification with mass barcodes 
The analysis sensitivity and mass accuracy with laser desorption ionization (LDI)-MS 
are greatly depending on analyte type, concentration and sample complexity. The limits of 
detection (LODs) of peptides and proteins with MALDI-MS are in practice somewhere 
between femtomoles and picomoles.32,33 The nucleic acids (DNA or RNA) are not so easy to 
be analyzed because of easy fragmentation and strong bonds between phosphodiester group 
and alkali metal atoms. In clinical diagnostics, the abnormal expression of an early stage 
disease-related biomarker is normally at an ultralow level in rather complex biofluids, which 
makes the direct LDI-MS identification challenging. Thus, many efforts have been devoted to 
concentrate the targets specifically and apply LDI-MS signal amplification strategies to 
realize the ultrasensitive and even single-molecule detection.  
Instead of detecting targets, a surrogate molecule, namely mass barcode here, is 
designed, grafted onto a surface in a large excess amount over the target analytes, and applied 
for different applications with LDI-MS.34,35 With the development of nanotechnology and 
nanoscience, nanomaterials hold great promise in signal amplification as carriers for high 
loading of mass barcodes, due to the large surface-to-volume ratio and easy synthesis. 
Among various nanomaterials, gold nanoparticles (AuNPs) are widely used due to the strong 
UV energy absorption, size and morphology-controlled synthesis, good biocompatibility, and 
easy modification of biomolecules for targeting.36 
Alkanethiols are the most widely used mass barcodes to date because they can be 
detected easily by LDI-MS and synthesized conveniently with unique structures and distinct 
masses.37,38 Besides, several polyethylene glycol units (PEG, -CH2CH2O-) could be 
incorporated into mass barcodes, acting as surfactants to reduce unspecific adsorption of 
analytes onto AuNPs. The mass barcodes could be readily attached to AuNPs through the 
formation of stable gold-thiol bonds, which could be cleaved efficiently upon laser irradiation. 
To improve the desorption/ionization efficiency of mass barcodes, some matrices, such as 
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1,5-diaminonaphthalene (DAN) or CHCA were added and proved to have a signal 
enhancement.35,39  
 
Figure 1.2.  Mass barcoded AuNPs and AuMPs for DNA sensing on different surfaces: (a) silica 
wafer chip, (b) gold chip, and (c) magnetic beads. Figure (a) from Angew. Chem. Int. Ed., 2008, 47, 
5009-5012; figure (b) from Analytical Biochemistry, 2013, 434, 199-201; figure (c) from Talanta, 
2011, 85, 1698-1702. 
The mass barcoded AuNPs (Mb-AuNPs) could be applied for different purposes, 
including biosensing and tissue imaging. Qiu et al. demonstrated the use of Mb-AuNPs to 
amplify the LDI-MS signals from DNA hybridization events on biochips or magnetic beads, 
as shown in Figure 1.2(a) and (c).40,41 Firstly, AuNPs were tagged with mass barcodes of 
alkanethiols as well as probe DNA strands. Capture DNA strands were covalently 
immobilized on a silica wafer chip or magnetic beads and then hybridized with target DNA 
strands, followed by washing to remove free target DNA. Next, hybridization of probe DNA 
on AuNPs with the overhanging target DNA sequence caused AuNPs to be captured on the 
chip. A single DNA binding event led to the detection of multiple mass barcodes directly on 
the biochip or in the elutant from magnetic beads with LDI-MS, which therefore provided 
LODs of DNA as low as 100 pM on biochips or 1 fM on magnetic beads. Multiplex DNA 
assays could also be realized using various mass barcodes with different numbers of PEG 
units. Similarly, Yeo et al. used larger Au microparticles (AuMPs), 2 μm in diameter, to load 
more mass barcodes (Mb-AuMPs) and lowered the LOD of a microRNA to 1 fM on a gold 
chip, in Figure 1.2(b).42 
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Figure 1.3. Mass barcoded AuNPs for protein assays on gold plates: (a) Au microparticles were used 
to futher enhance signal amplification effect; (b) relative quantification of proteins from cell lysates; 
(c) protein isolation with aptamer functionalized Mb-AuNPs from human serum or cell lysates. Figure 
(a) from Angew. Chem. Int. Ed., 2008, 47, 9518-9521; figure (b) from Chem. Commun., 2014, 50, 
4831-4834; figure (c) from Anal. Chem., 2016, 88, 6767-6772. 
Coupling Mb-Au particles with LDI-MS can provide the protein analysis over a wide 
m/z range with a good sensitivity. Yeo et al. also applied Mb-AuMPs for protein analysis in a 
sandwich assay format on a gold plate, in Figure 1.3(a).43 The LOD was as low as 1 aM with 
a wide dynamic range from 1 aM to 1 pM. For the quantification purpose, deuterium-
substituted Mb-AuNPs were deposited together with captured AuNPs probes as internal 
standards.44,45 With this approach, two protein biomarkers from cell lysates were quantified 
successfully, in good agreements with western blotting results, in Figure 1.3(b).45 For the 
target proteins with two affinity ligands of aptamers, a similar sandwich assay could also be 
formed to isolate the targets specifically. With this principle, thrombin and epithelial cell 
adhesion molecule (EpCAM) in human serum or cell lysate were detected with a superior 
sensitivity over the traditional enzyme-linked immunosorbent assay (ELISA), in Figure 
1.3(c).46 
Besides the bioassays, the surface functionalized AuNPs also hold great potential for 
drug delivery through efficient cellular uptake. Rotello’s group demonstrated a series of cell-
related applications with surface modified AuNPs. The cellular uptake or distribution of 
AuNPs can be tracked through the detection of mass barcodes by LDI-MS,47,48 as shown in 
Figure 1.4(a) and (b). The characteristic mass barcode MS signals allow side-by-side 
comparisons of cellular uptake efficiencies of AuNPs with different surface chemical and 
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physical parameters. In one set of experiments, the uptake of four different Mb-AuNPs by 
mammalian kidney cells was simultaneously identified and quantified at levels as low as 30 
pmol.49 Multiplex imaging of different Mb-AuNPs in tissues could also be performed with 
LDI-MS imaging (LDI-MSI) by the same group.50 With the inkjet printing technique, the 
Mb-AuNPs could be used as the security inks to print patterns that should be profiled only 
through LDI-MSI, which provides great potential for a wide range of anti-counterfeiting 
applications, as shown in Figure 1.4(c).51 
 
Figure 1.4. Mass barcoded AuNPs for cell applications with LDI-MS and MSI: (a) identification and 
quantification of Mb-AuNPs uptaken by cells; (b) LDI-MSI of multiplex Mb-AuNPs in tissues; (c) 
LDI-MSI of printed patterns with Mb-AuNPs as inks. Figure (a) from ACS Nano, 2016, 10, 6731-
6736; figure (b) from J. Am. Chem. Soc., 2013, 135, 12564-12567; figure (c) from Chem. Commun., 
2012, 48, 4543-4545. 
Other than polyethylene glycol molecules, plasmid-expressed peptides on AuNPs52 or 
gold cluster ions themselves generated by LDI-MS have also been reported as mass barcodes 
for bioassays,53 heavy metal ion detection,54 bacteria and tumor cell detection, or tissue 
imaging.55  
1.1.3. Electrospray ionization 
In the late 16th century, the Taylor cone formed by a water droplet in the presence of 
an electric field was observed by Gilbert,56 which was clearly related to electrosprays. The 
electrospray process was described by Nollet57 in 1750 and then pictured for the first time by 
Zeleny58 in the early 20th century. Although the electrospray of gas-phase polystyrene ions 
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and their subsequent detection by MS were first reported by Dole in 1968,12 it was only in the 
1980s that electrospray was established as a powerful technique to softly ionize biological 
macromolecules for MS analyses by Fenn13 and Aleksandrov59 and came to be 
commercialized. Since then, electrospray has become an essential ionization technique for 
proteomics study mainly due to its soft character and easy coupling with separation methods. 
1.1.3.1 Principle  
The exact mechanism of ESI has been studied theoretically and experimentally.60,61 A 
typical ESI process operated in a positive mode is depicted generally in Figure 1.5. When a 
potential difference is applied between an electrode in solution flowing through a capillary 
and a counter-electrode, e.g. mass spectrometer placed in the air outside facing the capillary 
outlet, the solution/air interface at the capillary tip is polarized into a shape of Taylor cone,11 
resulting from the balance between the electrostatic pressure of 
?? ?
??
???????? 
where ε0 is the permittivity of vacuum, q is the charge on the droplet and r is its radius, and 
the Laplace pressure of  
?? ? ? ? ? 
where ? is the surface tension of the liquid. If the applied voltage is sufficiently high, charges 
will greatly accumulate up to a point until PE is larger than PL.61 The tip of the Taylor cone 
becomes unstable, leading to the spray of individual charged droplets into gas phase. The 
onset voltage (Uon) of electrospray can be obtained as: 
??? ?
?? ?????
??? ? ??
??
?  
where 49o is the half-angle of the Taylor cone,11 d is the distance between the emitter tip and 
MS inlet.62 From this equation, the onset voltage could be reduced by using a smaller ESI 
emitter, a shorter distance between emitter tip and MS inlet and solvents with lower surface 
tensions. Organic solvents, e.g., methanol, acetonitrile and propanol are routinely added into 
aqueous samples for efficient ESI-MS analysis. 
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Figure 1.5. Classical electrospray ionization process. Figure from Annu. Rev. Anal. Chem., 2010, 3, 
231-254.  
Once in the gas phase, the PE of the charged droplets is increasing to an upper limit, 
which is known as the Rayleigh limit and reached when PE equals PL, due to the solvent 
evaporation. When the charge is larger or the radius is smaller, the droplets will break up to 
form smaller charged droplets continuously until the gas-phase ions are generated.  The 
formation process of gas-phase ions is usually explained by two theories, the charge residue 
model (CRM) proposed by Dole12,63 and the ion evaporation model (IEM) by Iribarne and 
Thomson.64 The CRM suggests that the solvent evaporation and droplet fission events repeat 
constantly until only one charged analyte molecule remains in a droplet. The IEM considers 
that when the radius of charged droplets reduces to be smaller than 10 nm, the small ions can 
be directly evaporated or ejected out of the droplet. Nevertheless, it’s generally accepted that 
both models regulate the formation of gas-phase ions, where CRM produces mainly large 
ions while IEM contributes the generation of small ions. The ions then enter the MS inlet and 
are eventually detected by the MS analyzer, providing a spectrum of m/z peaks.    
1.1.3.2 Micro/nano-electrospray ionization: principle  
Since Smith et al. found the detection sensitivity could be markedly increased at a 
lower flow rate down to 200 nL/min,65 the concept of micro-electrospray was introduced by 
Emmett and Caprioli one year later.66 The capillary needle was packed with C18 for liquid 
chromatography and optimized by HF etching to be 50 μm in inner diameter, which allowed 
the flow rate as low as 300 nL/min and yielded picomole per liter sensitivity for peptides and 
nanomole per liter sensitivity for proteins.  
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In the same year, a theoretical model was established by Wilm and Mann to explain 
the advantage of micro-electrospray ionization (microESI) and an equation was drawn to 
predict the proportionality between the two-thirds power of the flow rate and the size of the 
emission zone at the Taylor Cone tip from which smaller charged droplets are ejected, as 
following: 
r?= ?
4π2? tan π2 -?
Ua
UT
2
-1
1 3
× dV dt 2 3 
where r is the radius of the emission region at the Taylor Cone tip, ? is the surface tension of 
the liquid, ??refers the liquid cone angle (for the classical Taylor Cone model ? = 49.3?), ? is?
the liquid density, UT and Ua present the threshold voltage and applied voltage respectively, 
and dV/dt means the flow rate.61  
This formula provided guidance for the construction of a more sensitive ionization 
source and they verified this model experimentally with a modified ion source for microESI. 
To allow small flow rates and thus decrease r, a gold-coated glass capillary with an opening 
diameter of 1-3 μm at the tip was constructed to obtain a stable electrospray. They operated 
the analysis at a very low flow rate less than 25 nL/min to really achieve nano-electrospray 
ionization (nanoESI) and obtained an excellent sensitivity with an overall ion transmission 
efficiency of 8 × 10-4.61 Nowadays, the microESI refers to the flow rate between 100 to 1000 
nL/min, while nanoESI operates at a far slower flow rate less than 100 nL/min.67,68  
The ionization efficiency can be generally determined by the specific surface charge, 
which means the surface charge number per unit amount of analytes obtained when the 
Rayleigh limit is reached for every initial droplet emitted from the Taylor Cone, according to 
the equation of: 
surface charge number
sample amount
 = 
4πr2σ
4
3 πr
3C
 = 
3σ
rC
 = 6
γε0
C
1
r3 2
 
where σ is surface charge density, ε0 is vacuum permittivity, r is the radius of the initial 
charged droplet, γ refers to the surface tension of the liquid and C presents the analyte 
concentration.  
A larger proportion of analyte molecules could be ionized for MS detection when the 
initial droplets are smaller. Also, the smaller primary droplets need fewer steps to shrink 
through evaporation, undergo Coulomb fission and finally form gas phase ions. All these 
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factors make nanoESI more sensitive than traditional MS and microESI. The strong ion 
suppression is a common phenomenon when analyzing complex samples with a high 
concentration of surface-active molecules by conventional MS. However, the problem could 
be alleviated evidently by nanoESI, which is presumably due to the higher ionization 
efficiency of analytes. 
Besides the high ionization efficiency and high tolerance to contaminants, the rather 
low flow rate would in itself be beneficial by providing a long measurement time with a tiny 
amount of sample. This extremely economic sample consumption makes nanoESI very 
suitable to couple with separation methods for proteomic or metabolic studies with a limited 
volume of complicated biosamples. 
1.1.3.3 ESI-related ambient ionization techniques 
 
Figure 1.6. Various ESI-derived ambient ion sources: (a) ESI for desorption ionization; (b) ESI for 
post-ionization after laser-induced desorption of samples from surfaces; (c) ESI from a surface 
sampling probe with a liquid microjunction; (d) ESI from a solution sampling probe with a stainless 
needle. Figure (a) from Science, 2004, 306, 471-473; figure (b) from Annu. Rev. Anal. Chem., 2010, 
3, 43-65; figure (c) from Anal. Chem., 2002, 74, 6216-6223; figure (d) from Rapid Commun. Mass 
Spectrom., 2007, 21, 3139-3144. 
The advent and development of ambient ion sources went back to one decade ago and 
were to retain the highly specificity while greatly reducing the complexity of sample 
preparation or operation to improve the analysis speed and simplicity, which especially 
benefit the in-situ analysis and could find many applications in forensic analysis or clinical 
diagnosis. Combining ESI and different sampling strategies, ambient ionization can be 
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achieved through a one-step “desorption/extraction ionization” or a two-step 
“desorption/extraction and then ionization” procedure.  Depending on these criteria, various 
ESI-derived ion sources could be classified into three types, ESI for desorption ionization, 
ESI for post-ionization and ESI directly from sampling probes, and summarized as follows. 
ESI for desorption ionization. Integrating desorption and electrospray ionization in 
one step, desorption electrospray ionization (DESI) has been developed by Cooks et al. in 
2004.69 Figure 1.6(a) presents a conceptual diagram of DESI for surface sample analysis, 
where charged droplets generated by ESI were directed onto a sample surface with the 
assistance of a high-pressure sheath gas for desorption and ionization. The analyte-pickup 
process involves initial wetting of the surface to dissolve analytes and then projection of 
subsequent droplets resulting in the emission of secondary charged microdroplets containing 
analyte molecules.70–72 Because of the lack of sample pretreatment in principle, DESI holds 
the advantage in in-situ surface analysis, including the imaging of intact biological tissue and 
detection of active ingredients in tablets, industrial polymers, peroxide-based explosive 
chemicals and warfare agents, untreated bacteria cultures, alkaloids in plant tissues and so 
forth.73–78 In-situ analyses by DESI often require the development of portable mass 
spectrometers for a variety of public safety applications. 
ESI for post-ionization. In these techniques, a sample spray or plume was generated 
and then delivered into an ESI plume for analyte molecule extraction and post-ionization. 
Different strategies, including thermal evaporation, pyrolysis, pneumatic or ultrasonic 
nebulization, laser desorption, or laser-induced acoustic desorption, have been applied to 
assist the generation of a sample spray or plume. 
The fused-droplet ESI (FD-ESI) technique was developed to characterize large 
analytes, such as peptides and proteins.79 A probe nebulizes the aqueous sample solution 
ultrasonically or pneumatically in the absence of high voltage to form fine mists, which are 
then conducted into the ESI plume. The polarities of the solutions used to produce the sample 
mists and the ESI droplets should be close so that they can fuse efficiently. Because of the 
sample fusion process, the salt tolerance of FD-ESI is much higher than in conventional ESI 
analyses.80,81 Similarly, a method named extractive electrospray ionization (EESI) was 
developed in Cooks’ group for online droplet-droplet extraction followed with MS detection. 
It is useful for characterizing both volatile and nonvolatile compounds and has been used to 
analyze urine, serum, milk, perfume and so forth.82–84 Analytes can also be desorbed by 
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blowing the solid sample surface with heated gas stream for subsequent ionization in the ESI 
plume. This technique is known as neutral desorption extractive ESI and the desorbed analyte 
molecules can be transported efficiently over distances greater than 1m for remote analysis. 
Volatile components have been detected from human breath and other biological samples.85,86 
Various laser irradiation-assisted ESI techniques were developed, such as 
electrospray-assisted laser desorption ionization (ELDI)87 and laser-induced acoustic 
desorption/electrospray ionization (LIAD-ESI),88 as shown in Figure 1.6(b). For ELDI, the 
analyte molecules are desorbed by irradiating the sample surface with the pulsed UV laser 
and are then positioned in an ESI plume for ionization. A related technique named liquid 
ELDI-MS was also developed to characterize chemicals or monitor (bio)-chemical reactions 
directly from solutions by adding small amount of fine carbon powders into the solution to 
adsorb laser energy.89 Several other similar ionization methods, including matrix-assisted 
laser desorption electrospray ionization (MALDI-ESI)90 and laser ablation electrospray 
ionization (LA-ESI)91 with an IR laser, were subsequently developed. Additionally, a heated 
stream of high-velocity N2 gas or acoustic waves generated by laser irradiation in LIAD-ESI 
can thermally evaporate or mechanically desorb analyte molecules into the ESI plume for 
further ionization. 
ESI from sampling probes. Different from desorbing or extracting analytes sampled 
on a surface into an ESI plume for ionization, a direct sampling/ionization method becomes 
increasingly popular by performing ESI directly with the sampling probes as emitters, which 
avoids desorption/extraction steps and thus further accelerates the analysis speed. The 
original or modified sampling probes are usually sharp in tip and the sampled analytes on the 
probes could be directly sprayed into gas phase ions by delivering solutions and applying a 
high voltage to the conductive-coated probes. 
Several direct sampling/ionization techniques have been developed and differ in 
sampling probes. The direct electrospray probe (DEP) method developed by Shiea et al. 
generates electrospray from a sample droplet pre-deposited on a small metal ring subjected to 
a high voltage, which is useful for rapid analysis of dirty samples or of samples only 
available in extremely small volumes.92 Afterwards, several different solid probes, including 
copper wires, optical fibers, graphite fibers coiled with a copper or platinum wire, a glass rod 
and a nanostructured tungsten oxide surface, have been introduced.93,94 Based on DEP, probe 
electrospray ionization (PESI) method was further developed by applying a stainless needle 
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with a diameter of 4 μm to pick up as little as 4 pL of sample solutions on a surface 
automatically through a motor-driven motion followed by ESI process, in Figure 1.6(d).95  
 
Figure 1.7. Different sampling probes for ESI: (a) Needle biopsy on tissue for direct ESI; (b) High-
throughput paper spray-MS Platform; (c) Leaf for direct ESI; (d) Wetted ginseng tissue for ESI. 
Figure (a) from Anal. Chem., 2011, 83, 9221-9225; figure (b) from Clin. Chim. Acta., 2013, 420, 28-
33; figure (c) from Anal. Chem., 2011, 83, 7608-7613; figure (d) Rapid Commun. Mass Spectrom., 
2011, 25, 2837-2843.  
To sample solid analytes on a surface for direct ionization, another kind of efficient 
probe called surface-sampling probe (SSP) has been developed for the in-situ surface 
analysis, where a liquid microjunction is formed between the probe and surface to extract 
soluble chemicals and then delivered into an integrated ESI emitter for subsequent MS 
analysis, shown in Figure 1.6(c).96,97 Recently, a paper spray was introduced for MS analysis 
of dried blood spot (DBS) on a triangular section of chromatography paper by Cooks’ 
group.98 After being wetted by a mixture solution of methanol and water, the wet paper was 
applied with a high voltage to induce ESI at the triangular tip. A high-throughput device with 
multiple angles for loading multiple samples was developed by Ouyang et al. to achieve a 
relatively fast analysis speed of 7 s per sample, in Figure 1.7(b).99 Analogous to paper spray, 
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several other probes, such as leaf,100 wooden tip,101 tissue,102 and biopsy needle103 could also 
induce ESI and find a wide range of applications in blood, drug and food safety, as shown in 
Figure 1.7(a), (c) and (d). 
1.1.4. Electrostatic spray ionization: principle 
In traditional ESI-MS, a direct current high voltage is applied between an electrode 
contacting the solution in a microchannel or a capillary and the mass spectrometer. Recently, 
Cooks et al. have reported a contactless method to generate a pulsed spray.104,105 A pulsed 
high voltage waveform was applied on an electrode 2 mm away from a nanospray emitter to 
induce voltage inside the emitter. Similarly, Zhang et al. have used alternating current high 
voltages to perform a contactless spray, where the charge states of peptides were 
controllable.106 In comparison with classical ESI, the high voltage was not directly applied to 
the sample solution, and no electrode reaction could occur, which is an advantage when 
electrochemical reactions during conventional ESI need to be avoided.  
Herein, Girault’s group developed a contactless pulsed spray technique named as 
electrostatic spray ionization (ESTASI) and comprehensively investigated its working 
mechanism, which is of interest for the development of new ambient ionization techniques 
and for opening up a wide range of applications for mass spectrometry analysis.107 Sample 
solution will be deposited as a droplet on an insulating substrate. A disc electrode is placed 
behind the substrate and against the MS inlet. The droplet position on the substrate is 
precisely adjusted to be always in line with the electrode and MS inlet. A pulsed high voltage 
will be generated by amplifying square wave voltage pulses with a high voltage amplifier and 
applied to the electrode to induce ESTASI. The electrical setup is equivalent to two 
capacitors in series, as described previously in Figure 1.8. One capacitor is composed of 
electrode-insulating substrate-sample droplet. Another capacitor is at the tip of Taylor cone 
and is sample solution-air-mass spectrometer. The charging-discharging process of these two 
capacitors will induce ESTASI. When the voltage is at maximum, the positive charge will 
accumulate at the tip of spray emitter to the Rayleigh limit. When the electrostatic pressure is 
increasing and larger than the surface tension due to the solvent evaporation, the positive 
charged droplets will break up into smaller droplets continuously until the gas-phase ions are 
generated. In this case, the second capacitor can be considered as a leaky capacitor with a 
diode in parallel and cause an excess amount of negative charges remaining in the sample 
solution, which will prevent the continuous spray of positive charge. To alleviate this 
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problem, the square wave voltage value is then transited to 0 to discharge both capacitors and 
induces the spray of anions until the system returns back to be electroneutral, wherein the 
first capacitor acts as the power supply. Alternating electrostatic spray of cations and anions 
can be realized by repeating the charging-discharging process. 
 
Figure 1.8. Equivalent circuit of the ESTASI during the charging-discharging process. Figure from 
Anal. Chem., 2012, 84, 7422-7430. 
 ESTASI has been successfully demonstrated with different geometries including 
polymer coated silica capillaries, disposable plastic micropipette tips, polyimide microchips, 
polyacrylamide gel strip, and tissues.107–109 Because of its very convenient connection with 
many analytical techniques, ESTASI-MS is ideally suited for bioanalytical studies. 
1.2. Selected ESI-MS based applications  
1.2.1. Coupling with separation methods 
1.2.1.1 ESI-MS coupled with separation methods 
In order to analyze a complex mixture, for example biofluids or nature products, a 
separation technique is usually coupled with the MS to reduce the ion suppression effect and 
the complexity of the mass spectrum for easy interpretation. Compared to MALDI-MS, ESI-
MS holds great advantage of easy interfacing to separation systems for liquid sample 
analyses. Chromatography and electrophoresis are the two representative separation methods.  
ESI is by nature very easy to be on-line connected with LC systems with continuous 
flows and has been widely used for bottom-up proteomics, pharmacokinetics and drug 
development.110 In proteomics, the proteins/peptides are first desalted and fractionated by a 
LC system and then online analyzed by MS or tandem MS. The most widely used separation 
modes for LC are reverse phase (RP) and strong cation exchange (SCX). When analyzing 
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high-complicity and large-scale proteomics samples, multidimensional separation is usually 
performed with a 2D LC system combining RP and SCX. Depending on the column diameter 
and the packing particles size, various flow rates could be used ranging from submicroliter 
per minute to milliliter per minute and the separation efficiency or peak resolution could be 
improved by high performance LC (HPLC) or ultra-performance LC (UPLC).111  
 
Figure 1.9. Schematic illustration of the TLC/DESI-MS. Figure from Anal. Chem., 2005, 77, 1207-
1215. 
As another important chromatography technique, thin layer chromatography (TLC) is 
simple, cost-effective, and easy-to-operate for routine separation of non-volatile mixture. MS 
could be interfaced with TLC through a direct or indirect sampling mode. Conventionally, the 
indirect sampling is based on the extraction of compounds from a TLC plate and requires a 
number of labor-intensive and time-consuming processes, including locating, extraction, 
filtration and concentration of the compounds.112,113 While these shortcomings have been 
overcome with the development of ambient ion sources for direct sampling of TLC for MS 
analysis since the late 1960s. Several ESI related ambient ionization methods have been 
widely used for the direct coupling of TLC with MS. Van Berkel et al. exploited the SSP to 
sample organic compounds from TLC plate directly for MS analysis.96 Similarly, Luftmann 
et al. developed a plunger-based extraction device for TLC-ESI MS.97 Various laser 
irradiation-assisted ESI techniques for TLC-MS were developed, such as ELDI114 and LIAD-
ESI.115 In addition, charged or neutral droplets were also used for the direct sampling of TLC 
plates. For example, DESI has already been introduced to couple TLC with MS in 2005, 
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where the charged solvent droplets induced by ESI were directed to a TLC plate at an optimal 
angle to sample and ionize analytes on the plate, in Figure 1.9.116 Today, commercial TLC-
MS interfaces are available from CAMAG (Muttenz, Switzerland)117 and PROSOLIA 
(Indianapolis, IN).118  
As the classical proteomic methodology, two-dimensional polyacrylamide gel 
electrophoresis (2D-PAGE) is a powerful separation tool allowing simultaneous resolution of 
thousands of proteins based on two independent protein characteristics.119 Molecules are 
more effectively separated in 2D electrophoresis than in 1D electrophoresis, where molecules 
are separated linearly through isoelectric focusing based gel electrophoresis (IEF-GE) in the 
first dimension and then separated orthogonally to the first electropherogram according to the 
molecular weight in the second dimension. The protein spots were then stained and extracted 
for MS identification, which were time-consuming and cause sample loss. In 2002, OFFGEL 
electrophoresis was introduced by Girault’s group to separate proteins or peptides according 
to their isoelectric points and collect the separated components in liquid fractions for LC-MS 
analysis, making sample recovery much easier than with traditional gels.120 OFFGEL 
electrophoresis has been commercialized by Agilent Technologies since 2006, named as 
OFFGEL 3100 fractionator.121  
Another typical electrophoresis-based separation technique for MS coupling is 
capillary electrophoresis (CE) due to its fast speed, high resolution and small sample 
volume.122 Coupling CE with ESI is not so easy as LC due to the mismatches of flow rate and 
electric current. CE applied a higher voltage than that in ESI, therefore the CE current must 
be decoupled from ESI by grounding the ESI emitter to avoid the electrical current mismatch. 
The commercial interface from Agilent applies a high voltage inside the MS whilst grounding 
the ESI emitter tip, making it easier to decouple the CE current from ESI. To avoid the 
necessary sample dilution for MS analysis with conventional ESI source, the nanoESI is ideal 
to couple with CE since the flows in CE are typically in the range of nanoliters per minute.  
1.2.1.2 ESTASI-MS coupled with separation methods 
The ESTASI-MS cannot only analyze liquid droplets on a flat surface, but also dried 
samples deposited on a surface or inside a porous matrix, where the latter needs to drop an 
acidic solution to the substrate to dissolve or extract samples for ESTASI. Therefore, 
ESTASI has been used as an interface between MS and various separation techniques, such 
as CE and IEF.107,109 After CE separation, the fractions were directly collected on an 
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insulating polymer plate. After drying all the droplets, the polymer plate was placed between 
the electrode and MS inlet. A droplet of an acidic buffer was deposited on each sample spot 
to dissolve the samples for ESTASI-MS detection. 
ESTASI-MS has also been adapted to IEF-GE, where an immobilized pH gradient 
(IPG) strip containing fractions of proteins or peptides and supported on a thin piece of 
insulating polymer layer was placed in front of the MS inlet, as shown in Figure 1.10. Upon 
the application of acidic buffer and a high voltage pulse, the samples under the very acidic 
droplet can be positively charged and extracted from the gel to the droplet by the electric 
field. This droplet sprayed into charged microdroplets when the electrostatic pressure of the 
droplet was larger than the Laplace pressure. This direct coupling of ESTASI-MS with IEF-
GE improves the detection sensitivity and demonstrates a more powerful method compared 
with the classic methods for the proteins or peptides analysis. 
 
Figure 1.10. Schematic representation of ESTASI-MS coupled with IEF-GE. Figure from Anal. 
Chem., 2013, 85, 4745-4752. 
1.2.2. Coupling with microtiter plates 
High-throughput screening (HTS) is a powerful method for scientific 
experiments, especially used in drug discovery and biochemical or biological research, which 
allows conducting millions of chemical, genetic, or pharmacological tests within a single run 
analysis and improving analysis efficiency greatly.123,124 The key labware or testing vessel of 
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HTS is the microtiter plate with multiple wells as small test tubes and widely used for 
combinatorial chemistry and drug development. Coupled with MS, accurate qualification and 
quantification could be obtained for different applications of enzymatic assays, inhibitor 
screening assays and drug metabolism assays.125  
A liquid transfer system is normally required to probe samples with a capillary in 
Figure 1.11(a),126 or with an autosampler from the microtiter plates for MS analysis, such as 
the commercial TriVersa NanoMate by Advion,127 where the fractions of LC are collected in 
a microtiter plate and then an ESI chip aspirates the sample liquid for later analysis by 
nanoESI-MS. To overcome the disadvantage of low throughput with the single probe 
autosampler, a multi-probe autosampler was developed by Kassel et al. to greatly shorten the 
total analysis time of a whole 96-well plate from 48 min to 12 min.128 Later on, the analysis 
time of a 96-well plate was further reduced to 5 min by Morand et al.129 Though the 
improved throughput with the multi-probe autosampler, the cross contamination between 
wells is inevitable and washing steps are necessary when transferring the sample from one 
well to another. To overcome this shortcoming, avoiding using auto-samplers is another 
option, wherein each well on a microtiter plate was modified and integrated with an ESI 
emitter, such as disposable micropipette tips in Figure 1.11(b).130 
 
Figure 1.11. MS coupled with microtiter plates. (a) Direct-infusion with a capillary from microtiter 
plates for ESI-MS analysis; (b) Microtiter plates modified with multiple pipette tips for high 
throughput solvent assisted inlet ionization (SAII) MS analysis. Figure (a) from Anal. Chem., 2001, 
73, 1449-1454; figure (b) from Anal. Chem., 2014, 86, 1000-1006. 
1.2.3. Coupling with microfluidics : interface 
Microfluidic chip or so called “Lab-on-chip” has been greatly used in analytical and 
bioanalytical chemistry since the introduction of microfluidics in the beginning of 1980s. It 
refers to a miniaturized analytical device that integrates multiple functions on a single chip to 
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process fluids constrained to a microscale and thus shows advantages of low sample 
consumption, reduced analysis time, high throughput and potential for automation and 
portability. Compared with various detection methods based on spectroscopy and 
electrochemistry, MS provides label-free, sensitive and high throughput characterization of 
analyte and thus becomes an essential detection tool in microfluidic-based bioanalysis. 
Compatible with low sample consumption in microfluidics, micro/nanoESI is an ideal MS 
interface for integration with microfluidic chips as it provides good detection sensitivity at 
nanoscale flow rates. 
Three types of interfacing approaches have been developed for coupling microfluidic 
chips with micro/nanoESI-MS and presented in Figure 1.12.131 The simplest way is to spray 
directly from chips and such an interface was firstly reported in 1997 with a chip containing 9 
microfluidic channels.132 The performance of direct electrospray from microchannel is 
limited by the eluent spreading due to the hydrophilic and blunt edge of the glass chip. To 
prevent liquid spreading, the channel exit could be chemically treated to be more 
hydrophobic.133  
 
Figure 1.12. ESI for coupling microfluidic chips with MS from: (a) a blunt-end chip, (b) an attached 
emitter, and (c) an integrated emitter. Figure from J. Mass. Spectrom., 2009, 44, 579-593. 
An alternative interfacing approach is to spray samples from an external emitter 
attached onto the chip channel.134 A fused silica capillary pulled to a fine point is typically 
inserted into or glued to a microfluidic chip for sample infusion and micro/nanoESI.135 
However, the device was usually limited to continuous sample infusion and suffered from 
difficulties in alignment. A drilling procedure with a 200 μm tungsten carbide bit was 
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developed to make a hole for emitter attachment with a low dead volume connection between 
the emitter and microfluidic chip.136 Sub-attomole detection limits for peptides was reported 
by inserting a nanospray tip of 5 μm in i.d. into a hole perpendicular to the cover of the 
chip.137 Liquid junctions could also realize the connection between a removable emitter and 
the microfluidic chip and was maintained with a maker-up buffer between the on-chip CE 
channel and emitter.138 Although being simple and stable, the attached emitters cause dead 
volumes and deteriorate on-chip separation performance. 
 
Figure 1.13. ESI for coupling microfluidic chips with MS from integrated emitters of: (a) a graphite-
coated PDMS microchip tip, (b) a 96-capillary array, (c) a platform with 60 silicon microchip tips, 
and (d) nib-like tips fabricated using the negative photoresist SU-8. Figure (a) from Electrophoresis, 
2005, 26, 4674-4683; figure (b) from Anal. Chem., 2011, 83, 6082-6089; figure (c) from Lab Chip, 
2011, 11, 3011-3014; figure (d) from Electrophoresis, 2003, 24, 3640-3647. 
Instead, microfabricated emitters can be integrated on microfluidic chips with a 
precise and reproducible microfabrication procedure to avoid the dead volume and make the 
interfacing simpler and laborless. As examples in Figure 1.13(a) and (d), integrated emitters 
have been constructed on a large variety of substrates, including polydimethylsiloxane 
(PDMS),139 polycarbonate (PC),140 polyethylene terephthalate (PET),141 poly(methyl 
methacrylate) (PMMA),142 polyimide (PI),143 SU-8,144 as well as silicon and glass.145,146 Two 
multi-nozzle emitter array chips were developed for monolithic integration of SiO2-based 
multi-nozzle emitters with microfluidic channels, as shown in Figure 1.13(b).147 A wafer-
scale microfluidic platform with 60 identical micropillar emitter arrays was constructed and 
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fixed on a computer controlled rotating table in front of an MS analyzer to realize high 
throughput MS analysis of 60 samples in 8 min, as shown in Figure 1.13(c).148 A commercial 
device (Agilent, CA) has also been developed using a multilayer PI chip with an integrated 
spray tip formed by laser ablation.149,150  
Girault’s group has a long history in fabricating microfluidic chips by laser ablation 
since 2001 and hyphenating them with ESI-MS.141,151 The microchip could work as both a 
microreactor and an ESI emitter at the channel exit. Contrary to the PET-based chip, the 
wetting problem at the flat edge of the channel is easily eliminated by using PI as the chip 
substrate and cutting it into a pointed tip as an emitter. Various functional microfluidic chips 
have also been developed to realize many types of applications, e.g., tagging of cysteine and 
phosphopeptide,152 protein desalting with an on-chip PVDF membrane,152 micro-mixing153 
and on-chip reaction studies, including binding of Cu2+ to β-amyloid,154 tyrosine nitration,155 
and oil-water interface reactions.156 Proteins and peptides could be supercharged in the 
Taylor cone sprayed from two adjacent microchannels.157 A microchip with C8 or C18-coated 
magnetic beads trapped in the microchannel has also been designed, namely solid-phase 
extraction-gradient elution-MS (SPE-GEMS), for effective desalting, enrichment, sequential 
elution and ESI-MS detection of peptide mixtures for proteomic studies.158 Later on, C8 or 
C18-coated magnetic beads were replaced by C8-functionalized mesoporous magnetic 
microspheres to selectively enrich and analyze large hydrophobic peptides, matching the 
desired mass bin of the extended bottom-up proteomic approach.159  
 
Figure 1.14. On-chip spyhole coupled with ESTASI-MS for droplet-based microfluidics. Figure from 
Angew. Chem., 2014, 126, 4497-4501. 
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Recently, we have also realized the spray from a “spy hole” on a microfluidic channel 
in a direction orthogonal to the flow stream, in Figure 1.14. Oil/water droplets were 
introduced to the system and high voltage would only be applied when the water droplets 
pass below the spy hole to induce ESTASI-MS for monitoring droplet-based microfluidic 
reactions.160  
1.2.4. Ambient mass spectrometry imaging 
Mass spectrometry imaging (MSI) is a label free and high throughput technique to 
investigate the in-situ spatial distribution of peptides, proteins, biomarkers, or metabolites on 
a surface or in a tissue.161 In a typical MSI process, localized mass spectra are recorded 
sequentially on regular grid points and the spatial distribution is obtained by plotting the 
measured relative intensities of individual m/z data with respect to their local positions.  
 
Figure 1.15. Schematic representation of the setup for ESTASI-MSI. Figure from Anal. Chem., 2014, 
86, 2033-2041. 
The well-developed and commonly used methods in this field are MALDI-MSI and 
SIMS imaging.161,162 In general, MALDI-MSI can reach a spatial resolution of 10 μm, but it 
suffers limitations such as the influence of matrix molecules on the detection in low m/z 
regions and the limited quantitative analysis. In contrast to vacuum ionization MSI, the most 
representative ambient MSI method is based on DESI, which has been applied in imaging of 
both artificial sample surfaces and biological tissues.163,164 The spatial resolution of DESI is 
usually at 180-220 μm, which is limited by the large mist size generated by ESI.165 It has 
been recently reduced to 40 μm under particular operating conditions. Another limitation of 
DESI-MSI is the relatively low sensitivity compared to MALDI-MSI in the analysis of 
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biological tissue with complex matrice conditions. Recently, to exploit the outstanding 
property of ESTASI for in-situ surface analysis, we have recently constructed an ESTASI-
MSI setup to image peptides, proteins and cells distributed on a plastic plate, making it an 
alternative strategy to realize MSI as compared to LDI and DESI. It shows tolerance to the 
presence of salts, provides quantitative analyses with an internal standard, and holds an 
optimized lateral spatial resolution better than 110 μm.166 
The setup used for ESTASI-MSI is illustrated in Figure 1.15.166 The ion transfer 
capillary of MS inlet was modified into an “L” shape to scan a level surface. A disc electrode 
(200 μm in diameter) is placed behind the insulating plate and connected to a pulsed high 
voltage to induce ESTASI. A fused silica capillary was in contact with the sample surface to 
deliver an acidic solution under constant flow rate to dissolve samples from the surface for 
ESTASI MS analysis. The surface to be scanned is fixed on an x, y-stage that is controlled by 
LABVIEW software to move under the ion transfer capillary and fused silica capillary. 
Several important parameters should be optimized to obtain best MS signal, including 
distance between the sample surface and the ion transfer capillary, angle between the fused 
silica capillary and the sample surface, flow rate of the acidic solution and parameters of 
pulsed HV.  
1.2.5. Bottom-up proteomics 
The terminology of proteomics was coined in 1994 and devoted to the large-scale 
study of proteins, including expression, cellular localization, interactions, post-translational 
modifications (PTMs) and turnover as a function of time, space, and cell type.167 
Development of MS-based technologies for peptide/protein separation, detection, 
quantification and bioinformatics data analysis have driven the progress of proteomics.  
To fit the performance and mass range of available MS analyzers, two approaches, 
bottom-up and top-down proteomics, are used for characterizing proteins. Top-down protein 
analysis refers to the characterization of intact proteins and has some potential advantages for 
PTM and protein isoform determination.168 However, gas-phase fragmentation and the 
difficulties in protein fractionation and ionization have limited the wide application of top-
down proteomics. In contrast, bottom-up proteomics is used to identify a protein by analyzing 
peptides obtained from the proteolysis of the protein.169 In a typical experiment, the peptide 
mixture is fractionated and subjected to LC-MS/MS analysis. Peptides are identified by 
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MS/MS through fragmentation and compared to theoretical results of in silico proteolysis. 
Protein inference is achieved by assigning the identified peptide sequences to proteins. 
1.2.5.1 Tandem mass spectrometry 
Tandem MS is a crucial technique in proteome research to determinine peptide 
sequence and structural information by generating numerous fragments of precursor ions and 
could be realized in space, such as TOF-TOF, or in time, such as ion trap. A typical 
procedure of tamdem MS includes first the selection of precursor ions, then the fragmentation 
and finally the scan of fragments. Various methods, e.g., collision-induced dissociation 
(CID),170 electron capture dissociation (ECD),171 electron transfer dissociation (ETD),172 and 
electron-detachment dissociation (EDD),173 could be applied to activate the precursor ions for 
fragmentation.  
Among these techniques, CID is most popular and widely used in quadruple, ion trap 
and time of flight mass spectrometers partly owing to the ease of implementation. Normally, 
b- and y-type ions are generated by CID through two stages. In first stage, the selected ions 
collide with the neutral gas at high speeds and are activated into exicited states by transfering 
the kinetic energy into internal energy. The second stage is unimolecular decomposition of 
the activated ion. CID is an ‘ergodic’ ion activation method and the energy is redistributed 
over the chemical bonds of peptides. Therefore the amide bonds with lowest energy is 
preferencially disscoiated and ions of b- and y-type fragments are generated. The high energy 
CID could cleave the peptide side-chains to produce more types of fragments. Due to the 
removal of side-chains, the main drawback of CID is losing informations of PTM sites on 
peptides. As the complementary technologies, ETD/ECD can generate c, z-fragmentation by 
attracting electrons and keep peptide modifications, thereby suitable for PTM studies. 
Conversely, EDD can induce a, x-fragmentation through the oxidization of the nitrogen on 
the peptide backbone by losing one electron. 
1.2.5.2 Clinical application: sample processing 
The MS-based proteomics is an indispensable tool for clinic use by characterizing 
disease-specific biomarkers from clinical samples, such as plasma and tissues from patients. 
It provides great values for early diagnosis, treatment optimization and progress monitoring 
during treatment. The biofluids including blood,174 urine,175 cerebrospinal fluid,176 nipple 
aspirate fluid177 and bile178 are common sources for biomarkers. As an alternative to 
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biofluids, use of tumor tissues as a source of biomarkers is also crucial for cancer biology. 
Intact proteins could be extracted from formalin-fixed and paraffin-embedded tissues and 
provide a great potential for biomarker studies using millions of stored specimens.179  
Among these sources, blood is considered the optimal source for biomarker discovery 
due to the virtual contact of blood with all organism cells. However, plasma proteins show a 
big complexity and a wide dynamic range, up to 9 orders of magnitude.180 The complexity of 
the serum proteome brings technical limitations for its use in clinical proteome analysis. 
Therefore, for a more comprehensive proteome study of low abundance proteins, it is critical 
to adjust the protein dynamic range. In the case of plasma, the most abundant proteins are 
mainly serum albumin and thus can be easily and specifically depleted prior to LC-MS 
analysis by immunoaffinity or chemical-based approaches. Antibody-coated columns are 
applied to capture most of high abundance proteins and improve the proteomic coverage of 
clinical samples.181 The significant shortcomings of antibody depletion methodologies are the 
high cost and limited binding capacity of only several microliter sample amounts. 
Alternatively, various chemicals including sodium chloride and ethanol,182 acetonitrile,183 the 
disulfide reducing agents of DTT and TCEP,184 and ammonium sulfate,185 could selectively 
precipitate abundant albumin proteins to improve depletion throughput and proteomic depth.  
Combinatorial ligand library is another cheaper and more holistic approach to collect 
the captured proteins for analysis, wherenin a large collection of ligands from the 
combinatorial hexapeptide library are conjugated onto beads and bind to a wide range of 
proteins.186 The approximately equimolar amounts of the ligands could equalize the protein 
concentrations and thus benefit the bottom-up proteomics study. More recently, the proteins 
could also be digested by a protease and then a molecular weight cutoff filter was exploited to 
remove the abundant peptides.187 The remaining undigested or partially digested proteins 
existing in less abundance were then digested to completion for analysis, resulting in a great 
improvement of identified protein number, sequence coverage and quantification of low 
abundant proteins. 
Although the sample complexity could be greatly reduced by protein depletion, the 
remaining protein mixture still requires efficient separation to improve identification 
efficiency and accuracy. The commonly used separation methods including 2D-PAGE, LC, 
off-gel and CE have been described in the part of ESI coupling with separation methods. For 
protein separation, 2D gel-based proteomics is a mature technology that has been employed 
in  proteomics for over three decades and is still a powerful tool to study bacterial proteomics 
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with low complexity, and protein with PTMs. Combined with LC-MS/MS, 2D gel could be 
reduced to 1D gel to separate complex protein mixture according to their molecular weight. 
This methodology has been standardardized as gel enhanced LC-MS to represent the hybrid 
gel and LC-MS analysis.188  
Recently, a great deal of work attempts to discover potential biomarkers with bottom-
up proteomics method based on glycopeptide/glycoprotein structures, since alteration of 
cellular glycosylation is known to be disease-related and most protein biomarkers used 
clinically are glycosylated. Various types of lectin chromatography189 and a covalent method 
using hydrazide190 are commonly used for glycoproteins enrichment. The glycan isoforms 
could be differentiated by structure-specific chromatography based on porous graphitized 
carbon and hydrophilic interaction.191  
Despite the discovery of many new potential markers using proteomics, only a few 
biomarkers have been developed into clinical applications for disease screening, due to 
several limitations, such as false discovery or the lack of standardization of workflow, 
appropriate biospecimens, bioinformatics et al.. However, the advances in MS-based 
proteomics technology will benefit the biomarker development, from discovery to clinical 
application.  
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1.3. Thesis outline 
This thesis containing four chapters focuses on two major aspects, direct coupling of 
various analytical tools with ESTASI-MS and MS sensitivity improvement for bioanalytical 
applications. Chapter II and III describe the direct coupling of ESTASI-MS with TLC and 
384-well plate to expand the applications of ESTASI-MS in various research fields. In 
Chapter II, ESTASI-TLC-MSI is presented for the identification and imaging of different 
types of compounds separated on either hydrophilic or hydrophobic silica plates. Chapter III 
describes a 384-well plate as an emitter for ESTASI-MS. With this setup, enzyme assay and 
drug metabolism studies were performed in a high throughput and fast way.  
The MALDI-MS and ESI-MS signal intensities were greatly improved with two 
different strategies, as reported in Chapter IV and V respectively. Chapter IV employed Mb-
AuNPs for the multiplex separation and sensitive probing of specific IgE antibodies (Abs) 
from allergic patient blood serum, combined with magnetic separation in a sandwich 
immunoassay format and MALDI-MS detection of the large amount of mass barcodes. In 
Chapter V, a novel interface of spyhole between MS and microfluidic chip was created by 
laser ablation as a nanoESI emitter. The ultrahigh sensitivity provided by the disposable 
microchip coupled with MS/MS offers the potential application in cancer diagnosis with 
limited sample amount and simplified experimental procedure. Finally, Chapter VI concluded 
this thesis generally and described the future perspectives with the presented techniques. 
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CHAPTER II. 
 
Ambient in-situ analysis and imaging of both hydrophilic and hydrophobic 
thin layer chromatography plates by electrostatic spray ionization mass 
spectrometry 
 
Based on X. Zhong et al., RSC Adv., 2015, 5, 75395-75402. 
 
Abstract 
Electrostatic spray ionization (ESTASI) mass spectrometry imaging (MSI) recently 
developed to profile spatial distribution of chemical and biochemical molecules on an 
insulating surface under ambient conditions has been applied to extract and identify 
chemicals from silica gel surfaces. Both hydrophilic or hydrophobic silica plates have been 
imaged with a good resolution providing a direct identification of the samples. For the 
hydrophilic silica gel substrate, silanization of the plate before ESTASI-MS analysis was 
used to render the surface hydrophobic. ESTASI-MSI is shown to be a sensitive technique for 
the identification of a wide range of molecules of different polarities and chemical structures 
with minimal sample consumption in the femtomole range. 
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2.1. Introduction 
Compared to vacuum ionization mass spectrometry imaging (MSI), ambient 
ionization MSI holds the advantages of minimal sample preparation, more flexible device 
design and in-situ analysis. The commonly used ambient ionization methods for MSI include 
desorption electrospray ionization (DESI),1 laser ablation electrospray ionization (LAESI), 
desorption atmospheric pressure photoionization (DAPPI),2 laser desorption atmospheric 
pressure chemical ionization (LD-APCI),3 low-temperature plasma (LTP) mass 
spectrometry,4 and liquid extraction surface analysis.5 Recently, LEPA has developed a novel 
ambient MSI system based on the newly introduced technology named electrostatic spray 
ionization (ESTASI),6 as described in § 1.1.4 and 1.2.4, and successfully imaged dried 
peptide spots and black dye patterns on polyimide substrates.7 However, a major problem of 
ESTASI-MSI has been the low spatial resolution due to the tailing effect resulting from 
droplet based extraction of the weakly bound samples on insulating polymer substrates. The 
purpose of this work is to show that this drawback can be circumvented when imaging thin-
layer chromatography (TLC) plates by ESTASI-MSI. The strong hydrophobic or hydrophilic 
affinity between samples and substrates minimizes the tailing effect. By optimizing the 
extraction buffer conditions, selective sampling from the substrates can be realized.  
TLC, one of the earliest forms of chromatography for the separation of a wide range 
of samples,8-12 is still widely used nowadays in food analysis, pharmaceutical research, 
forensic science, biochemistry, clinical chemistry, etc. The compounds separated by TLC are 
amenable to the post-chromatographic detection and profiling by typical methods such as 
optical visualization and spectroscopic measurements. However, these detection methods 
usually have poor specificity and are restricted by the chemical or optical properties of 
analytes. For these reasons, MS is a suitable technique to couple with TLC due to its rapid 
analysis, high specificity and structural characterization ability.13,14 Various vacuum-based 
desorption ionization techniques have been applied to sample and ionize non-volatile or 
thermally labile compounds directly from TLC surfaces.15-20 Nevertheless, the widespread 
application of vacuum-based TLC-MS techniques has been hindered by several problems 
such as the requirement of a high-vacuum apparatus, difficult detection of volatile or semi-
volatile compounds and interference of matrix ions in the low mass range (< 700 Da) during 
MALDI-MS analysis. Interfacing TLC with ambient ionization MS without much sample 
pretreatment prior to MS analysis is more convenient in the view of fast analysis. Recently, 
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several ambient ionization methods, including ESI based techniques, as described in § 
1.2.1.1,21-27 APCI,28 DART29 and inductively coupled plasma ICP30, 31 have been introduced 
for the direct coupling of TLC with MS. Among the ESI based techniques, desorption 
electrospray ionization (DESI) is a powerful technique and has been combined with TLC, 
where the charged solvent droplets induced by electrospray ionization were directed to the 
TLC plate to sample and ionize the analytes.24 Then a closely related approach, named nano-
DESI, was developed in 2010, which enables the separation of desorption and ionization 
events by providing two capillaries to form a solvent bridge to desorb analytes from 
substrates followed by ionization through self-aspirating nanospray.27 Afterwards, tissue 
imaging was demonstrated by using this technique with good spatial resolution and high 
sensitivity.32 
Here, ESTASI is coupled with TLC directly. Sample spots separated by TLC were 
profiled by ESTASI-MSI, including drug molecules on normal phase silica TLC plates and 
dyes on high performance reverse phase (HPRP) C18 silica plates. In the former case, the 
highly hydrophilic silica plates were modified by chlorotrimethylsilane after TLC separation 
to form hydrophobic surfaces for ESTASI-MS analyses. The HPRP C18 and the modified 
normal phase silica plates provide ideal substrates for in-situ characterization and accurate 
sample location by ESTASI-MS with efficient sample extraction, reduced tailing effect due 
to the hydrophobic-hydrophobic or hydrophilic-hydrophilic interactions between samples and 
TLC substrates and even the abilities of sample desalting to enhance the detection sensitivity. 
The TLC-ESTASI-MS is universal for a wide range of organic molecules with very different 
chemical properties and polarities. The sample consumption can be as low as 75 fmole of 
fluorescein on the HPRP C18 plate, or ≤33 fmole of enrofloxacin on the normal phase silica 
plate. In addition to the identification of sample spots, the TLC-ESTASI-MS strategy can 
also provide a separation profile of the samples on the plates in a line-scan mode, or even a 
distribution image of the spots in a 2D-scan mode, which is of great value when the samples 
are colourless and do not give a clear image under UV illumination on the TLC plates with 
fluorescent indicators.  
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2.2. Experimental section 
2.2.1. Materials and methods 
Methanol (99.9% HPLC grade), acetic acid (>99.9%), 4-acetamidophenol (98%), 
aspirin (99%) and chlorotrimethylsilane (≥98% GC grade) were obtained from Sigma-
Aldrich (Schnelldorf, Switzerland). 25% aqueous ammonia and tetrahydrofuran (99.8%) were 
from VWR (Nyon, Switzerland). Ammonium acetate (98%) was obtained from Merck (Zug, 
Switzerland). Rhodamine B (99%), rhodamine 6G (99%), caffeine (98.5%), formic acid 
(99%) and acetonitrile (99.9% HPLC grade) were purchased from Acros Organics (Geel, 
Belgium). Fluorescein (Reag. Ph. Eur.), methylene blue (95%), sudan III (≥96%), crystal 
violet (AR grade) and ethyl acetate (99.9% HPLC grade) were obtained from Fluka (St. 
Gallen, Switzerland). Enrofloxacin (ENR, 98%), fleroxacin (FLE, 98%) and lomefloxacin 
(LOM, 98%) were purchased from TCI (Tokyo, Japan). Angiotensin I (NH2-DRVYIHPFHL-
COOH, 98%) was obtained from Bachem (Bubendorf, Switzerland). Deionized water (18.2 
MΩ cm) was purified by an alpha Q Millipore system (Zug, Switzerland) and used in all 
aqueous solutions. 
Silica TLC plates (20 cm × 20 cm, 200 μm layer thickness, PET foil base (0.4 mm 
thickness) with fluorescent indicator 254 nm) were purchased from Fluka (St. Gallen, 
Switzerland). HPRP C18 plates (10 cm × 10 cm, 200 μm layer thickness, glass plate (1.2 mm 
thickness) with fluorescent indicator 254 nm) were obtained from Merck (Zug, Switzerland). 
2.2.2. Thin-layer chromatography 
For the TLC-ESTASI-MS analyses of drugs (ENR, 4-Acetamidophenol, aspirin, 
caffeine, LOM or FLE), 1 μL of sample solution (0.5 mg/mL in methanol) was deposited on a 
silica TLC plate and developed under the mobile solution composed of methanol, 25% 
aqueous ammonia, ethyl acetate and acetonitrile (1:1:2:1 by volume). In the analysis of a drug 
mixture, an aqueous droplet (1 μL) containing ENR (1.4 nmole) and acetaminophen (3.3 
nmole) was spotted on a silica TLC plate for the separation with the mobile solution as 
reported.33  
For the TLC-ESTASI-MS analyses of dyes (fluorescein, rhodamine B, rhodamine 6G, 
sudan III, methylene blue or crystal violet), HPRP C18 plates were used. In the analysis of a 
dye mixture, a droplet (1 μL) of the dye mixture (1.7 nmole of methylene blue, 1 nmole of 
Chapter II: Ambient in-situ analysis and imaging of both hydrophilic and hydrophobic thin layer chromatog-
raphy plates by electrostatic spray ionization mass spectrometry 
 
43 
rhodamine 6G and 1.5 nmole of fluorescein) was spotted on a HPRP C18 plate, and developed 
with the mobile phase composed of methanol, tetrahydrofuran (60: 40 by volume) and 100 
mM ammonium acetate as reported.21  
 
Figure 2.1. Schematic representation of the setup used for TLC-ESTASI-MS. 
2.2.3. Modification and characterization of TLC plates 
After sample separation, the silica gel TLC plates were coated by 
chlorotrimethylsilane to form hydrophobic surfaces. During the coating procedure, both a dry 
silica plate and a small bottle with 2 mL of chlorotrimethylsilane were placed inside a closed 
plastic box and all together in a fume hood overnight (~16 hours). The chlorotrimethylsilane 
was evaporated from the small bottle to react with silicon hydroxyl of the TLC plate. 
Afterwards, the modified plate was taken out of the box and placed in the fume hood for 
another 1h to let the excess chlorotrimethylsilane vapour evacuate.  
Characterization of the modified and unmodified silica TLC and the HPRP C18 plate 
was performed by a Drop Shape Analysis System DSA100 from Krüss GmbH (Hamburg, 
Germany), where the contact angles of different solvents on the plates were tested. 
2.2.4. ESTASI-MS 
The mass spectrometer used to detect ions produced by ESTASI was a linear ion trap 
(Thermo LTQ Velos), where the MS inlet was always grounded and the positive ion-scanning 
mode was chosen. The ESI voltage of the internal power source of the MS instrument was 
always set as 0 during ESTASI-MS experiments. The enhanced ion trap scanning rate of 
10000 mass-to-charge ratio (m/z) per second was used. 
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The ESTASI setup was illustrated in Figure 2.1. High voltage pulses (from 0 V up to 
9 kV, 20 Hz) were generated by amplifying square wave voltage pulses with a high voltage 
amplifier (10HVA24-P1, HVP High Voltage Products GmbH, Martinsried/Planegg, 
Germany) to induce the ESTASI. A self-designed ion transfer capillary in “L” shape (2 mm 
of outer diameter (o.d.), 0.8 mm of inner diameter (i.d.)) replaced the original one for 
convenient scan of a horizontally placed surface. A TLC plate containing sample spots was 
supported on a thin insulating polymer substrate (PET, 0.2 mm thickness) and placed under 
the ion transfer capillary. The TLC plate was moved by two motored travel stages (MTS50-
Z8, Thorlabs, Dachau/Munich, Germany) in x and y directions to bring the sample spots 
under the MS inlet for detection, linear scans or 2D MSI. A fused silica capillary (150 μm 
o.d., 50 μm i.d.) named wetting capillary was in contact with the TLC plate surface to deliver 
acidic solvent for sample extraction and ionization. Several parameters were adjusted 
precisely to obtain good MS signals, including the distance between the sample surface and 
the ion transfer capillary, the angle between the fused silica capillary and the sample surface, 
the flow rate of the acidic solvent and the solvent component. 
ESTASI-MS selected reaction monitoring (SRM) was performed by collision induced 
dissociation (CID) with normalized collision energy of 25. The isolation width of precursor 
ion was set as 2 m/z and the scan range of SRM was set as ± 16 m/z. Data analysis was 
performed by Xcalibur Qual Browser (ThermoFisher Scientific, Reinach, Switzerland). The 
line-scan results and mass spectra were plotted by IGOR Pro (Version 6.00 for Macintosh, 
WaveMetrics, Lake Oswego, OR, USA). 2D MS image and 3D TLC-ESTASI-MS map were 
plotted by the data processing software MIRA (G. Wittstock, University of Oldenburg, 
http://www.uni-oldenburg.de/chemie/pc2/pc2forschung/secm-tools/mira/). 
2.3. Results and discussion 
2.3.1. ESTASI-MS analyses of samples from HPRP C18 plates 
In TLC-ESTASI-MS, a wetting capillary was used to deliver extraction solution to a 
TLC plate locally, and extract samples from the plate. ESTASI-MS analysis7 of the samples 
can be accomplished only when the extraction solvent can establish a droplet under the MS 
inlet and when the samples can be efficiently extracted into the droplet. Thus, the extracting 
solvent needs to be well chosen to combine a good solubility for the analytes and a good 
Chapter II: Ambient in-situ analysis and imaging of both hydrophilic and hydrophobic thin layer chromatog-
raphy plates by electrostatic spray ionization mass spectrometry 
 
45 
wettability for the TLC plates. For different samples and TLC plates, the different solvent 
composition should be optimized accordingly. 
One typical application of the TLC-ESTASI-MS system is based on reverse phase 
TLC plates. In this work, a HPRP C18 plate was selected, because of its excellent separation 
ability with respect to various organic molecules, and its highly hydrophobic surface 
property. Several identical sample droplets (1 μL, 0.3 mM fluorescein) were deposited on a 
HPRP C18 plate and then developed in parallel by the mobile solution of methanol and 
tetrahydrofuran (60: 40 v/v) with 100 mM ammonium acetate to obtain several sample spots 
with the size of ~5 mm in diameter each. Five extraction solvents, containing 0%, 25%, 50%, 
75% and 99% H2O respectively, in methanol with 1% acetic acid were tested. Sampling with 
each solvent lasted for 30 s on the centre of the fluorescein spot with continuous ESTASI-MS 
detection. Due to the different absorption of the HPRP C18 plate to different extraction 
solvents, the injection flow rate of each solvent was adjusted to obtain the best MS signals for 
the solvent.  
 
Figure 2.2. Extraction solvent optimization and detection limit of fluorescein on HPRP C18 plate. (a) 
Optimization of the extraction solvent (water and methanol mixture with 1% acetic acid). Ifluoresceine: 
intensity of singly protonated fluorescein at m/z = 333.3; IAng I: intensity of three-protonated 
angiotensin I at m/z = 432.9. (b) Mass spectrum of fluorescein detected by ESTASI-MS from the 
HPRP C18 plate with 1% acetic acid, 75% methanol and 24% H2O as the extraction solvent under a 
flow rate of 1 μL/min. Sample on TLC: fluorescein (1 μL, 30 μM aqueous solution) developed by the 
mobile solution of methanol and tetrahydrofuran (60: 40 v/v) with 100 mM ammonium acetate.  
From the recorded mass spectra, ratios between the peak intensities of the fluorescein 
ion and the internal standard (IS) ion, which was the triply protonated Ang I, were calculated, 
averaged and plotted versus the percentages of water in the extraction solvent, as shown in 
Figure 2.2(a). The MS intensity of fluorescein in comparison with the IS reduced greatly with 
the incremental change of water percentage. It is reasonable by considering that the less-
polarized solvent with more methanol should have a better extraction capacity of samples 
Chapter II: Ambient in-situ analysis and imaging of both hydrophilic and hydrophobic thin layer chromatog-
raphy plates by electrostatic spray ionization mass spectrometry 
 
46 
from the reverse phase TLC plates, where the affinity between the samples and the C18 
modified plate is based on hydrophobic-hydrophobic interactions. In spite of the largest 
extraction efficiency, it was difficult to form a stable ESTASI MS signal with the solvent 
consisting of 99% methanol and 1% acetic acid. Because of the relatively strong absorption 
of the HPRP C18 plate to methanol, the extraction solvent with 99% methanol can also induce 
the development of the sample in the plate, which would especially influence the linear scan 
or 2D imaging of TLC spots by MS. Therefore, the solvent composed of 75% methanol, 24% 
water and 1% acetic acid was selected for the further experiments on the HPRP C18 plate to 
evaluate the detection limit of fluorescein by TLC-ESTASI-MS. 
 
Figure 2.3. Molecular structures of the used six dyes and six drugs. LOM: lomefloxacin; ENR: 
enrofloxacin; FLE: fleroxacin. 
Stock solutions with different concentrations of fluorescein were prepared. 1 μL of 
each was spotted on a HPRP C18 plate and then developed by the mobile phase described 
above to form final sample spots. The fluorescein spot dried from 1 μL of 30 μM solution 
could still be easily detected by ESTASI-MS with the signal-to-noise ratio (S/N) of about 12, 
Figure 2.2(b). The spot diameter was around 5 mm, while the extraction area was about 250 
μm in diameter. Accordingly, the fluorescein consumption amount was estimated to be ≤75 
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fmole, indicating that the HPRP C18 TLC-ESTASI-MS system is suitable for the analyses of 
trace analytes.  
 
Figure 2.4. (a), (b), (c) and (d) individual ESTASI-MS spectra of methylene blue (1.7 nmole), rho-
damine B (1.1 nmole), sudan III (1.4 nmole) and crystal violet (1.3 nmole), respectively. (e), (f) and 
(g) mass spectra obtained at x =7.5 mm and y =3 mm, x =4.5 mm and y =4 mm, x =5.5 mm and y =7 
mm, respectively, of Figure 2.6. (Dye + H)+: singly protonated dye; (Dye - Cl)+: dechlorinated dye;  
(Ang Ι + 3H)3+: triply protonated Ang Ι. 
Rhodamine B, rhodamine 6G, sudan III, methylene blue and crystal violet can also be 
analyzed in the same way on the HPRP C18 plate by ESTASI-MS, as shown in Figure 2.3 and 
2.4, indicating that the method is universal to a wide range of molecules with different 
chemical properties and polarities. 
2.3.2. ESTASI line-scan and 2D imaging of sample spots separated by 
HPRP C18 plates 
Based on the characterization of TLC spots by ESTASI-MS, line scan and 2D 
imaging of the spots were performed, which could be useful in discerning slightly 
overlapping spots or the analytes not readily visible on the plate. A dye mixture containing 
methylene blue (1.7 nmole), rhodamine 6G (1 nmole) and fluorescein (1.5 nmole) was 
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separated by a HPRP C18 plate. The obtained dye spots were subjected to line scan and 2D 
imaging by ESTASI-MS. The extraction solution of 3 μM Ang I in 1% acetic acid, 75% 
methanol and 24% water was delivered at 1 μL/min. In the line scan, the motored travel stage 
moved with the step size of 100 μm, the translation rate of 5 mm/s and the delay time of 1 s to 
bring different regions of the TLC plate to the wetting capillary for analyses. MS signals were 
recorded, and the ion current (IC) ratio between target molecule and internal standard was 
calculated and normalized as shown in Figure 2.5 for quantification. 
 
Figure 2.5. ESTASI-MS line scan of a dye mixture separated on a HPRP C18 plate. The dye mixture 
contains methylene blue (1.7 nmole), rhodamine 6G (1 nmole) and fluorescein (1.5 nmole). (a) 
Optical image of the dried samples. (b), (c) and (d) normalized relative ion current (Rel. IC/%) 
chromatography of methylene blue, rhodamine 6G and fluorescein, respectively. (e) 3D TLC-ESTASI 
MS map of the three dyes. Rel. IC of each dye was calculated by dividing the IC of singly protonated 
sample molecule by that of the triply protonated Ang I, and then normalized, respectively. 
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Figure 2.5(a)-(d) showed the optical image of the development lane containing 
methylene blue, rhodamine 6G and fluorescein spots, and the IC chromatography of each dye 
from ESTASI-MS line-scan. The white arrow on the optical image indicated the TLC 
developing direction, which was also the line-scan direction. The line scan crossed the centre 
of the TLC spots. Although the amount of each dye was almost the same in the mixture, the 
mass spectra signals varied a lot because of the different extraction and ionization efficiencies 
of the samples. Comparing Figure 2.5(a) with Figure 2.5(b), (c) and (d), the ESTASI-MS 
line-scan showed the chromatography quite close to the optical image, but still with the 
following differences. The IC bandwidth of fluorescein in Figure 2.5(d) was larger than that 
of the visual fluorescein spot in Figure 2.5(a). From Figure 2.5(c) and (d), there was a small 
overlap between rhodamine 6G and fluorescein spots, which could not be discerned visually 
from the optical image. The resolution of chromatographic bands in TLC was further 
considered to evaluate the TLC-ESTASI-MS, which is defined as the distance between the 
band centres divided by the average width of the bands.12 The calculated TLC resolutions 
were 5.52 and 5.38 for the separation of methylene blue and rhodamine 6G, and 1.60 and 
1.20 for the separation of rhodamine 6G and fluorescein, based on the optical image and 
ESTASI-MS, respectively. On one hand, the difference between the IC chromatography and 
the optical image can stem from the limited spatial resolution of ESTASI-MS, which is 
regulated by the wetting capillary size, and the step size. On the other hand, the optical image 
could hinder some details of the sample spots when their surface concentration is too low to 
give a colour strong enough to see, which could still be revealed by ESTASI-MS. 
 
Figure 2.6. 2D TLC-ESTASI-MSI of rhodamine 6G and fluorescein spots in Figure 2.5(a). Rel. IC/% 
of each dye was plotted with respect to the position on the TLC plate and represented individually as 
the z-axis in a form of green (fluorescein) or red (rhodamine 6G) colour gradient.  
Chapter II: Ambient in-situ analysis and imaging of both hydrophilic and hydrophobic thin layer chromatog-
raphy plates by electrostatic spray ionization mass spectrometry 
 
50 
The main advantages of MS scan of TLC plates compared with any spectroscopy 
detection method are the direct characterization of analytes and the possibility to differentiate 
in m/z the analytes not well separated by TLC. For this purpose, a concept of 3D TLC-
ESTASI-MS map is shown here, with the x-axis representing the position of the sample spot 
on the scanned lane, the y-axis representing the m/z ratio and the z-axis in colour gradient 
representing the surface density. Figure 2.5(e) showed the 3D TLC-ESTASI-MS map 
reconstructed from the line scan MS data. There is a small degree of overlap on the x-axis 
between fluorescein and rhodamine 6G spots as already found in Figure 2.5(c) and (d), while 
the spots are well separated on the 3D map by m/z that brings a great value to the TLC 
analyses of mixtures. 
2D ESTASI-MSI was further performed on the same rhodamine 6G and fluorescein 
bands on the TLC plate in Figure 2.5(a) with a protocol described in detail in a recent 
publication.7 The same extraction solvent was used, and the motored travel stage was moved 
in both x and y directions with the step size of 200 μm, the translation rate of 5 mm/s and the 
delay time of 1s to accomplish the 2D scan. Normalized relative IC of each dye was 
calculated and plotted versus the position on the TLC plate to form a 2D MS image of the dye 
spots, where a more bright colour means a more intensive signal of the corresponding sample 
on mass spectrum, shown as Figure 2.6. The plotted image of the two dye spots by TLC-
ESTASI-MSI was similar to the optical image. Before reaching the sample spots, only the 3 
protonated Ang I was observed on the mass spectra in Figure 2.4(g) while both 3 protonated 
Ang I and dye ions were observed when ESTASI-MS was performed on the corresponding 
dye spot, in Figure 2.4(e) and (f). Considering that the spots had already been used for line 
scan before the 2D imaging, the ESTASI-MS consumed only small amount of samples for 
each analysis, making it possible to reanalyse the plate several times. The good 
correspondence between Figure 2.5(a) and 2.6 demonstrated that 2D ESTASI-MSI is a 
powerful method to reveal completely and accurately the spatial distribution of the analytes 
separated by TLC. Compared with the images obtained previously,7 the image resolution and 
integrity have been improved significantly, which could be contributed to the hydrophobic-
hydrophobic or hydrophilic-hydrophilic interactions between samples and TLC substrates 
leading to a reduced tailing effect.  
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2.3.3. Quantification of rhodamine 6G on HPRP C18 plates 
Quantitative capability of TLC-ESTASI-MS was also explored by performing 
uniform ESTASI line-scans across the centre of five sample bands developed on a HPRP C18 
plate, each band containing 1 μL 0.01 mg/mL, 0.05 mg/mL, 0.1 mg/mL, 0.15 mg/mL and 0.2 
mg/mL rhodamine 6G respectively. 3 μM Ang I in 1% acetic acid, 75% methanol and 24% 
water was delivered at 1 μL/min to extract sample and act as internal standard for the 
quantitation. Three parallel tests were performed to determine the relative standard deviation 
(RSD). The integrated peak areas from the extracted relative ion current chromatography of 
rhodamine 6G to Ang I, as shown in Figure 2.7(b)-(f), were plotted with respect to rhodamine 
6G solution concentrations to obtain the calibration curve as y = 30.666 x - 0.105, in Figure 
2.7(a).  
 
Figure 2.7. (a) Calibration plot of peak area of Rel. IC chromatography of sample spots versus the 
rhodamine solution concentration. The error bar was obtained from three parallel tests to show the 
standard deviation. (b), (c), (d), (e) and (f) Rel. IC chromatography of dried spots on HPRP C18 plates 
from 1 μL rhodamine 6G solution at concentration of 0.01 mg/mL, 0.05 mg/mL, 0.1 mg/ml, 0.15 
mg/mL and 0.2 mg/mL, respectively. Rel. IC was calculated by dividing the IC of singly protonated 
rhodamine 6G by that of triply protonated Ang I. 
Two calibration curves employing different ranges, 0.01 μg/mL-0.1 μg/mL and 0.1 
μg/mL-10 μg/mL, were used to determine the recovery rate of rhodamine 6G from the HPRP 
C18 plate. Rhodamine 6G solutions with different concentration were mixed with internal 
standard (3 μM Ang I) in 1% acetic acid, 75% methanol and 24% water and delivered by the 
wetting capillary at 1 μL/min for ESTASI-MS analyses. The MS signal was recorded for 3 
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min. The IC ratio between rhodamine 6G and Ang I was calculated, averaged and plotted 
with respect to rhodamine 6G solution concentration to make the two calibration curves with 
different ranges, respectively, as shown in Figure 2.7(a) and (b). The error bar was obtained 
from three parallel tests to show the relative standard deviation.  
 
Figure 2.8. (a) and (b) calibration plot of Rel. IC intensity of rhodamine 6G to Ang I versus 
rhodamine 6G concentration in the wetting capillary among the 0.01 μg/mL-0.1 μg/mL and 0.1 
μg/mL-10 μg/mL ranges, respectively. (c) Rel. IC chromatography of rhodamine 6G recovered from 
dried sample spot of 1 μL of 10 μg/mL rhodamine 6G on a HPRP C18 plate. (d) concentration 
chromatography of rhodamine 6G obtained by transforming the Rel. IC intensity into the 
concentration with the two calibration curves respectively.  
Then, 3 μM Ang I in 1% acetic acid, 75% methanol and 24% water was delivered by 
the wetting capillary at 1 μL/min to extract sample continuously from the central point of a 
developed band of 1 μL, 10 μg/mL rhodamine 6G on a HPRP C18 plate for ESTASI analyses. 
The MS recording was kept until the signal of rhodamine 6G became rather weak to be 
around the background level. Rel. IC chromatography of rhodamine 6G, in Figure 2.8(c), was 
obtained by dividing the IC of singly protonated sample molecule by that of the triply 
protonated Ang I and transformed to be concentration chromatography with the two 
calibration curves, respectively, as in Figure 2.8(d). Considering the flow rate was at 1 
μL/min, the integrated peak area of the concentration chromatography was calculated, which 
indicated the recovered amount of rhodamine 6G from the HPRP C18 plate. The theoretical 
amount of rhodamine 6G at the sampling point could be obtained by measuring the diameter 
of the sampling point, which was about 360 μm. By dividing the peak area of the 
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concentration chromatography by the theoretical amount of rhodamine 6G, the mean 
recovery rate was measured as 78 ± 3.5% based on three parallel tests. 
2.3.4. Surface modification of normal phase silica TLC plates for ESTASI-
MS analyses 
 
Figure 2.9. Contact angles of solvents on TLC plates. (a) Contact angles of the solvents containing 
50%, 75% and 99% H2O respectively on the silane-modified silica gel TLC plate. (b) Contact angles 
of the solvents containing 25%, 50%, 75% and 99% H2O respectively on the HPTLC RP C18 plate. 
The error bar was obtained from three parallel tests to show the standard deviation. (c) Photograph of 
75% H2O on the silica plate. (d) Photograph of 75% H2O on the silane-modified silica plate. (e) 
Photograph of 25% H2O on the HPTLC RP C18 plate.  
Solvent mixtures containing methanol, water and acetic acid are commonly used in 
most ESI-based MS systems. However, both water and methanol can be absorbed quickly by 
normal phase silica gel TLC plates without forming small droplets for the sample extraction 
of ESTASI-MS analysis. Furthermore, the absorbed liquid can induce sample developing 
inside the TLC plate. Therefore, normal phase and any water-wettable plates are very 
difficult to be directly analyzed by liquid-extraction based MS analysis methods. Surface 
modification of the plates is normally required before MS analysis. For example, silicone oil 
was sprayed onto the normal phase silica gel plates and HPTLC cellulose plates to form 
hydrophobic surfaces to enable the MS analysis by a liquid microjunction surface sampling 
probe.34  
In this work, we use chlorotrimethylsilane vapour to modify silica gel TLC plates 
after sample separation to form highly hydrophobic surfaces for ESTASI-MS analyses. 
Chlorotrimethylsilane is volatile and reactive toward silicon hydroxyl groups, resulting in the 
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replacement of the hydrophilic hydroxyl groups by hydrophobic silane. Compared to other 
modification procedures, such as physical cover with paraffin or silicone oil,35 the vapour 
reaction of chlorotrimethylsilane with silica gel can provide a surface homogeneously 
modified in a thin layer, and without the coverage of the sample molecules that can lead to 
lower sensitivity during MS analysis. In addition, the silane does not influence MS analysis 
as it is chemically immobilized on the stationary phase of TLC plates that cannot be removed 
during ESTASI.  
 
Figure 2.10. ESTASI-MS spectra of sample spots from: (a) 1 μL, 1 mg/mL ENR aqueous solution 
developed on a silica gel TLC plate, (b) 1 μL, 1 mg/mL ENR aqueous solution developed on a silica 
gel TLC plate with silane modification, and (c) 1 μL 5 μg/mL ENR solution developed on a silica gel 
TLC plate with silane modification. (d) ESTASI extraction solvent composed of 75% water, 24% 
methanol and 1% acetic acid, (e) 1 μL, 10 μg/mL ENR aqueous solution developed on a silica gel 
TLC plate with silane modification. (f) ESTASI-MS/MS SRM spectrum of a sample spot from 1 μL, 
0.5 μg/mL ENR aqueous solution developed on a silica gel TLC plate with silane modification. The 
fragment at m/z 316 was selected as the diagnostic ion of ENR.  
To evaluate the modification method, the contact angles of solvents containing 
different percentages of methanol and water were measured on the modified silica gel plate, 
the unmodified silica gel plate and the HPTLC RP C18 plate. As shown in Figure 2.9(a), the 
contact angles of the solvents composed of 99%, 75% and 50% water in methanol with 1% 
acetic acid on the silane modified silica gel plate was measured as 84°, 77° and 63°, 
respectively. When the water concentration was 25%, the solvent could no longer form a 
stable droplet. In contrast, on the silica gel plate without silane modifications, even the 
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solvent containing 75% of water cannot form a stable droplet, Figure 2.9(c). When the 
HPTLC RP C18 plate was employed, the contact angles for the solvents of 99%, 75%, 50% 
and 25% water in methanol with 1% acetic acid were measured as 135°, 126°, 90° and 39° 
respectively, in Figure 2.9(b). Therefore, although the silane-modified silica TLC plate is not 
as hydrophobic as the HPRP C18 plate, it is much more hydrophobic than the unmodified one 
and may be used in many liquid extraction based MS analysis methods. Because the affinity 
between the silica gel plate and samples is mainly based on hydrophilic-hydrophilic 
interactions, a higher concentration of water in the extraction solvent could benefit ESTASI-
MS analysis. However, the surface tension of the solvent also increases with the amount of 
water, making the ESTASI itself more difficult.6 Therefore, the solvent containing 75% 
water, 24% methanol and 1% acetic acid was used as the extraction solvent when analyzing 
the silica TLC plate. 
 
Figure 2.11. ESTASI-MS line-scan of a drug mixture containing ENR (1.4 nmole) and 4-
acetamidophenol (3.3 nmole) on a silica gel TLC plate with silane modification. (a) an optical image 
of the dried sample spots on the TLC plate. (b) and (c) Rel. IC/% chromatography of ENR and 4-
acetamidophenol, respectively.  
To demonstrate the effect of the silane modification in ESTASI-MS analysis, 
enrofloxacin (ENR), an antibiotic, was developed in parallel on two silica TLC plates by the 
mobile solution of methanol, 25% aqueous ammonia, ethyl acetate and acetonitrile (1:1:2:1 
by volume), and then analyzed by ESTASI-MS, one with silane modification and the other 
not. In Figure 2.10(a), only a weak MS peak with the S/N of about 10 was observed for ENR 
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at high amount (2.7 nmole) on the plate without modification under the extraction solvent 
flow rate of 2 μL/min. The high flow rate was used here to form temporarily a droplet for 
ESTASI-MS analysis under the strong absorption of the solvent by the TLC plate, which 
would induce quick diffusion of samples inside the TLC plate from the extraction droplet 
region. Therefore, only the spot of very high amount of ENR can be detected by ESTASI-
MS. When the sample amount was lowered to 0.27 nmole, no signal of ENR was obtained 
from the silica gel TLC plate under optimized experimental conditions. In comparison, a 
much stronger MS peak of ENR with the S/N larger than 100 was obtained from the 
developed sample spot containing 2.7 nmole of ENR, when the silane modification was 
performed after TLC separation and before MS analysis, as shown in Figure 2.10(b). Even 
when the sample amount was lowered to 14 pmole, the ENR was still detectable from the 
TLC plate after silane modification with the S/N of about 3 in Figure 2.10(c). It should be 
mentioned that the flow rate was lowered to 1 μL/min during the analyses of the silane-
modified silica gel TLC plate, since the plate cannot absorb the solvent any more. To confirm 
the signal at m/z 360 with quite low S/N comes from singly protonated ENR instead of noise 
signal, ESTASI-MS fragmentation of precursor ions at m/z 360 induced by CID was 
performed. A strong fragment ion at m/z 316 was obtained from a dried spot of 1 μL, 10 
μg/mL ENR on a silica plate with silane modification, which was not observed for the 
extraction solvent composed of 75% water, 24% methanol and 1% acetic acid, in Figure 
2.10(d) and (e). Therefore, fragment ion at m/z 316, which comes from the reduction of H2O 
and CO2 groups from ENR molecule, was selected as the diagnostic ion of ENR. ESTASI-
MS/MS SRM of the diagnostic ion was further performed to evaluate the sensitivity of ENR 
analysis from the modified silica plate, in Figure 2.10(f). The diagnostic ion was still easily 
detectable with quite high S/N by ESTASI-MS/MS SRM even when the sample amount was 
lowed to 1.4 pmole in Figure 2.10(f). The sample amount could be further lowered until the 
S/N value of the diagnostic ion was around 3 (data not shown), indicating that ESTASI-
MS/MS SRM can improve analysis specificity and sensitivity greatly from the modified silica 
plate. In the same way, we demonstrated that 4-acetamidophenol, aspirin, caffeine, 
lomefloxacin and fleroxacin can also been detected by ESTASI-MS from the silica gel TLC 
plate after silane modification, illustrating the universal applicability to a wide range of 
samples, in Figure 2.3 and 2.12. It is worth mentioning that ESTASI-MS under negative 
mode provides lower LOD for aspirin (0.42 μg/mL) compared with that (84 μg/mL) under 
positive mode (data not shown), which may be due to the susceptibility of aspirin molecule to 
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be negatively charged and further confirmed the alternative sprays of both cations and anions 
in ESTASI-MS and its advantage in the efficient analyses of samples with weak 
electronegativities. 
 
Figure 2.12. (a), (b), (c) and (d) individual ESTASI-MS spectra of aspirin (2.7 nmole), caffeine (2.6 
nmole), FLE (1.3 nmole) and LOM (1.4 nmole), respectively. (e), (f) and (g) mass spectra obtained at 
x =7 mm, x =23 mm and x =14 mm, respectively, of Figure 2.11. (Drug + H)+: singly protonated drug; 
(Ang Ι + 3H)3+: triply protonated Ang Ι. 
The line scan of sample spots on the silica gel TLC plate after silane modification can 
also be performed with ESTASI-MS. The drug mixture containing ENR (1.4 nmole) and 4-
acetamidophenol (3.3 nmole) was separated by a silica plate. The obtained plate was then 
modified by silane before the ESTASI-MS line scan. The line scan was performed along the 
centre lane of the development bands in the developing direction indicated with a white arrow 
in Figure 2.11(a). The extraction solution was 3 μM Ang I in 1% acetic acid, 75% water and 
24% methanol, injected at the flow rate of 1 μL/min. The motored travel stage moved with 
the step size of 100 μm, the translation rate of 5 mm/s and the delay time of 1 s. The 
normalized relative IC of ENR and 4-acetamidophenol was calculated and plotted to form the 
IC chromatography, as shown in Figure 2.11(b) and (c), which is in good correspondence 
with the optical TLC image. The TLC resolution for the separation of ENR and 4-
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acetamidophenol was calculated as 4.0 from the optical image and 3.8 from the ESTASI-MS 
chromatography. Typical mass spectra in Figure 2.12(e), (f) and (g) presented the existence 
of the two drugs at different positions on the development band, or the background signal. 
2.4. Conclusions 
In this study, we have developed a direct coupling of TLC with ESTASI-MS for in-
situ analyses under ambient conditions with no sample pretreatment. Dried samples separated 
by high performance reverse phase TLC plates can be analyzed directly by ESTASI-MS. We 
also proposed an effective, simple surface modification process using chlorotrimethylsilane 
to modify hydrophilic silica gel. In a line scan mode, both chemical identification and TLC 
separation information can be obtained from a number of mass spectra to generate a 3D TLC-
MS map. The distribution image of compounds on TLC plates can also be accomplished with 
a good spatial resolution in the 2D scan mode. The method was found to be appropriate to the 
12 tested samples. TLC-ESTASI-MS can be readily applied in many other chemical and 
biochemical analyses. 
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CHAPTER III. 
 
Electrostatic spray ionization from 384-well microtiter plates for mass 
spectrometry analysis based enzyme assay and drug metabolism screening 
 
Based on L. Qiao and X. Zhong et al. Anal. Chem., 2017, 89, 5983-5990. 
 
Abstract 
We have realized the direct ionization of samples from wells of microtiter plates under 
atmospheric conditions for mass spectrometry analysis without any liquid delivery system or 
any additional interface. The microtiter plate is a commercially available 384-well plate 
without any modification, working as a container and an emitter for electrostatic spray 
ionization of analytes. The approach provides high throughput for the large batches of 
reactions and both the qualitative and quantitative analysis of a single compound or mixture. 
The limits of detection in small drug molecules, peptides and proteins are similar in 
comparison with standard direct infusion electrospray ionization. The analysis time per well 
is only seconds. These analytical merits benefit many microtiter plate-based studies such as 
combinatorial chemistry and high throughput screening in enzyme assay or drug metabolism. 
Herein, we illustrate the application in enzyme assay using tyrosine oxidation catalyzed by 
tyrosinase in the presence or absence of inhibitors. The potential application in drug 
development is also demonstrated with cytochrome P450-catalyzed metabolic reactions of 
two drugs in microtiter plates followed with direct ESTASI-MS/MS based characterization of 
the metabolism products. 
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3.1. Introduction 
Microtiter plates are used as a standard tool in analytical chemistry, clinical assay, and 
life science study. Because of the large number of wells per plate, it is widely used for 
combinatorial chemistry and high throughput screening. Coupled with various chemical 
analysis techniques, such as ultraviolet-visible spectroscopy, fluorescence spectroscopy, 
liquid chromatography, capillary electrophoresis, and mass spectrometry, it is extensively 
used for enzyme-linked immunosorbent assays,1 enzyme activity or inhibition assays,2,3 and 
drug metabolism studies.4,5 Compared to spectroscopy techniques, MS can offer direct 
qualification and quantification of a wide range of analytes, providing accurate and specific 
characterization to avoid false positive or negative results, thereby is highly suitable for the 
studies of enzymatic assays, inhibitor screening assays, and drug metabolism assays.6-10 
MS is normally coupled with microtiter plates with the help of liquid delivery robots 
or autosamplers from various suppliers. To improve analysis throughput and speed, a multi-
probe autosampler was developed by Kassel et al.11 and thereafter modified by Morand et al. 
to finish the analysis of a 96-well plate in 5 minutes.12 The 96-well plate could also be 
modified with disposable micropipette tips as emitters for solvent assisted inlet ionization 
(SAII).13 More details could be found in § 1.2.2. 
Herein, we have realized direct ionization of liquid samples from an unmodified 
microtiter plate, where the plate itself works as both containers and emitters for ionization. It 
is the first method of direct ionization from a microtiter plate without any liquid delivery 
interface and any modification to the plate. The ionization is achieved using the recently 
developed electrostatic spray ionization (ESTASI) method.14-16 The microtiter plate is simply 
placed between the ion transfer capillary of a mass spectrometer and the electrode connected 
to a pulsed high voltage (HV) power source. When the pulsed HV is applied, ESTASI occurs 
to generate alternative spray of cations and anions for MS analysis, as shown in § 1.1.4.14 
The performance of the ionization for qualification and quantification was evaluated. 
Different types of samples, including small drug molecules, amino acids, peptides and 
proteins could be detected with limits of detection (LOD) similar as standard direct infusion 
ESI. Quantitative analysis was also realized by adding a proper internal standard into the 
tested sample. Because the microtiter plate is disposable and no liquid delivery is needed, 
washing steps can be avoided to shorten analysis time and eliminate cross contamination 
between samples. The analysis time per well is only seconds. With the advantages, the 
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technique is highly suitable for fast analysis of a single compound or mixture. In addition, it 
holds potential applications in high throughput assays, such as enzyme inhibition screening 
and drug metabolism studies. To illustrate these, tyrosinase-catalyzed oxidation of tyrosine 
with or without inhibitors and the in-vitro drug metabolism by cytochrome P450 in microtiter 
plates were directly read by ESTASI-MS.  
3.2. Experimental section  
3.2.1. Chemicals and materials 
Ciprofloxacin (CIP), enrofloxacin (ENR), lomefloxacin (LOM) and fleroxacin (FLE) 
of analytical reagent grade were purchased from TCI Deutschland GmbH (Eschborn, 
Germany). Angiotensin I (Ang I, 98%) was obtained from Bachem (Bubendorf, Switzerland). 
Cytochrome c (Cyt c, horse heart, 95%), magnesium chloride hexahydrate (98%), sodium 
phosphate dibasic dodecahydrate (99%), sodium phosphate monobasic (99%) and sodium 
chloride (99.5%) were obtained from Fluka (St. Gallen, Switzerland). Methanol (99.9%, 
HPLC grade) was purchased from Applichem GmbH (Darmstadt, Germany). Acetic acid 
(HAc, 99%) was obtained from Merck (Zug, Switzerland). Ammonium bicarbonate 
(NH4HCO3, 99%,), calcium chloride (93%), tyrosinase (from mushroom, lyophilized powder, 
≥1000 unit/mg solid), L-tyrosine (99%), reduced nicotinamide adenine dinucleotide 
phosphate (NADPH), nifedipine (≥98%, powder), testosterone (≥98%, powder) and 
cytochrome P450 CYP3A4 isozyme microsomes expressed in baculovirus-infected cells were 
purchased from Sigma-Aldrich (St. Gallen, Switzerland). Potassium chloride (99%) was 
obtained from Roth AG (Arlesheim, Switzerland). Cupferron (for analysis) was purchased 
from Fisher Scientific (Waltham, MA, USA). All these reagents and materials were used as 
received without further purification. Deionized water (18.2 MΩ cm) was obtained from an 
ultra-pure water system (Milli-Q 185 Plus, Millipore) and used for all experiments. 
MicroAmp® optical 384-well reaction plate with barcode was purchased from life 
technologies (Carlsbad, CA, USA). 
3.2.2. Tyrosine oxidation and drug metabolism 
Wells of a 384-well microtiter plate were filled with 8 μL of phosphate buffered saline 
(PBS, 2 mM, pH 7.4), 1 μL of tyrosinase (0.2 mg/mL in 2 mM PBS) and 1 μL of tyrosine 
(0.5 mg/mL in 2 mM PBS). The detection by ESTASI-MS was directly performed from the 
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wells at different time intervals to monitor the oxidation results. When enzyme inhibition was 
studied, 1 μL of ascorbic acid (AA, 1 mg/mL or 0.1 mg/mL in 2 mM PBS) or 1 μL of 
cupferron (20 mM in 2 mM PBS) was added, followed by the addition of 7 μL of PBS (2 
mM), 1 μL of tyrosinase (0.2 mg/mL in 2 mM PBS), and 1 μL of tyrosine (0.5 mg/mL in 2 
mM PBS).  
For drug metabolism, 80 μg/mL of nifedipine or 40 μg/mL of testosterone was 
prepared in 10 mM NH4HCO3 (pH 7.4), respectively. 1 μL of NADPH (50 mg/mL in 10 mM 
NH4HCO3), 1 μL of CYP3A4 (1 μM in 100 mM KH2PO4, pH 7.4) and 8 μL of the drug 
solution were added in multiple wells of a 38-well plate. After being incubated for different 
periods under room temperature, 9 μL of the reaction solution was discarded and 9 μL of 50% 
MeOH/49% H2O/1% acetic acid was added for ESTASI-MS analysis.  
3.2.3. ESTASI-MS 
ESTASI-MS was performed as described in previous publications,14,17 and illustrated 
by Figure 3.1. A 384-well plate was placed on a PET substrate (120 μm thickness), and all 
together between an electrode and the ion transfer capillary of a linear ion trap mass 
spectrometer (LTQ Velos, Thermo scientific). The ion transfer capillary was a self-designed 
“L-shaped” ion transfer capillary instead of the original linear one of the MS instrument in 
order to place the microtiter plate horizontally for MS analysis. The plate was moved in x, y, z 
directions by travel translation stages to bring different wells under the ion transfer capillary. 
A pulsed high voltage (HV, from 0 V to 8 kV, frequency 20 Hz) was generated by amplifying 
voltage square wave pulses (0 to 8 V) with a high voltage amplifier (10HVA24-P1, HVP 
High Voltage Products GmbH, Martinsried/Planegg, Germany), and applied on the electrode 
to induce ESTASI against the ion transfer capillary that was set at 275 °C and always 
grounded. The ESI voltage of the internal power of the MS instrument was always set as 0 
and all the source gas flow rates were set at 0. Enhanced ion trap scanning rate of 10,000 m/z 
per second was used. The other parameters of the MS instrument were optimized for the 
selected analytes. All MS analyses were performed under positive scanning mode. For the 
collision-induced dissociation (CID), full scan mode was performed with normalized 
collision energy of 30 and isolation width of 1 m/z. 
For the sensitivity comparison, the samples were also applied via a direct infusion 
mode with a syringe at the flow rate of 3 μL/min and analyzed with the standard ESI. The 
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sample spray with the commercial ESI source is from a needle of 500 μm in diameter and 
assisted with a sheath gas flow of 10 arbitrary units and aux gas flow of 5 arbitrary units. The 
ESI voltage of the internal power of the MS instrument was always set as 3.7 kV. The 
temperatures of the heater and the MS inlet capillary were set at 42 °C and 275 °C, 
respectively. All other parameters of the MS instrument were the same as those for ESTASI 
analysis. 
 
Figure 3.1. Schematic representation of the setup used for ESTASI-MS from a 384-well plate. HV: 
high voltage, which is a square wave pulsed HV here. 
3.3. Results and discussion 
3.3.1. 384-well plate ESTASI-MS 
According to the previous studies, ESTASI occurs during electrostatic 
charging/discharging of the capacitors formed by (i) electrode-insulator-electrolyte solution 
and (ii) electrolyte solution-gas-ion transfer capillary.14 Charge separation happens inside the 
electrolyte solution during charging of the capacitors, e.g. anions to the part close to the 
electrode and cations to the part close to the ion transfer capillary when a positive HV is 
applied on the electrode. When the charge density on the part close to the ion transfer 
capillary is large enough, electrospray of cations occurs. Afterwards, spray of anions can be 
induced by simply grounding the electrode to make the electrolyte solution neutral. 
According to this ionization principle, it is crucial to reach a large charge density to start 
ESTASI that can be realized either by increasing the charge amount accumulated on the part 
of the electrolyte solution close to the ion transfer capillary or by reducing the surface area of 
the region. The charge amount can be increased by increasing the HV, increasing the surface 
area of the electrode, decreasing the thickness of the insulator, and decreasing the distance 
from the electrolyte solution to the ion transfer capillary.14  
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When the solution is inside the wells of a microtiter plate, its surface area exposed to 
the ion transfer capillary is determined by the shape of the well. A typical 96-well plate has 
normally quasi-cylindrical wells (about 8 mm Ø) with the volume up to 1 mL each, resulting 
in a large area of sample solution inside exposed to the ion transfer capillary during ESTASI. 
Indeed, it is very difficult to perform direct ESTASI of samples from a normal 96-well plate. 
Herein, we chose a commercially available 384-well plate with cone-shaped wells that had 
the volume of 40 μL each with the diameter of 3 mm at the base of the cone. When 10 μL of 
sample solution was filled in a well for ESTASI-MS analysis, the liquid exposed to the ion 
transfer capillary was a disc with a diameter less than 2 mm. The ion transfer capillary probed 
into the well and kept the distance of 1-2 mm from the sample to avoid sucking the sample 
solution. As soon as the pulsed HV was applied on the electrode, ESTASI happened to 
produce ions for MS analysis. During ESTASI, the sample was consumed, resulting in 
enlarging the distance between the ion transfer capillary and the sample solution. This would 
decrease the charge amount on the liquid surface, and finally stop ESTASI. Therefore, the 
384-well plate should be lifted up during ESTASI until all the sample solution in the well was 
exhausted. The analysis of many wells was performed with the help of an x, y, z translation 
system.  
 
Figure 3.2. Mass spectra obtained by the 384-well plate ESTASI-MS of (a) 1.5 μM of CIP, (b) 15 nM 
of CIP, (c) 15 μM of Ang I, (d) 15 nM of Ang I, (e) 10 μM of Cyt c and (f) 100 nM of Cyt c. Solution: 
50% MeOH/49% H2O/1% acetic acid. CIP+H+: singly protonated CIP; (Ang I)x+: Ang I ion with x 
proton(s); XH+: Cyt c ion with x proton(s). 
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The 384-well plate ESTASI-MS was tested with different samples, including small 
organic molecules, peptides and proteins. A group of synthetic antibiotics derived from 
quinolone nalidixic acid, including ciprofloxacin (CIP), enrofloxacin (ENR), lomefloxacin 
(LOM) and fleroxacin (FLE), were selected as examples of small organic drug molecules. 
These antibiotics were introduced for the therapeutic treatment of respiratory and urinary 
infections since the mid-1990s.18 The extensive use of the antibiotics has led to their 
accumulation in food, which have potential health hazard for humans.19 Therefore, it is highly 
important to develop analytical techniques in the detection of trace amount of the antibiotics. 
As shown in Figure 3.2(a), an intense peak of the single protonated CIP was obtained from 
1.5 μM CIP in 50% MeOH/49% H2O/1% acetic acid by the 384-well plate ESTASI-MS. 
When the concentration of CIP was lowered to 15 nM, the peak was still clearly observed 
with the signal-to-noise (S/N) ratio >10, Figure 3.2(b) and Table 3.1. Detection of other 
antibiotics was also performed. When 1.4 μM LOM, FLE and ENR were used, peaks for the 
single protonated antibiotics were easily observed. When the concentration was lowered to 
140 nM, the peaks could still be observed but with the S/N of only 4, 2, and 3 for LOM, FLE 
and ENR, respectively, Table 3.1. The results were compared with standard direct infusion 
ESI-MS analysis of the same samples by the same linear ion trap mass spectrometer 
(Thermo, LTQ Velos). Similar LOD was demonstrated under the optimized instrumental 
conditions, Table 3.1. 
Peptide (angiotensin I (Ang I), 1295 Da) was also tested by the 384-well plate 
ESTASI-MS. As illustrated in Figure 3.2(c), a mass spectrum similar to that from the 
standard direct infusion ESI-MS was obtained from 15 μM Ang I in 50% MeOH/49% 
H2O/1% acetic acid. The LOD of Ang I by the 384-well plate ESTASI-MS was found about 
15 nM, where a peak at m/z 649 for the doubly protonated Ang I was observed with the S/N 
of 5, Figure 3.2(d). In contrast, standard infusion mode ESI-MS needs at least 50 nM of Ang 
I to generate a clear peak (S/N=10) of the peptide at m/z 433 for the triply protonated ion, 
Table 3.1.  
The analysis of proteins by the 384-well plate ESTASI-MS was demonstrated using 
cytochrome c from horse heart (Cyt c, 12 kDa). When the concentration of Cyt c was high 
(10 μM in 50% MeOH/49% H2O/1% acetic acid), the obtained mass spectrum showed the 
strongest peak at m/z 1546 for the protein ions with 8 protons, Figure 3.2(e). The LOD was 
found at 100 nM of Cyt c, with the strongest peak (S/N=10) at m/z 773 for the protein ions 
with 16 protons. The shift of proton’s number from 8 to 16 may originate from the change of 
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pH value caused by different concentrations of Cyt c, as previously reported.20 Direct 
infusion mode ESI-MS provides the LOD of Cyt c (70 nM) slightly better than the 384-well 
plate ESTASI-MS, with also the strongest peak (S/N=10) at m/z 773, Table 3.1. 
Table 3.1. Comparison of the detection of antibiotics, Ang I and Cyt c by 384-well plate ESTASI-MS 
and standard direct infusion ESI-MS. 
Compound Method m/z LOD S/N 
CIP ESTASI-MS 332 15 nM >10 
CIP ESI-MS 332 15 nM 3 
LOM ESTASI-MS 352 140 nM 4 
LOM ESI-MS 352 140 nM 4 
FLE ESTASI-MS 370 140 nM 2 
FLE ESI-MS 370 140 nM 3 
ENR ESTASI-MS 360 140 nM 3 
ENR ESI-MS 360 140 nM 5 
Ang I ESTASI-MS 649a 15 nM 5 
Ang I ESI-MS 433b 50 nM 10 
Cyt c ESTASI-MS 773c 100 nM 10 
Cyt c ESI-MS 773c 70 nM 10 
a: doubly protonated angiotensin I; b: triply protonated angiotensin I; c: Cyt c with 16 protons 
Besides the sample characteristics, mainly including the molecule size, the amount, 
exposure and pKa values of the easily protonated sites in the structure, the analysis sensitivity 
is also determined by the ionization technique used. According to the results, the 384-well 
plate ESTASI-MS is as sensitive as standard direct infusion ESI-MS in the analysis of small 
organic molecules and peptides. For proteins, the slightly better sensitivity of standard ESI-
MS than 384-well plate ESTASI-MS may be mainly contributed to the smaller commercial 
emitter size of 500 μm in diameter, which could facilitate the multi-protonation of proteins 
for efficient detection by the ion trap. The easy multi-protonation also explains the dominant 
ions of triply protonated angiotensin I in ESI-MS detection. However, different from the 
standard ESI-MS, the 384-well plate ESTASI-MS can provide much higher throughput and 
lower sample consumption in analysis. During 384-well plate ESTASI-MS, the sample 
volume in each well is normally from 2 to 10 μL. The ionization device is simply a 
disposable microtiter plate, where washing procedures are not required from one analysis to 
the next. The analysis time per well is seconds. In contrast, direct infusion ESI-MS requires 
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either a LC autoinjector or continuous syringe injection. In the both cases of direct infusion 
ESI-MS, washing of the liquid delivery part is required after each analysis, which is time-
consuming especially when the analytes are strongly adsorbed by the tubing system. 
3.3.2. Enzyme inhibition assay by 384-well plate ESTASI-MS  
One of the potential applications of the 384-well plate ESTASI-MS is the enzyme 
assay study. MS has drawn increasing interests in enzyme activity assays and enzyme 
inhibition assays during the last years.6 Compared to spectroscopy-based methods, MS 
strategy does not need expensive labelling reagents, and provides highly accurate 
identification to avoid false positive results. Both laser desorption/ionization and electrospray 
ionization based MS techniques are used for enzyme assay study.8,21 The former holds the 
advantage of high throughput, but difficulty in quantification. The later provides better 
quantification, but is limited by throughput. ESTASI was demonstrated as a concentration-
dependent ionization technique, similar to ESI, suitable for quantification.16 Therefore, the 
384-well plate ESTASI-MS can hold both the advantages of quantitative analysis like ESI-
MS and high throughput like LDI-MS. By avoiding the washing procedure, the time to 
analyze a sample is only seconds. 
 
Figure 3.3. (a) Liner curve fitted for tyrosine quantification with internal standard calibration method. 
I182/I106 : relative ion intensities between tyrosine (I182) and serine (I106). (b), (c) and (d) Mass spectra 
for 50 mg/L, 8 mg/L and 2 mg/L of tyrosine, respectively. The analyses were performed with direct 
ESTASI-MS from a 384-well plate, each well containing 10 μL of analyte solution in 50% 
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MeOH/49% H2O/1% acetic acid. The internal standard of serine was always kept at 10 mg/L. Error 
bar shows standard deviation (n=3). 
The quantitative capability of 384-well plate ESTASI-MS was demonstrated by 
detecting tyrosine of different concentrations. The classical method of internal standard 
calibration was used for tyrosine quantification, where serine was chosen as the internal 
standard. The high correlation coefficient value (R2 = 0.992) obtained from the fitted curve in 
Figure 3.3 indicates the good linear response of the relative ion intensities to the tyrosine 
concentrations within the range of 2 to 50 mg/L, demonstrating the concentration-dependent 
ionization performance of the 384-well plate ESTASI-MS. 
 
Scheme 3.1. Oxidation of tyrosine catalyzed by tyrosinase. 
To demonstrate the application in enzyme assay, we performed the oxidation of 
tyrosine in the presence of tyrosinase without and with inhibitors, followed by ESTASI-MS 
analysis. Oxidation of tyrosine catalyzed by tyrosinase, peroxidases or haem-containing 
proteins can form DOPA, 5,6-dihydroxyindole (5,6-DHI), and finally melanin,22 as show in 
Scheme 3.1. It is also involved in browning reactions in damaged fruits.23 A number of wells 
were prepared containing tyrosine (0.05 mg/mL) and tyrosinase (0.02 mg/mL) in 2 mM PBS 
(pH 7.4), and incubated at room temperature for various periods before ESTASI-MS analysis. 
After 3 min of reaction, a clear peak for single protonated 5,6-DHI at m/z 150 was observed 
in Figure 3.4(a), together with a peak for singly protonated tyrosine at m/z 182. The other 
oxidation products were hardly observed, indicating that they were quickly consumed after 
formation to produce 5,6-DHI or hardly ionized for MS analysis. During ESTASI-MS 
analysis, the buffer was 2 mM PBS at pH 7.4. Prolonging the reaction time, the tyrosine 
concentration continued to decrease slowly. After 20 min of reaction, only a very weak peak 
of tyrosine was obtained in Figure 3.4(b), indicating that most of the reactant was consumed. 
The reaction kinetics was analyzed based on the classic Michaelis-Menten kinetic process24 
and followed pseudo-first-order reaction with the reaction rate constant of 0.069 min−1, 
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indicating that the Michaelis constant KM is much larger than the substrate (tyrosine) 
concentration (0.05 mg/mL) in the case, Figure 3.4(c) and (d). 
 
Figure 3.4. Mass spectra of the products of tyrosine (0.05 mg/mL) oxidation catalyzed by tyrosinase 
(0.02 mg/mL) after (a) 3min and (b) 20 min of reaction. (c) Concentration variation of tyrosine during 
the enzyme-catalytic oxidization within 40 min. (d) Reaction kinetics of tyrosine oxidation. The 
reaction was performed in the wells of a 384-well plate followed with direct ESTASI-MS analysis in 
a buffer condition of 2 mM PBS at pH 7.4. Error bar shows standard deviation (n=3). 
The inhibition of tyrosinase-catalyzed tyrosine oxidation is an important topic in food 
and cosmetic chemistry to avoid hyperpigmentation in human skin and enzymatic browning 
in fruits or fungi. Recently developed inhibitors have been summarized in several 
reviews.23,25,26 In this work, we used two inhibitors, ascorbic acid and cupferron, to illustrate 
the feasibility of applying the 384-well plate ESTASI-MS in enzyme inhibition assays. 
Ascorbic acid is an antioxidant, working as an inhibitor of many enzymatic oxidative 
reactions. The enzyme inhibition assay was performed by preparing a number of wells 
containing ascorbic acid at different concentrations (0.1 mg/mL and 0.01 mg/mL) with 
tyrosine (0.05 mg/mL) and tyrosinase (0.02 mg/mL) in 2 mM PBS, followed by ESTASI-MS 
analysis after different time of incubation. As shown in Figure 3.4(a), tyrosine oxidation was 
efficiently inhibited by 0.01 mg/mL ascorbic acid within 20 min of incubation but the 
tyrosine concentration started to decrease sharply when prolonging the incubation time and 
was almost completely consumed after 40 min. It suggests that ascorbic acid works as a 
competitive inhibitor, continuously consumed during the enzymatic reaction. In contrast, with 
a higher concentration of ascorbic acid (0.1 mg/mL), the inhibition can last effectively for at 
Chapter III: Electrostatic spray ionization from 384-well microtiter plates for mass spectrometry analysis based 
enzyme assay and drug metabolism screening  
 
72 
least 40 min, in Figure 3.4(b). Therefore, a successful and continuous inhibition requires 
proper amount of ascorbic acid or the addition of ascorbic acid round-the-clock. 
Cupferron is a metal-chelating agent that can coordinate the copper ion of mushroom 
tyrosinase to inhibit completely its activity.27 Replacing ascorbic acid by cupferron, the 
inhibition was studied by 384-well plate ESTASI-MS. As a competitive inhibitor, the 
concentration of cupferron should be sufficiently higher than that of tyrosine for the efficient 
inhibition of tyrosinase (0.15 μM). Theoretically, at least 1 mM of cupferron is required for 
complete inhibition of tyrosinase when existing 0.3 mM of tyrosine.27 Here, 2 mM of 
cupferron was applied to ensure maximum inhibition of tyrosinase. As shown in Figure 
3.5(c), no oxidation product was observed after 10 min of reaction. With longer incubation 
time, the oxidation was still not observed by ESTASI-MS, in consistent with the proposed 
inhibition mechanism that cupferron deactivates completely tyrosinase. The strong peak on 
Figure 3.5(c) at m/z 157 was from cupferron, which was also observed by standard direct 
infusion ESI-MS of pure cupferron in 50% MeOH/49% H2O/1% acetic acid (data not 
shown). 
 
Figure 3.5. Tyrosinase inhibition assay with different amounts of ascorbic acid as the inhibitor. (a) 
0.01 mg/mL of ascorbic acid (b) 0.1 mg/mL of ascorbic acid. (c) Mass spectrum obtained after 10 min 
of reaction inhibited by 2 mM of cupferron. The reactions were performed in 10 μL solutions contain-
ing 0.05 mg/mL of tyrosine, 0.02 mg/mL of tyrosinase and different amounts of inhibitors in a buffer 
of 2 mM PBS at pH 7.4 in the wells of a 384-well plate followed by direct ESTASI-MS analysis. 
3.3.3. Drug metabolites screening by the 384-well plate ESTASI-MS.  
Another important application of 384-well plate is drug candidate screening. In-vitro 
studies of drug candidate metabolism could predict its potential toxicity, which is crucial in 
early-stage drug discovery.28 The rapid development of combinatorial chemistry and 
advances in bioinformatics, genomics and proteomics have driven the potential targets for 
new drug development increase dramatically in the past decade.29 
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Scheme 3.2. Oxidative metabolisms of (a) nifedipine and (b) testosterone catalyzed by cytochrome 
P450 CYP3A4. 
Therefore, low-cost, rapid and high throughput drug candidates screening methods are 
urgently needed. 384-well plate combined with ESTASI-MS or ESTASI-MS/MS can be 
applied in drug candidates screening by characterizing the metabolites of drug candidates in a 
high throughput manner. 
 
Figure 3.6. The test of ESTASI tolerance to salt by the analysis of 10 μL 50 nM Ang I in the well of a 
384-well plate. The buffer of 50% methanol, 49% H2O and 1% acetic acid contains (a) no salt or (b) 
30 mM NaCl. 
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To demonstrate this application, cytochrome P450, one major family of human liver 
microsome enzymes widely used for in vitro metabolism and toxicity studies,30 was chosen to 
induce drug metabolism in the wells of microtiter plates, while nifedipine and testosterone 
were used as substrates. Nifedipine is a prototype of the dihydropyridine class of calcium 
channel blockers that is widely used in the treatment of hypertension, prinzmtal’s angina 
pectoris and other vascular disorders,31 while testosterone is a male sex hormone that is 
important for sexual and reproductive development and plays a vital role in carbohydrate, fat, 
and protein metabolism.32 
 
Figure 3.7. Fitted curves and mass spectra for CYP3A4-catalyzed metabolism of nifedipine. (a) 
Conversion ratio of nifedipine as a function of time. (b) Reaction kinetics of nifedipine metabolism. 
(c) and (d) Mass spectra of nifedipine and its metabolites before reaction and after 30 min of reaction, 
respectively. (e) CID spectrum of the precursor ion at m/z 345 with normalized collision energy of 30 
and isolation width of 1 m/z. The reactions were performed with 64 μg/mL of nifedipine, 1 mg/mL of 
NADPH and 0.1 μM of CYP3A4 in 10 μL of 10 mM NH4HCO3 (pH 7.4) in a 384-well plate. 9 μL of 
the reaction solution was discarded and replaced with 9 μL of the ionization buffer (50% MeOH/49% 
H2O/1% acetic acid) prior to ESTASI-MS analysis. 
The CYP3A4-catalyzed metabolisms of both nifedipine and testosterone were 
simultaneously studied by the 384-well plate ESTASI-MS during a single run analysis. In 
both cases, NADPH was added as an electron donor. Multiple wells in a 384-well plate were 
filled with 10 μL of solutions, each containing 64 μg/mL of nifedipine or 32 μg/mL of 
testosterone, 1 mg/mL of NADPH and 0.1 μM CYP3A4 in 10 mM NH4HCO3 (pH 7.4). The 
solutions were incubated for a certain time under room temperature and then directly 
analyzed by ESTASI-MS at different time intervals. The tolerance to salty solution of the 
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384-well plate ESTASI-MS was estimated be around 30 mM NaCl for the analysis of 50 nM 
Ang I, in Figure 3.6. Considering that the high concentration of salts (around 30 mM) in the 
reaction solution could hinder the efficient detection of the drugs and their metabolic 
products, 9 μL of the reaction mixture was discarded and replaced by 9 μL of the ionization 
buffer (50% MeOH/49% H2O/1% acetic acid) for ESTASI-MS analysis.  
The primary product of nifedipine metabolism catalyzed by CYP3A4 is 
dehydronifedipine with the m/z at 345, as shown in Scheme 3.2(a) and Figure 3.7(d), in 
consistent with the literature report.31 After 30 min of incubation, the majority of nifedipine 
were oxidized and the conversion ratio reached around 70%, as shown in Figure 3.7(a). When 
prolonging the reaction time to 90 min, little nifedipine was further oxidized. A linear 
regression was obtained in Figure 3.7(b) and the nifedipine oxidation could be considered as 
the pseudo-first-order reaction. Within 30 min, the reaction rate constant was determined as 
0.037 min−1, in Figure 3.7(b).  
Structural elucidation of drug candidates metabolic products could facilitate the 
prediction of its toxicity based on the regression model of quantitative structure-toxicity 
relationship (QSTR), which relates the structure variables to the potency of toxicity 
variables.33 For this purpose, tandem MS with collision-induced dissociation (CID) was 
further applied to characterize the structure of the oxidized nifedipine. With normalized 
collision energy of 30, the precursor ion of m/z 345 generated a predominant fragment ion 
with m/z 284, corresponding to the loss of CH3COOH from the metabolic product, in Figure 
3.7(e). Both the precursor ion and the fragments indicated the generation of 
dehydronifedipine.  
Metabolic oxidation of testosterone was also monitored in the same 384-well plate 
together with nifedipine during a single run of analysis. From Scheme 3.2(b) and Figure 
3.8(d), the testosterone metabolism generated hydroxytestosterone and 6β-
hydroxytestosterone is the primary structure, according to the literature report.32 Figure 3.8(a) 
and (b) presented the oxidation process and only 40 % of conversion ratio was obtained until 
90 min of incubation. A reaction rate constant was obtained as 0.0072 min−1 for the 
metabolism of testosterone, Figure 3.8(b). Corresponding mass spectra of the testosterone and 
its oxidation product are shown in Figure 3.8(c) and (d). The metabolic product ion with m/z 
305 was selected for the CID process and generated the primary fragments by the detachment 
of two -OH groups, confirming the formation of hydroxytestosterone, Figure 3.8(e).  
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Figure 3.8. Fitted curves and mass spectra for CYP3A4-catalyzed metabolism of testosterone. (a) 
Conversion ratio of testosterone as a function of time. (b) Reaction kinetics of testosterone 
metabolism. (c) and (d) Mass spectra of testosterone and its metabolites before reaction and after 90 
min reaction, respectively. (e) CID spectrum of the precursor ion at m/z 305 with normalized collision 
energy of 30 and isolation width of 1 m/z. The reactions were performed with 32 μg/mL of nifedipine, 
1 mg/mL of NADPH and 0.1 μM of CYP3A4 in 10 μL of 10 mM NH4HCO3 (pH 7.4) in a 384-well 
plate. 9 μL of the reaction solution was discarded replaced with 9 μL of the ionization buffer (50% 
MeOH/49% H2O/1% acetic acid) prior to ESTASI-MS analysis. 
These results show that the 384-well plate ESTASI-MS/MS provides the possibility to 
directly characterize metabolic products in a high speed and throughput way without any 
solution purification or delivery interface. The 384-well plate ESTASI-MS and ESTASI 
MS/MS will be of great value in rapid and accurate in-vitro drug metabolism study and 
toxicity prediction. 
3.4. Conclusion 
In conclusion, we have realized direct ionization of liquid samples inside a microtiter 
plate by electrostatic spray ionization. Analytical characters, including sensitivity and 
quantification capability, were evaluated. The method can be universally applied for a wide 
range of samples, from organic molecules with molecular weight of ~150 Da to proteins of 
>10 kDa. The ionization device is demonstrated as efficient as standard ESI in the view of 
sensitivity to trace amount of analytes, while holds advantages in analysis throughput. Two 
applications were further explored, enzyme assay and drug metabolism screening. We would 
expect the current ionization method a powerful tool in high throughput MS-based enzyme 
activity assays, enzyme inhibition assays, immunoassays and drug candidate screenings.  
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CHAPTER IV. 
 
Mass barcode signal amplification for multiplex allergy diagnosis by 
MALDI-MS 
 
Based on X. Zhong et al., Anal. Chem., 2016, 88, 6184-6189. 
 
Abstract 
A highly sensitive method based on mass-barcoded gold nanoparticles (AuNPs) and 
immunomagnetic separation has been developed for multiplex allergy diagnosis by MALDI 
mass spectrometry in a component-resolved manner. Different analytical probes were 
prepared by coating AuNPs with individual allergenic proteins and mass barcode, represented 
by polyethylene glycol molecules of various chain lengths. Magnetic beads (MBs) 
functionalized with anti-human IgE antibodies (Abs) were used as immunomagnetic capture 
probes. IgE Abs were extracted from a patient’s blood serum by the formation of a sandwich 
structure between the AuNPs and MBs. Multiple specific IgE Abs were simultaneously 
identified by mass spectrometry detection of the mass barcodes, providing an efficient 
component-resolved allergy diagnosis. Because of the signal amplification provided by the 
mass barcodes, the developed diagnosis method is very sensitive with a limit of detection 
down to picograms per milliliter level for specific IgE Abs. The method can be potentially 
useful when the sample amount is highly limited and a multiplex diagnostic procedure is 
required. 
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4.1. Introduction 
Mass barcode-based mass spectrometry signal amplification is a technique widely 
utilized in DNA assays,1,2 immunoassays3,4 and tissue imaging, as shown in § 1.1.2.3.5,6 Mass 
barcodes, which are small tag molecules and easily detectable by MS, are grafted on nano-
/micro-particles in large excess together with the large target biomolecules. The detection of 
these tag molecules results in an amplified signal of the targets. For immunoassays,3,4,7 the 
mass barcodes have been utilized to probe the IgG antibodies (Abs)-involved immune 
binding events on a biochip or a gold plate, which acted as a flat surface to capture and 
separate the antigens from bulk solutions. This surface-based separation approach requires a 
multiple-step procedure, which is rather cumbersome and time-consuming. Besides, the full 
accessibility of antigens to the Abs, which are pre-immobilized on a 2D surface, is also 
limited.  
Meanwhile, commercially available micro-magnetic beads (MBs) with 
immunoaffinity coating are more advantageous for fast and convenient isolation of the target 
molecules. They possess large active surface area and are easy in manipulation. The 
immunoreactions can be performed in a homogenous way through gentle mixing of MBs 
with other reagents and may result in a faster target-binding process. Optimization of the 
target enrichment for sensitive analysis can also be easily realized by adjusting the MBs 
amount and the final sample volume applied for analysis. Therefore, the combination of 
MBs-based immunoassays with mass barcode signal amplification protocol can be promising 
for MS detection of large biomolecules such as allergens. 
Allergies, especially the ones caused by food products and plant pollen, are a 
constantly growing health problem worldwide.8 As pollen and foodstuff often contain 
multiple allergenic proteins that can provoke allergic reactions for a patient, component 
resolved diagnosis (CRD) should be performed.8 Allergy CRD is typically performed with 
individual purified allergenic proteins to detect the level of specific IgE Abs in human blood 
serum by enzyme-linked immunosorbent assay (ELISA).9 Commercially available ELISA-
based kits10 or automated platforms for allergy CRD usually require 20-50 μL of blood serum 
and provide the limit of detection (LOD) for specific IgE Abs as low as 0.24 ng/mL (0.1 
IU/mL) level.11 Fluorophore-labeled immunoassay,12 magnetophoretic immunoassay,13 
interferometric reflectance imaging sensors,14 microfluidic ELISA coupled with 
electrochemical detection,15 and immunoaffinity capillary electrophoresis (IACE) coupled 
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with fluorescence16 or MS detection,17 were also developed. However, in the listed analytical 
methods, the allergy diagnosis usually relies on expensive enzyme or fluorescent labels.  
Special devices, such as the antigen array immobilized on a 2D surface, the microfluidic chip 
or the separation capillary preloaded with affinity probes, are also required for these 
techniques, making them quite complex and laborious. Regarding these factors above, the 
simplification of the device, improvement of sensitivity and reduction of sample consumption 
are still needed and under development for the analysis of specific IgE Abs in the allergic 
patient’s blood serum. 
Here, we employ a mass barcode amplification strategy combined with commercial 
protein A/G coated-MBs (protein A/G@MBs) to enhance the simplicity and sensitivity of the 
multiplex allergy CRD with MS detection as displayed in Figure 4.3. Polyethylene glycol 
molecules with different chain lengths were chosen as mass barcodes and grafted onto gold 
nanoparticles (AuNPs) that were further modified with specific allergenic proteins to form 
AuNPs probes. At the same time, protein A/G@MBs were modified with anti-human IgE 
Abs and formed a sandwich structure with specific IgE Abs from patient’s blood serum and 
AuNPs probes. The MS detection of the mass barcodes from AuNPs indicated the presence 
of respective specific IgE Abs and allowed allergy CRD in a highly sensitive manner. LOD 
of 18 pg/mL (7.5 mIU/mL) for specific IgE Abs was achieved for the analysis of anti-beta-
lactoglobulin Abs in model experiments, allowing using afterwards only 1 μL of blood serum 
from allergic patient for CRD diagnosis. 
4.2. Experimental section 
4.2.1. Materials and reagents 
Pierce protein A/G@MBs (1 μm diameter) were purchased from Thermo Fisher 
Scientific (Reinach, Switzerland). Estapor tosyl-activated MBs (1.29 µm diameter) were 
kindly offered by Merck Chimie (France). Three kinds of mass barcodes, 
[S(CH2)11(OCH2CH2)xOH]2), x=3 for Mbc1 (670 Da), x=4 for Mbc2 (758 Da), x=6 for Mbc3 
(934 Da), were bought from Sigma-Aldrich (Buchs, Switzerland). Protein linker 1 (PL1, 
98%), HS-(CH2)10-COOH, was purchased from Sigma-Aldrich (Buchs, Switzerland). PL2 
(HS-(PEG)n-CH2CH2-COOH, MW 2000) and PL3 (HS-(PEG)n-NHS, MW 2000) were 
bought from Nanocs (NY, USA). PL4 (HS-(CH2)11(OCH2CH2)6-OCH2COOH) was obtained 
from SensoPath technologies (MT, USA). N-hydroxysuccinimide (NHS, 98%), 1-ethyl-3(3-
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dimethylaminopropyl) carbodiimide hydrochloride (EDC, >98%), 2-(N-
morpholino)ethanesulfonic acid (MES), gold(III) chloride trihydrate (>99.9%), sodium citrate 
dehydrate (>99%), sodium phosphate dibasic dehydrate (>99%), sodium phosphate 
monobasic dehydrate (>99%) and polyoxyethylene-sorbitan monolaurate (Tween 20) were 
obtained from Sigma-Aldrich (Buchs, switzerland). Acetic acid (99.5%), acetonitrile 
(99.8%), trifluoroacetic acid (TFA, >99%), sinapinic acid (≥ 99%), and 2,5-dihydroxybenzoic 
acid (DHB) (>99%) were purchased from Fluka (Buchs, Switzerland). Purified bovine milk 
proteins, including β-lactoglobulin B (β-lac B), bovine serum albumin (BSA), lactoferrin, α-
casein, β-casein, and κ-casein were obtained from Sigma-Aldrich (Buchs, Switzerland). 
Polyclonal anti-bovine β-lac B antibodies (Abs) and monoclonal anti-human IgE Abs were 
purchased from AbD Serotec (Oxford, U.K.). Blood serum of patient allergic to cow’s milk 
was purchased from Bioreclamation LLC (Westbury, NY, USA). Deionized water (18.2 MΩ 
cm) was purified by an alpha Q Millipore system (Zug, Switzerland) and used in all aqueous 
solutions. 
4.2.2. Synthesis and characterization of AuNPs 
 
Figure 4.1. (a) TEM image of synthesized AuNPs. (b) UV-Vis spectrum of the synthesized AuNPs. 
The citrate stabilized AuNPs were synthesized following a protocol reported 
previously.18 Briefly, 250 mL of 1 mM HAuCl4 in water was brought to the boil with 
vigorous stirring, and then rapidly mixed with 25 mL of 38.8 mM sodium citrate. Boiling was 
continued for 10 min. The heating source was then removed and stirring was continued for 
another 15 min.  
The mean diameter of the synthesized AuNPs was defined as ~12 nm by the 
transmission electron microscopy (TEM) image recorded by a FEI CM12 (Phillips, 
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Eindhoven, Netherlands) transmission electron microscope, operating with a LaB6 electron 
source at 120 kV, as shown in Figure 4.1(a). An alternative method to determine the mean 
diameter and approximate concentration of the colloidal AuNPs solution is UV-Vis 
spectroscopy analysis on a PerkinElmer Lambda XLS+ spectrophotometer (Waltham, MA, 
USA) with a 10 mm polystyrene cell, as detailed by Haiss et al.19 Based on this method, the 
concentration was calculated as 4.5×1012 particles/mL, and the mean diameter was defined as 
13 nm, in Figure 4.1(b). Considering that the AuNPs solutions were diluted twice for UV-Vis 
absorption measurement, the original concentration of AuNPs was 9×1012 particles/mL (~15 
nM). 
4.2.3. Preparation of mass-barcoded AuNPs probes. 
 
Figure 4.2. (a) MALDI-MS analysis of mass barcode Mbc1 and chosen protein linker PL4 present on 
modified AuNPs. The Mbc1 corresponded to a peak at m/z 693 (M+Na)+. The PL4 formed disulfide 
bonds with Mbc1 ((HO(OCH2CH2)3(CH2)11S-S(CH2)11(OCH2CH2)6-OCH2COOH) and presented as a 
major peak at m/z 883 (M+Na)+, indicating the successful immobilization of PL4 to the AuNPs. PL: 
protein linker. (b) MALDI-MS analysis of β-lac B (1 μg/mL, blue spectrum) and β-lac B@AuNPs (15 
nM, red spectrum) with 5 mg/mL sinapinic acid as the matrix. There is a mass shift of around 900 Da 
for β-lac B covalently conjugated on Mbc1-coded AuNPs, which may origin from the Mbc1-PL4 
modification (+860 Da) to β-lac B. 
To prepare the AuNPs probes, the obtained AuNPs were firstly derivatized with mass 
barcodes and protein linkers through the formation of stable Au-S bonds on particle surfaces. 
The saturation amount of thiol-terminated oligomers that can replace citrates and fully wrap 
the AuNPs in a brush shape was estimated to be around 15 nmol for 500 μL of AuNPs by 
considering that each thiol-PEG molecule occupied a footprint area of 0.35 nm2 on the 
AuNPs surface.20 It is necessary to ensure complete surface functionalization for efficient 
protection of AuNPs from the salt-induced aggregation and nonspecific adsorption during the 
following protein conjugation and immunobinding steps. Therefore, in a typical experiment, 
(b) (a) 
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five times higher amount (75 nmol) of thiol-containing oligomer mixture of mass barcodes 
(64 nmol) and protein linkers (11 nmol) in ethanol was mixed with 500 μL of AuNPs in water 
and incubated for 12 h with moderate vortexing. Excessive reagents were removed by 
centrifugation for 20 min at 13000 rpm. The precipitate was washed with pure water (1 mL 
each) for three times by successive centrifugation and redispersion. For semi-quantification 
purposes, similar protocol was applied for the preparation of internal standard conjugated 
AuNPs (IS@AuNPs), just by replacing the polymer mixture with pure IS (75 nmol), which 
was Mbc2, when Mbc1 was used for AuNPs probe in the analysis of a model analyte, anti-
bovine β-lac B Abs. The successful modification of AuNPs by the mass barcode, e.g. Mbc1, 
and the chosen protein linker PL4 was demonstrated by MALDI-MS analysis in Figure 
4.2(a). 
In a second step, proteins were immobilized on the mass-barcoded AuNPs via EDC-
NHS coupling protocol. Before protein conjugation, 500 μL of AuNPs probes were 
concentrated to 10 μL by centrifugation. Then, they were activated with 50 μL of freshly 
prepared EDC (15 mg/mL) and NHS (15 mg/mL) in 15 mM MES buffer (pH 5) for 30 min at 
room temperature (RT). After washing with MES buffer for 3 times (1 mL each), the NHS-
activated AuNPs were immediately incubated with sufficient amount of appropriate 
allergenic proteins (30 μL, 1 mg/mL) in 10 mM phosphate buffer (PB, pH 7.4) for 3h at RT. 
Then, after washing with 10 mM PB for 3 times to remove unbound proteins, obtained 
proteins@AuNPs were finally resuspended in 500 μL of 10 mM PB to a final concentration 
of 15 nM and stored at 4 °C. The successful immobilization of proteins, e.g. β-lac B, was also 
demonstrated by MALDI-MS analysis in Figure 4.2(b), providing β-lac B@AuNPs. 
4.2.4. Semi-quantification of anti-bovine β-lac B Abs.  
The experimental procedure was shown in Figure 4.3(a). 300 μL of anti-bovine β-lac 
B Abs at different concentrations in 10 mM PB were incubated with 10 μL of 10 mg/mL 
protein A/G@MBs for 30 min at RT. After magnetic separation, the captured anti-bovine β-
lac B Abs on the MBs were mixed with 300 μL of β-lac B@AuNPs (1 nM AuNPs)21 for 
another 30 min. After rinsing with 10 mM PB for 3 times (300 μL each), the β-lac B@AuNPs 
captured on MBs surface were eluted with 5 μL of 10% acetic acid and then concentrated to 
~1 μL with a weak stream of nitrogen. The concentrated sample was deposited together with 
0.5 μL of 10 mg/mL DHB (dissolved in 70% acetonitrile, 29.9% water, 0.1% TFA) and 0.5 
μL of IS@AuNPs (0.1 nM AuNPs) on a MALDI target plate for MS detection by a Microflex 
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LRF MALDI TOF instrument (Brüker Daltonics, Bremen, Germany). The instrument was 
operated in a positive reflectron mode. An average spectrum from 800 laser shots at different 
positions was collected for each sample spot. Instrumental parameters were optimized to 
achieve highest sensitivity and resolution for the detection of mass barcode molecules. 
Figure 4.3. Schematic representation of (a) β-lac B Abs semi-quantification and (b) simultaneous 
diagnosis of multiple allergic reactions via detection of specific IgE Abs with mass barcoded AuNPs 
and MBs. MALDI-MS: matrix–assisted laser desorption/ionization mass spectrometry; MBs: 
magnetic beads; Mbc: mass barcode; IS: internal standard; Abs: antibodies. 
4.2.5. Allergy CRD with the patient’s blood serum  
Firstly, the citrate-stabilized AuNPs were derivatized with the mixed thiol-containing 
oligomers of mass barcodes and protein linkers. Various allergenic proteins-conjugated 
AuNPs probes were then produced by immobilizing individual purified cow’s milk proteins, 
including lactoferrin, bovine serum albumin (BSA), β-lactoglobulin B (β-lac B), α-casein, β-
casein, and κ-casein, onto the AuNPs with distinct mass barcodes covalently, with synthesis 
procedures as described in experimental parts of 4.2.2 and 4.2.3.  
The anti-human IgE Abs-modified MBs were prepared by incubating 10 μL of 10 
mg/mL protein A/G@MBs with 5 μL of 1 mg/mL anti-human IgE Abs for 30 min at room 
temperature (RT). Blood serum of a milk allergic patient was always diluted with 10 mM 
phosphate buffer (PB, pH 7.4) prior to the diagnosis. Initial required volume of the serum 
(a) 
(b) 
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varied from 50 to 1 μL depending on the dilution factor changing from 10 up to 100000 
times. The modified MBs were then added to 300 μL of the diluted blood serum to extract 
human IgE Abs through 30 min of incubation at RT. The supernatant was discarded and the 
protein A/G-anti-human IgE Abs-human IgE Abs immunocomplex formed on MBs was 
resuspended into 10 μL of 10 mM PB, pH 7.4 for subsequent use.  
Allergy diagnosis was firstly performed with each type of the allergen-conjugated 
AuNPs separately. 20 μL of appropriate protein-conjugated AuNPs (15 nM AuNPs) were 
mixed with 10 μL of the prepared human IgE-based immunocomplex on MBs. The mixture 
was diluted to 300 μL with 10 mM PB and incubated for 30 min at RT. After magnetic 
separation step, acidic elution and MALDI-MS detection of captured allergen-coated AuNPs 
were carried out as described in Figure 4.3(b). Multiplex allergy diagnosis was realized by 
adding simultaneously various AuNPs probes (20 μL and 15 nM, each) into 10 μL of the 
human IgE-captured MBs. The mixture was diluted to 300 μL with 10 mM PB and incubated 
for 30 min at RT, followed by magnetic separation step, AuNPs elution and MALDI-MS 
detection. 
4.3. Results and discussion 
4.3.1. Immunoaffinity MBs and protein linker 
In the preliminary feasibility test, two kinds of MBs, tosyl-activated MBs and protein 
A/G@MBs, were compared. The immunoaffinity reaction between β-lac B Abs captured on 
MBs and β-lac B on AuNPs was studied as the model system. To simplify the process, 2.5 µg 
of β-lac B were nonspecifically adsorbed onto 500 µL of 15 nM AuNPs that were further 
blocked with 1 µL of Tween 20 prior to the washing step. The β-lac B-coated AuNPs through 
nonspecific adsorption (β-lac B_NA@AuNPs) were finally dissolved in 500 µL of 10 mM 
PB containing 0.1% Tween 20.  
Anti-bovine β-lac B Abs can be covalently immobilized onto tosyl-activated MBs 
following a commercially available protocol.22 20 µL of the formed β-lac B Abs@MBs (5 
mg/mL) were then treated with 20 µL of β-lac B_NA@AuNPs for 30 min at RT in 300 µL 10 
mM PB. No obvious red colour was observed in the supernatant after acidic elution and 
MALDI-MS analysis of the supernatant gave weak signal of β-lac B. The low 
immunobinding efficiency of β-lac B Abs@MBs with β-lac B_NA@AuNPs may come from 
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the steric hindrance between the two kinds of particles and the random orientation of the Abs 
and antigens on particles. 
Instead, we adopted commercial recombinant protein A/G@MBs, where each protein 
A/G holds four Fc binding domains toward anti-bovine β-lac B Abs and thus can capture 
more Abs on MBs. Moreover, the Abs are highly oriented on MBs, exposing Fab-binding 
domains outside properly for efficient binding with antigens. A high concentration of anti-
bovine β-lac B Abs (10 nM in 300 µL of 10 mM PB) were analyzed with 10 µL protein 
A/G@MBs (10 mg/mL) and 20 µL β-lac B_NA@AuNPs (15 nM). The collected and 
concentrated supernatant had a red colour and gave a strong peak of β-lac B in MALDI mass 
spectra (data not shown). Therefore, protein A/G@MBs were employed as the 
immunomagnetic support in this work. 
Four protein linkers (PLs) were compared for the protein conjugation on AuNPs. 
Their structures were as shown below: PL1: HS-(CH2)10-COOH, MW 218 Da; PL2: HS-
(PEG)n-CH2CH2-COOH, MW 2000 Da; PL3: HS-(PEG)n-NHS, MW 2000 Da; PL4: HS-
(CH2)11(OCH2CH2)6-OCH2COOH, MW 526 Da. 
The carboxyl-based PLs, including PL1, PL2 and PL4, were modified onto AuNPs 
together with Mbc1 at an amount ratio of 10:90. The total amount of the oligomer mixture 
was 75 nmol per 500 µL of AuNPs. Then, three kinds of β-lac B@AuNPs probes were 
prepared via EDC-NHS reaction with the three PLs. Κ-casein@AuNPs were also prepared 
with the PLs and used for control experiments. These AuNPs probes were utilized with 
protein A/G@MBs to detect 10 nM of anti-bovine β-lac B Abs in 300 µL 10 mM PB. For 
PL1, serious nonspecific adsorption was observed from control experiments, which may 
come from the strong hydrophobicity of the PL1. For PL2, the obtained AuNPs could not be 
stabilized in salt-rich solution during the NHS activation-based protein conjugation process.  
To prepare proteins@AuNPs via PL3, 50 µL of protein solution (1 mg/mL) in 10 mM 
PB firstly reacted with excess amount of PL3 (3 µL, 10 mg/mL) for 3h at RT. Then, the 
formed protein-PL3 complex was purified by ultrafiltration with Amicon Ultra-2mL 
centrifugal filter to remove excess PL3. The purification procedure was repeated for 3 times. 
2.5 µg of the protein-PL3 complex was added into 500 µL of 15 nM AuNPs solution for 20 
min reaction. The protein-conjugated AuNPs were further treated with excess amount of 
Mbc1 (75 nmol) for 12h at RT. The obtained β-lac B@AuNPs probes were then used with 
protein A/G@MBs to detect 10 nM anti-bovine β-lac B Abs in 300 µL 10 mM PB. However, 
the captured AuNPs gave only weak MS signal of Mbc1. 
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Finally, PL4 was chosen as the protein linker for the allergy CRD application. The 
resulting AuNPs co-modified with Mbc1 and PL4 were stable throughout the NHS 
activation-based protein conjugation process, showed low level of nonspecific adsorption 
during the immunoassay, and higher signal intensity of Mbc1 than the AuNPs probes 
prepared with PL3.  
4.3.2. Combining MALDI-MS signal amplification by mass barcoded 
AuNPs with immunomagnetic separation: optimization and validation 
With the optimal immunomagnetic support and protein linker, analysis of anti-bovine 
β-lac B IgG Abs was chosen as a model system for the protocol optimization. Anti-bovine β-
lac B Abs could bind with both protein A/G@MBs and β-lac B-coated AuNPs (β-lac B 
@AuNPs) probe forming a sandwich structure and then be detected through MALDI-MS 
analysis of corresponding mass barcode, as shown in Figure 4.3(a). The validity and 
sensitivity of the method were also evaluated based on this model. 
 
Figure 4.4. (a) and (b) MALDI mass spectra of 1 nM Mbc1-coded AuNPs with and without DHB as 
matrix, respectively. The spectra were acquired under positive mode with an accelerating voltage of 
19 kV, a 20 Hz repetition rate, the laser intensity of ~ 40% (instrumental value) and an average of 800 
shots. 
First of all, the amount ratio between mass barcode and protein linker for AuNPs 
surface modification needed the optimization. Excessive mass barcode amount in comparison 
to the protein linker could negatively affect the protein conjugation efficiency. In contrast, 
insufficient amount of mass barcode would lead to limited signal amplification effect. To find 
an optimal mass barcode/protein linker ratio, several identical solutions containing 1 nM of 
anti-bovine β-lac B IgG Abs in 300 μL of 10 mM PB were analyzed separately with the fixed 
amount of protein A/G@MBs (100 μg) and 20 μL of β-lac B@AuNPs prepared with various 
mass barcode-to-protein linker amount ratios (n : m) ranging from 95:5 to 75:25. The amount 
of MBs was much more excessive in comparison to the amount of IgG Abs. According to the 
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protocol,25 provided by the manufacturer of protein A/G@MBs, the chosen amount was 
enough to fix 4 μg of IgG Abs. Therefore, most of the anti-bovine β-lac B IgG Abs should be 
immobilized on the MBs. The amount of β-lac B@AuNPs was chosen to match the amount 
of IgG Abs. 
For semi-quantitative comparison, internal standard-coated AuNPs (IS@AuNPs) and 
proper matrix were deposited together with the concentrated sample on a MALDI target plate 
for MS detection. AuNPs were previously demonstrated to facilitate MS analysis and used as 
desorption/ionization matrices.26,27 In the current work, we have compared the MS analysis of 
mass barcodes with and without organic matrices. The results showed that mass barcode was 
detectable with only AuNPs-assisted LDI. However, the Mbc1 signal could be highly 
enhanced in the presence of 2,5-dihydroxybenzoic acid (DHB) as a matrix, in Figure 4.4. It is 
worth to mention that DHB was used as the matrix due to its low interference to the MS 
signal of the chosen mass barcodes. Therefore, all the mass spectra presented in the paper 
were obtained with DHB matrix. 
 
Figure 4.5. Detection of 1 nM anti-bovine β-lac B IgG Abs by the mass-barcoded AuNPs MALDI-
MS signal amplification method combined with immunomagnetic separation. (a) Optimization of the 
amount ratio between mass barcode Mbc1 and protein linker PL4 on AuNPs. (b) Mass spectrum of 
the Mbc1 (M + Na+ = 693 m/z) under the optimized condition for AuNPs functionalization. 
Conditions: 1 nM anti-bovine β-lac B Abs in 300 μL 10 mM PB, 100 μg of protein A/G@MBs, and 
300 fmol β-lac B@AuNPs.  
Mass barcode 2 (Mbc2) was used as the IS, which has similar molecular structure as 
the signal reporter, Mbc1, coated on AuNPs to ensure similar ionization efficiency during 
MALDI-MS analysis. The relative intensity of the mass barcode to IS was considered for the 
evaluation of the signal amplification effect during the detection of anti-bovine β-lac B Abs. 
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From the recorded MALDI mass spectra, Mbc1 relative intensity reached the highest value, 
when the mass barcode-to-protein linker ratio was 85:15, in Figure 4.5. Therefore, the 
oligomer mixture composed of 85% mass barcode and 15% protein linker was selected to 
functionalize AuNPs for all the following immunoassays.  
 
Figure 4.6. (a) Detection of anti-bovine β-lac B IgG Abs by mass barcoded AuNPs-based MALDI-
MS signal amplification method combined with immunomagnetic separation. MALDI mass spectra 
obtained for the analyses of (a1) 1 pM, (a2) 300 fM, (a3) 100 fM and (a4) 30 fM of anti-bovine β-lac 
B Abs. (a5) 1 pM of anti-bovine β-lac B Abs analyzed with κ-casein conjugated AuNPs as a negative 
control. (b) Optical image (b1) and UV-Vis spectra (b2) of 5 μL eluents from 100 μg of protein 
A/G@MBs and diluted in 500 μL H2O for the analysis of (1) blank sample and 1 nM anti-bovine β-lac 
B Abs in 300 μL 10 mM PB with 300 fmol (2) β-lac B@AuNPs, and (3) κ-casein@AuNPs, 
respectively. Rel.: relative. Conditions: Abs in 300 μL of 10 mM PB, 100 μg of protein A/G@MBs, 
300 fmol AuNPs, 85:15 of Mbc1: protein linker ratio.  
With the proposed strategy, the semi-quantification of anti-bovine β-lac B IgG Abs 
was further performed. The method sensitivity was accessed by determining the LOD of anti-
bovine β-lac B IgG Abs. Following the optimized conditions, both the amounts of the β-lac 
B@AuNPs probes and protein A/G@MBs were kept constant at 300 fmol and 100 μg 
respectively, while the concentration of target Abs were decreased from 1 pM to 30 fM. 
Figure 4.6(a) shows the obtained mass spectra of Mbc1 and IS with intensities normalized to 
the intensity of IS. As expected, the relative intensity of Mbc1 gradually decreased, as the 
concentration of Abs decreased, from Figure 4.6(a1) to (a4). Due to the signal amplification 
(a) 
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effect, the lowest concentration of anti-bovine β-lac B IgG Abs that can be analyzed with a 
good reproducibility was around 100 fM (18 pg/mL). Once the concentration was lowered to 
70 fM, the signal of Mbc1 was hardly detected with S/N around or less than 3 (data not 
shown). 
In the negative control experiment using κ-casein@AuNPs and anti-bovine β-lac B 
Abs, only IS signal was observed in Figure 4.6(a5). Thanks to the oligomer coating of AuNPs 
and washing step applied, the obtained spectrum demonstrated clearly the high specificity of 
the system. Successful suppression of nonspecific interactions by the ethylene glycol 
oligomers26 was also confirmed by the optical estimation of the colour difference and UV-Vis 
absorption measurement of the supernatant eluted from the MBs by acidic solution when 
analyzing anti-bovine β-lac B Abs at high concentration (1 nM) or blank sample with β-lac 
B@AuNPs and κ-casein@AuNPs, as shown in Figure 4.6(b1) and (b2). 
4.3.3. Multiplex allergy CRD 
The mass barcode-based MALDI-MS signal amplification strategy was further 
applied to cow’s milk allergy CRD. In this case, the immunoaffinity reactions between 
specific IgE Abs from the patient’s blood serum and allergenic proteins were detected via the 
observation of amplified mass barcodes signals. Anti-human IgE Abs were immobilized onto 
protein A/G@MBs to selectively extract human IgE Abs from the blood serum of the patient. 
A large amount of magnetic immunosupport carrying anti-human IgE Abs could be prepared 
at once with the commercial protocol23 and divided into equal portions for all the following 
diagnostic steps, 100 μg per each analysis. This amount of anti-human IgE-protein 
A/G@MBs was chosen to be largely in excess in comparison to the total IgE Abs in patient’s 
blood serum. The total IgE Abs concentration in the original blood serum of the milk allergic 
patient was detected as 2150 ± 160 ng/mL (10 nM, or 900 ± 70 IU/mL, n=3) by classical 
commercial ELISA.17 Initial volume of the blood serum was diluted continuously with 10 
mM PB and, therefore varied depending on the dilution factor: for example, 50 μL were for 
10 times dilution, 10 μL for 50 times dilution and 1 μL for the dilution 500 times and higher. 
Then, 300 μL of the samples diluted were analyzed separately to evaluate the diagnosis 
sensitivity as described below.  
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Figure 4.7. Diagnosis of cow’s milk allergy with individual AuNPs probes combined with 
immunomagnetic separation. MALDI mass spectra of Mbc1 for lactoferrin allergy diagnosis with the 
patient’s serum diluted (a) 30,000 and (b) 100,000 times. MALDI mass spectra of Mbc2 for BSA 
allergy diagnosis with the patient’s blood serum diluted (c) 10,000 and (d) 30,000 times. (e) Mass 
spectrum obtained using the Mbc3 coded β-lac@AuNPs and 10 times diluted patient’s serum. 
Conditions: diluted sample volume of 300 μL, 100 μg of anti-human IgE-protein A/G@MBs and 300 
fmol AuNPs probes. 
Firstly, diagnosis was performed with individual AuNPs probes, Mbc1-coded 
lactoferrin@AuNPs, Mbc2-coded BSA@AuNPs or Mbc3-coded β-lac B@AuNPs using the 
protocol, illustrated in Figure 4.3(b). Among the three whey proteins, BSA@AuNPs and 
lactoferrin@AuNPs displayed the binding with the patient’s IgE Abs on MBs based on the 
corresponding observation of Mbc1 and Mbc2 peaks in MS spectra (Figure 4.7). The Mbc1 
and Mbc2 signals were still detectable even when the blood serum was diluted 100,000 and 
30,000 times, as shown in Figure 4.7(b) and (d), respectively. Considering that the original 
total concentration of the IgE Abs in the blood serum was around 10 nM (900 IU/mL), 
lactoferrin- and BSA-specific IgE Abs were still detectable with the total IgE Abs 
concentrations of 100 and 300 fM (18 and 54 pg/mL or 7.5 and 22.5 mIU/mL), respectively. 
Owing to such sensitivity, less than 1 μL of original patient’s blood serum could be enough 
for the allergy CRD based on MS signal amplification.  
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In contrast, no signal of Mbc3 at m/z 957 was observed for β-lac B@AuNPs even with 
the 10 times diluted patient’s blood serum, (Figure 4.7(e)), indicating that the patient should 
not be allergic to bovine β-lac, while he may have an allergy to BSA and lactoferrin.  
 
Figure 4.8. (a) Multiplex diagnosis of lactoferrin allergy (Mbc1), BSA allergy (Mbc2) and β-lac B 
allergy (Mb3) by AuNPs probes combined with immunomagnetic separation. MALDI mass spectra 
obtained with the patient’s blood serum diluted (1) 30,000 and (2) 100,000 times. (b) Multiplex 
diagnosis of α-casein (Mbc1 coded), β-casein (Mbc2 coded) and κ-casein (Mbc3 coded) allergies. 
MALDI mass spectra obtained with the patient’s blood serum diluted (1) 50 and (2) 1000 times. 
Conditions: diluted sample volume of 300 μL, 100 μg of anti-human IgE coated MBs and 300 fmol of 
each kind of AuNPs probes. 
To check the feasibility of the present strategy for multiplex analysis, the CRD of 
cow’s milk allergy was performed with various AuNPs probes simultaneously in a single run. 
For this purpose, same amounts of the three kinds of AuNPs probes (300 fmol each) were 
mixed together to react with the patient’s IgE Abs extracted on the MBs. As each kind of 
AuNPs probe binds with its specific IgE Abs from the patient’s serum without competition, 
the experimental parameters, e.g. amount of individual AuNPs probes, were kept the same as 
those in individual allergen identification. As expected, for patient’s blood serum diluted 
30,000 times, both signals of Mbc1 for lactoferrin specific IgE Abs and Mbc2 for BSA 
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specific IgE Abs were detected, but without Mbc3 signal for β-lac B specific IgE Abs, as 
shown in Figure 4.8(a1). When the serum was diluted by 100,000 times, the Mbc2 signal 
could not be observed any more, while Mbc1 was still detectable (Figure 4.8(a2)), in 
accordance with the results obtained using individual AuNPs probes. These results 
demonstrate that the multiplex diagnosis would not sacrifice detection sensitivity, but could 
provide a gain in time and reagent consumption. 
The same protocol was further applied for the multiplex diagnosis of allergy to 
caseins. Mbc1 mass barcode was used for α-casein@AuNPs, while Mbc2 and Mbc3 mass 
barcodes were utilized for β- and κ-casein@AuNPs probes. With 50 times and 1,000 times 
diluted patient’s serum, only Mbc1 was observed, demonstrating that the patient is solely 
allergic to α-casein. In comparison with lactoferrin and BSA, the Mbc1 signal from α-casein 
conjugated AuNPs probes was observed at LOD level with 1000 times diluted serum, as 
shown in Figure 4.8(b2). These data reveal that the amount of α-casein specific IgE Abs 
existing in the blood serum is approximately 30 and 100 times lower than the amount of BSA 
and lactoferrin specific IgE Abs, respectively. 
 
Figure 4.9. MALDI mass spectra of the mass barcodes: 1 μL of (a) 2.5 ng/mL Mbc1, (b) 5 ng/mL 
Mbc2, and (c) 5 ng/mL Mbc3. 0.5 μL of 10 mg/mL DHB was used as the matrix. 
These results are in good accordance with those, previously obtained by IACE-
UV/MS strategy and classical ELISA protocol,17 confirming the reliability of the present 
procedure. This diagnostic approach is qualitative, but provides the possibility to make a 
conclusion about the relative abundance of individual allergen specific IgE Abs coexisting in 
Chapter IV: Mass barcode signal amplification for multiplex allergy diagnosis by MALDI-MS 
 
95 
the patient’s blood serum: specific IgE Abs to lactoferrin > IgE Abs to BSA > IgE Abs to α-
casein. Such a comparison is feasible, since the diagnosis is only based on the observation of 
mass barcode molecules, which have similar molecular structures and comparable 
sensitivities during MALDI-MS analysis, as shown in Figure 4.9. 
4.3.4. Comparison with existing approaches for allergy diagnosis 
Different from the previous work based on IACE-UV/-MS, this strategy aims at 
sensitively detecting specific IgE Abs in the allergic patient’s blood serum with a set of 
known allergenic proteins. With the three mass-barcoded and allergen-conjugated AuNPs, we 
have demonstrated the proof-of-concept of this strategy for qualitative multiplex allergy CRD. 
A high throughput multiplex diagnosis can be potentially realized by preparing more AuNPs 
modified with different mass barcode molecules and allergenic proteins. The high resolution 
of MS detection affords a wide choice of PEG based mass barcodes to perform the analysis of 
specific IgE Abs against various allergens within a single assay. 
The arbitrarily selected mass barcodes, easily controllable MBs in tube and sensitive 
MS detection allow performing multiplexed allergy diagnosis in a simple manner, avoiding 
the use of spatially resolved architectures, such as microarray systems,11,12 costly 
fluorescent27 or enzyme labels,28 and capillary electrophoresis that needs laborious preloading 
of immunoaffinity MBs and coupling with MS detection of the collected CE fractions for 
simultaneous antigen identification instead of UV analysis.17 Owing to the signal 
amplification procedure, the allergy diagnosis sensitivity has been enhanced to a level, which 
is 13 times better than that obtained with IACE-UV analysis,17 and comparable to previously 
reported results employing nanocrystal clusters29 or nanoparticle hybrid probes.30 In another 
case, surface plasmon resonance signals from AuNPs have been shown to provide 
ultrasensitive total IgE quantification with LOD of only 0.18 pg/mL (0.075 mIU/mL).31 
However, the method only provided quantification of the standard IgE solution instead of 
allergy CRD using patient’s blood serum. Due to the high sensitivity, our method requires 
extremely low amount (3-30 nL in theory) of patient’s blood serum in contrast to 20-100 μL 
of blood serum consumption by commercial ELISA or other developed methods and 2 μL by 
microarray chip with DLC solid support32 or IACE-UV/MS approach.17 
In addition, another three specific features distinguish this analysis platform from 
previously developed Au particle-based MS signal amplification for immunoassay performed 
on gold chips.3,4 First, MBs as the immunosupport with large surface area are commercially 
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available with a wide variety of surface functionalization. They provide great flexibility for 
immunoassay design in effective and simple manner without complex and time-consuming 
surface conjugation processes for the gold chip. Second, the immune reactions may be faster 
in bulk solution with stirring in comparison with one on a fixed gold surface, facilitating 
sample handling and accelerating the immunobinding process. Third, deposition of 
concentrated AuNPs together with IS on the MALDI plate can provide more homogeneous 
MS analysis and allow avoiding spot-to-spot variation during the direct detection on the gold 
chip or complicated concentration process of AuNPs by centrifugation after their detachment 
from the gold chip. 
All in all, due to the simplicity, tiny sample consumption and high sensitivity, the 
present technique can be a helpful tool for ultratrace analysis during clinical allergy 
diagnosis.  
4.4. Conclusions 
In this study, we have constructed a MALDI-MS signal amplification system based on 
mass-barcoded AuNPs and immunomagnetic separation. We have applied this system to 
enhance the sensitivity of allergy CRD. For diagnostic purpose, the patient’s IgE Abs were 
firstly extracted from the blood serum by anti-human IgE Abs modified MBs, and then 
probed by different mass-barcoded and allergenic proteins-conjugated AuNPs. The 
immunobinding events between the patient’s IgE Abs and allergens were reported by the 
corresponding mass barcodes. High sensitivity and potential for multiplexing allergy CRD 
were successfully demonstrated with down to 1 μL of the initial patient’s blood serum, that 
could be diluted up to 100000 times prior to the analysis. Besides the food allergen diagnosis, 
we believe that this system can be easily modified and applied to many other immunoassays 
with a vast range of target analytes. 
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CHAPTER V. 
 
On-chip spyhole nanoelectrospray ionization mass spectrometry for 
sensitive biomarker detection in small volumes 
Based on the manuscript submitted to JASMS. 
Abstract 
A polyimide microfluidic chip with a microhole emitter (Ø 10-12 μm) on top of a 
microchannel has been designed for nanoelectrospray ionization (spyhole-nanoESI) to couple 
microfluidics with mass spectrometry. The spyhole-nanoESI showed higher sensitivity 
compared to standard ESI and microESI from the end of the microchannel. The limits of 
detection (LOD) for peptide with the spyhole-nanoESI MS reached 50 pM, which was 600 
times lower than that with standard ESI. The present microchip emitter allows the analysis of 
small volumes of samples. As an example, a small cell lung cancer biomarker, neuron-
specific enolase (NSE), was detected by monitoring the transition of its unique peptide with 
the spyhole-nanoESI MS/MS. NSE at 0.2 nM could be well identified with a signal to noise 
ratio (S/N) of 50 and thereby its LOD was estimated to be 12 pM. The potential application 
of the spyhole-nanoESI MS/MS in cancer diagnosis was further demonstrated with the 
successful detection of 2 nM NSE from 1 μL of human serum without any complicated 
sample preparation steps. The concentration matched the real condition of clinical samples. In 
addition, the microchips can be disposable to avoid any cross contamination. The present 
technique provides a highly efficient way to couple microfluidics with MS, which brings 
additional values to various microfluidics and MS based analysis.  
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5.1. Introduction 
Biosensors and clinical diagnostic tools based on microfluidics are now commercially 
available for point-of-care diagnosis.1,2 These devices usually rely on three major detection 
methods: spectroscopic, electrochemical and mass spectrometry (MS) methods.3 Despite their 
simplicity and high sensitivity, optical and electrochemical methods often require labeling 
procedures using tags with optical or electrochemical properties. The indirect sensing process 
can cause false positive signals and cannot provide exact information about the analyte 
itself.4,5 In contrast, MS provides direct, highly specific and accurate characterization and 
quantification of target analytes and thereby has gained increasing importance as a detection 
method for microfluidic chips.6 However, compared to optical and electrochemical methods, 
which can be integrated in chips, a key difficulty in coupling microfluidics with MS is the 
design of the emitter.7  
Compatible with the small volumes of samples used in microfluidic chips, 
nanoelectrospray ionization (nanoESI) is one of the most suitable interfaces for integrating 
microfluidics with MS, as it provides good detection sensitivity at sub microliter/min flow 
rates.8 NanoESI interfaces between MS and microfluidic chips can be classified in three 
types: i) spraying from the microchannel outlet;9,10 ii) spraying from an externally coupled 
emitter;11 iii) spraying from an emitter integrated on chip.12,13 Electrospray directly from a 
microfluidic channel is the most straightforward interfacing approach used in early days, but 
the performance is limited by the solution spreading at the nontapered and hydrophilic flat 
edge of the channel.9,10 Many approaches have been followed to address this problem. For 
example, Bedair et al. constructed a polymeric monolith at the edge of an open channel to 
spray samples from the pores.14 Another option is to integrate the microfluidic chip with an 
external nanoESI emitter, which is normally obtained from a conventional pulled glass 
capillary with a diameter of several micrometers to several hundred nanometers.15,16 
However, the dead volume originating from the external connection is inevitable. Clogging of 
the emitter tip is also a disturbing aspect for stable performance.17 As a result, on-chip 
integrated emitters have become popular and a wide range of fabrication methods have been 
employed to build them.18-21 Microchannel created by laser ablation as an ESI emitter is 
perhaps the easiest approach,22-24 where a channel outlet could also be cut into a sharp-tip 
shape to assist stable electrospray ionization, as described in §1.2.3.25,26 Lower sample 
consumption and higher detection sensitivity could be obtained by decreasing the size of 
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sample infusion channel or delivering sample solution into another dedicated nanoESI emitter 
channel. However, the continuous sample infusion will be impeded in both cases due to the 
large backpressure caused by the small emitter channel with a length of several millimeters. 
An on-chip microhole as an emitter for electrostatic spray ionization was created for coupling 
MS with droplet-based microfluidics previously (spyhole-ESTASI), as shown in §1.2.3. 
However, it was difficult to align the contactless electrode with the spyhole and MS inlet, and 
the spray performance was limited by the electrical field spreading due to the much larger 
size of the electrode compared with the spyhole.  
To alleviate these problems, I present here a novel interface (spyhole-nanoESI) to 
couple microfluidic chips with MS by drilling a microhole with a diameter of 10-12 μm 
directly on top of a microchannel. Different from spyhole-ESTASI, an internal electrode 
contacting the sample channel was integrated on the chip to induce nanoESI for higher 
sensitivity and better spray performance. Under optimal conditions, the flow rate could be 
lowered to 100 nL/min for nanoESI. The dead volume of the microchip emitter is about 100 
nL and an easy way to reduce the sample consumption is to use an 8-way valve to split the 
flow and pressure. Limits of detections (LODs) could be obtained at attomole per microliter 
levels for small organic molecules and peptides, which is 600 times lower than that usually 
obtained with standard ESI and microESI. To take advantages of the high sensitivity and low 
dead volume, the spyhole-nanoESI was used to detect a small cell lung cancer (SCLC) 
biomarker protein of neuron-specific enolase (NSE). By monitoring the transition of the 
unique peptide of NSE, LOD for the biomarker by the spyhole-nanoESI was at 12 pM. Its 
potential application in cancer diagnosis was further demonstrated with 1 μL of human serum 
containing 2 nM NSE, which is in accordance with the real abundance of the biomarker in 
blood at the extensive stage of the lung cancer,27 without any complicated sample preparation 
steps, such as immunoaffinity extraction and liquid chromatography separation. In addition, 
the microchips can be disposable to avoid any cross contamination. 
5.2. Experimental Section 
5.2.1. Chemicals and materials 
Angiotensin I (Ang I, trifluoroacetate salt, 98%) was obtained from Bachem 
(Dübendorf, Switzerland). Cytochrome c (from horse heart), acetic acid (99.5%), 
trifluoroacetic acid (TFA), 1,4-dithiothreitol (DTT, ≥99%), and ammonium bicarbonate 
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(NH4HCO3, 99.5%) were purchased from Fluka (Buchs, Switzerland). Methanol (99.9%), 
isopropanol (≥99.5%), reserpine (≥99%), iodoacetamide (IAA, 97%), insulin (from bovine 
pancreas, HPLC) and recombinant human neuron-specific enolase (NSE, ≥95%) were 
obtained from Sigma-Aldrich (Buchs, Switzerland). Trypsin (from bovine pancreas) was 
obtained from Applichem (Darmstadt, Germany). Human plasma was purchased from 
Bioreclamation LLC (Westbury, NY, USA). Deionized water produced by an alpha Q-
Millipore System (Zug, Switzerland) was used for all experiments. Pierce Top 12 abundant 
protein depletion Spin Columns were purchased from Thermo Scientific (Switzerland). 
Amicon Ultra-2 centrifugal filters were ordered from Merck Millipore (Schaffhausen, 
Switzerland). Aquapel® solution was obtained from Aquapel Glass Treatment (Pittsburgh, 
USA). 
 
Figure 5.1. Schematic representation of the spyhole-nanoESI device: (a) top-view image, (b) side-
view image, (c) 3D image, and (d) real picture on a plastic holder. The holder was fixed onto an x, y, z 
positioning stage and placed horizontally under an “L-shaped” MS ion transfer capillary. HV: high 
voltage. LIT-MS: linear ion trap mass spectrometry.  
5.2.2. Spyhole-nanoESI fabrication, treatment and MS experiment 
A spyhole-nanoESI device was designed as shown in Figure 5.1 and fabricated from a 
polyimide (PI) substrate (125 μm thick, Dupont, Switzerland) by scanning laser ablation as 
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previously reported.28 The photoablation was performed with an ArgonFluoride excimer laser 
(Lambda Physics LPX 210I, Göttingen, Germany) at 193 nm with a pulse width about 20 ns, 
fluence of 0.35 J and frequency of 50 Hz. With these parameters, the microchannels for 
sample infusion and electrode strip were made around 50 μm in depth and 100 μm in width 
through the inspection under a laser-scanning microscope VK-8710 (Keyence Corporation, 
Osaka, Japan). A deeper short channel called reservoir was created with a depth around 115 
μm and length of 10 mm at the end of the sample channel (30 mm length) to facilitate 
continuous sample delivery and avoid easy clogging of the spyhole. On top of this reservoir, 
a spyhole with a diameter of ~10 μm was drilled from the same side of the channels using a 
proper mask for the laser ablation in a static shot mode. The constructed spyhole was cleaned 
by the consecutive sonication in isopropanol and pure water for 10 min, respectively. The 
electrode microchannel was filled with conductive carbon ink (Electrador, Electra Polymer & 
Chemicals Ltd., UK) and the substrate was cured for 30 min at 80 ºC in the oven. Finally, the 
channel side of the spyhole-nanoESI was laminated with a 25/10 μm thick 
polyethylene/polyethylene terephthalate (PE/PET) layer using a lamination apparatus 
(Morane Senator, Oxon, UK) at 135 ºC and 3 bars and further cured for 1 h at 85 °C in the 
oven. The spyhole remained open for the sample spray on the opposite side of channel after 
the lamination. 
A water-repellent commercial solution called Aquapel®, was flown through the 
sample channel for about 2 minutes and dipped around the spyhole outlet for the hydrophobic 
modification. To avoid the clogging of the channel and spyhole, the spyhole was immediately 
washed with water and ready to use. During the experiments, the solutions were injected into 
the fused silica capillary (75 μm i.d, 360 μm o.d., BGB analytik AG, Böckten, Switzerland) 
via a glass syringe (Hamilton, Bonaduz, Switzerland) by a syringe pump (KD Scientific, 
Holliston, MA, USA) and delivered to the spyhole via a homemade plastic holder with tight 
fittings (IDEX Health and Science LLC, Oak Harbor, WA, USA).  
For the MS analysis, the spyhole-nanoESI assembled on a homemade holder was 
fixed onto an x, y, z positioning stage (Thorlabs, Dachau/Munich, Germany) and placed 
horizontally under a self-designed “L-shaped” ion transfer capillary instead of the original 
linear one of the Thermo LTQ Velo instrument (Thermo Scientific, San Jose, USA), as 
shown in Figure 5.1(d). The vertical distance between the spyhole and the ion transfer 
capillary was adjusted accurately with the positioning stage and kept always at around 1 mm. 
The sample was infused at 100 nL/min with a syringe pump. The nanoESI was induced by 
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applying an optimized voltage of 3 kV to the electrode on the spyhole against the MS inlet 
and the MS detection was performed under positive mode with a normal scan rate and an 
optimal automatic gain control (AGC) target value of 10’000. The maximum ion injection 
time for a single MS microscan was 500 ms. The ion transfer capillary was always set at 275 
°C and all the source gases were set at 0. During tandem MS analysis, the AGC target values 
for MS and MS2 were set at 30’000 and 10’000, respectively. Collision-induced dissociation 
(CID) was used for the fragmentation of the isolated precursor ion with an isolation width of 
1 m/z and optimized collision energy of 20 under a single reaction monitoring (SRM) scan 
mode. The maximum ion injection time of MS and MSn were all set as 500 ms for a single 
microscan. 
5.2.3. Chiptip-ESI, spyhole-nanoESTASI and standard ESI 
For sensitivity comparisons, three other setups, called chiptip-ESI,25 spyhole-
nanoelectrostatic spray ionization (nanoESTASI)28 and standard ESI, were also used, as 
described below.  
Chiptip-ESI. Besides the spyhole-nanoESI, another two similar microchips, chiptip-
ESI and spyhole-nanoESTASI, were designed and fabricated with the same laser ablation 
process in spyhole-nanoESI. In chiptip-ESI, the sample channel and electrode were same as 
those in spyhole-nanoESI but the reservoir and spyhole were removed. Instead, the sample 
channel exit was cut into a V-shape and acted as a spray emitter, as shown in Figure 5.2(a). 
The V-shaped emitter was measured exactly as 110 μm in length and 50 μm in width. The 
hydrophobic modification of chiptip-ESI was also performed with a same procedure as for 
spyhole-nanoESI.  
The commercial linear ion transfer capillary of LTQ Velos was used for the chiptip-
ESI. The lamination in chiptip-ESI could resist the flow rate up to 8 μL/min. To obtain a 
stable spray from chiptip-ESI, 5 nM Ang I in ESI buffer (50% MeOH, 49% H2O and 1% 
acetic acid) was infused at 1 μL/min and 2.3 kV was found to be optimal when the V-shape 
tip of chiptip-ESI was placed 1 mm away from and in line with MS inlet. Therefore, 2.3 kV 
was applied for all the following analyses with chiptip-ESI. The parameters of the MS 
instrument for MS and tandem MS analyses were the same as those for spyhole-nanoESI.  
Spyhole-nanoESTASI. Similarly, the sample spray with a spyhole-nanoelectrostatic 
spray ionization (spyhole-nanoESTASI) was from a spyhole but through a different 
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ionization process of ESTASI recently developed in our group. In spyhole-nanoESTASI, the 
sample channel and spyhole were the same as those in spyhole-nanoESI but the electrode 
strip was removed. Instead, a disk electrode (Ø 1 mm) was placed below the microchip and in 
line with the spyhole and the “L-shaped” ion transfer capillary inlet, as shown in Figure 
5.2(b). A pulsed high voltage (HV, from 0 V to 10 kV, frequency 40 Hz) was generated by 
amplifying voltage square wave pulses (0 to 10 V) with a high voltage amplifier (10HVA24-
P1, HVP High Voltage Products GmbH, Martinsried/Planegg, Germany), and applied on the 
disk electrode to induce ESTASI against MS inlet that was set at 275 °C and always 
grounded. The ESI voltage of the internal power of the MS instrument was always set as 0 
and all the source gas flow rates were set at 0. Other MS parameters were set the same as 
those in spyhole-nanoESI. The flow rate was adjusted in each case to obtain a stable signal.  
 
Figure 5.2. Schematic representation of different devices: (a) 3D image of chiptip-ESI and (b) side-
view image of spyhole-nanoESTASI. HV: high voltage. LIT-MS: linear ion trap mass spectrometry.  
Standard ESI. The samples were also applied via a direct infusion mode with a 
syringe at the flow rate of 3 μL/min and analyzed with the standard ESI. The sample spray 
with the commercial ESI source is from a needle of 500 μm in diameter and assisted with a 
sheath gas flow of 10 arbitrary units and aux gas flow of 5 arbitrary units. The ESI voltage of 
the internal power of the MS instrument was always set as 3.7 kV. The temperatures of the 
CHAPTER V: On-chip spyhole nanoelectrospray ionization mass spectrometry for sensitive biomarker detec-
tion in small volumes 
 
106 
heater and the MS inlet capillary were set at 42 °C and 275 °C, respectively. All other 
parameters of the MS instrument were the same as those in spyhole-nanoESI. 
5.2.4. NSE tryptic digestion, in silico digestion and unique peptide 
determination  
Enzymatic digestion of NSE was performed with a commonly used procedure, 
including reduction, alkylation and tryptic digestion. First, 30 μL NSE at 10 μg/mL and 100 
ng/mL in 10 mM NH4HCO3 buffer (pH 8) were denatured at 95 °C for 5 min and then 
incubated with 0.5 μL of freshly prepared 60 mM DTT in H2O at 57 °C for 30 min, 
respectively. After being cooled to room temperature (RT), 0.5 μL of freshly prepared 30 mM 
IAA in H2O were added into the sample solutions and placed in dark for another 30 min at 
RT. For the tryptic digestion, 0.5 μL trypsin solutions at 12 μg/mL and 0.6 μg/mL in 10 mM 
NH4HCO3 buffer (pH 8) were added into these two samples containing 10 μg/mL and 100 
ng/mL NSE respectively, and incubated overnight at 37 °C with moderate shaking. The 
digestions were quenched by adding 0.5 μL TFA and the diluted digests in ESI buffer (50% 
MeOH, 49% H2O and 1% acetic acid) were ready to be directly analyzed by spyhole-ESI 
MS/MS under the optimized conditions as described above without any additional procedure.  
The NSE sequence was acquired through the UniprotKB database with the accession 
number of P09104. MS-digest program from protein prospector version 5.19.1 (University of 
California, San Francisco, CA, USA) was used to perform an in silico digest of NSE. The 
results allowed the selection of possible unique peptide candidates by matching with the 
experimental data. To investigate if the candidate peptides solely originate from NSE, peptide 
search with Uniprot was performed to find all proteins in UniProtKB that contain the query 
peptide sequence. The search was limited to homo sapiens and bos taurus because trypsin 
was derived from bovine pancreas. 
5.2.5. Detection of NSE in human serum 
The serum was derived from the human plasma by overnight clotting and 
centrifugation, and certain amounts of NSE were fortified into 30 μL serum to reach a final 
concentration of 200 ng/mL, 100 ng/mL and 50 ng/mL respectively. Firstly, the depletion of 
high abundant proteins in the serum was performed to reduce the sample complexity. 30 μL 
of the serum sample was pooled into a Pierce Top 12 abundant protein depletion spin column 
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and incubated for 1 h at RT. Centrifugation at 1000 × g was then performed with the spin 
column for 2 min to collect the depleted serum sample in 500 μL 10 mM phosphate-
buffered saline (PBS) buffer (0.15 M NaCl, 0.02% azide, pH 7.4). Before tryptic digestion, 
500 μL of the protein solution collected from the 30 μL depleted serum sample was desalted 
by an Amicon Ultra-2 centrifugal filter device with the nominal molecular weight limit of 
10K and finally concentrated in 30 μL 10 mM NH4HCO3 buffer (pH 8). After denaturation at 
95 °C for 5 min, 1 μL of freshly prepared DTT (150 mM) was added and incubated at 57 °C 
for 30 min. Then, the sample solution was alkylated by 1 μL of freshly prepared IAA (75 
mM) in dark for 30 min at RT, followed by digestion with 0.5 μL of 600 μg/mL trypsin 
(freshly prepared in 10 mM NH4HCO3) overnight at 37 °C with moderate shaking. After the 
digestion quenched by 0.5 μL TFA, the serum digests with or without fortified NSE were 
diluted 10 times with ESI buffer (50% MeOH, 49% H2O and 1% acetic acid) and then 
analyzed directly with different methods, including the spyhole-nanoESI MS/MS, chiptip-
ESI MS/MS and standard ESI MS/MS without additional desalting, concentration or 
fractionation procedures. The MS parameters were described in experimental part of 5.2.2. 
5.3. Results and discussion 
5.3.1. Spyhole-nanoESI MS: microchip design and setup optimization 
Two parameters of the spyhole, depth and width, were optimized. The spyhole depth 
was the distance between the spyhole outlet and the sample channel, and should be as small 
as possible to facilitate the continuous sample delivery and avoid being susceptible to 
clogging. Instead of making the whole sample channel deeper, a short reservoir was created 
on the bottom of the sample channel to keep the total chip volume as small as possible to 
minimize dead volumes and sample consumption. Using a test sample of angiotensin I (Ang 
I) in ESI buffer (50% MeOH, 49 % H2O and 1% acetic acid), the optimal spyhole depth was 
found to be 10 μm. A smaller depth of spyhole was not considered, because the short 
reservoir would then be easily penetrated during the laser ablation or the following treatment 
of the microchip. For nanoESI, the spyhole size plays a critical impact on the ionization 
efficiency and should be fabricated as small as possible. A spyhole with the diameter of 10-
12 μm could be made reproducibly by laser ablation, as shown in Figure 5.3(a). In addition, 
the surface of the polyimide microchip was further modified to be hydrophobic by a 
commercial water-repellent Aquapel® solution, in order to form a stable and small droplet 
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for nanoESI. Under optimal conditions, 0.15 nM of Ang I could be detected at 433 m/z with a 
signal-to-noise ratio (S/N) of 10 by the spyhole-nanoESI with an ion trap mass spectrometer 
(Thermo LTQ Velos), Figure 5.3 (c). 
 
Figure 5.3. Optimization of the spyhole width and depth of the spyhole-nanoESI microchip: (a) 
microscopic images of spyholes with diameters of 12 μm, 25 μm and 35 μm. (b) microscopic image of 
the charged droplet generated at the spyhole of 12 μm in diameter. (c) LODs of Ang I in ESI buffer 
(50% MeOH, 49% H2O and 1% acetic acid) by three spyhole-nanoESI microchips with different 
spyhole dimensions. The MS detection conditions were optimized as given in experimental part of 
5.2.2. 
The optimization of the spyhole-nanoESI MS with respect to hydrophobic 
modification, ESI voltage, the automatic gain control (AGC) target value of the ion trap 
instrument, and the vertical distance between the spyhole and the ion transfer capillary were 
performed with 0.15 nM Ang I in ESI buffer (50% MeOH, 49% H2O and 1% acetic acid). 
The other analysis parameters were the same as those described in experimental part of 5.2.2.  
The AGC value was initially set as 10’000. Five voltage values, 2.6, 2.8, 3, 3.2 and 
3.4 kV, were tested individually and 3 kV was found to give the highest S/N of 10 for the 
triply charged Ang I ions at m/z 433 in Figure 5.4(c). Increasing the voltage to 3.2 kV did not 
make the S/N better because the analyte ions were overwhelmed by noisy background ions. 
When the voltage was increased to a point of 3.4 kV, the Taylor cone would break down 
instantly before ejecting the analyte ions into MS and no significant signal was observed, as 
shown in Figure 5.4(e). In contrast, fewer analyte ions were generated under a lower voltage 
of 2.8 kV comparing to 3 kV. When the voltage was decreased to 2.6 kV, the sample solution 
accumulated extensively at the spyhole instead of forming a Taylor cone and thereby no ions 
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were measured, in Figure 5.4(a). In summary, a stable nanoelectrospray could be induced by 
a voltage ranging from 2.8 kV to 3.2 kV and 3 kV was chosen for all the following tests 
under the detection conditions given in experimental part of 5.2.2. 
 
Figure 5.4. Analyses of 0.15 nM Ang I in ESI buffer by spyhole-nanoESI MS with voltages of: (a) 
2.6 kV, (b) 2.8 kV, (c) 3 kV, (d) 3.2 kV and (e) 3.4 kV. AGC target value was set as 10’000. The 
other detection conditions were the same as those given in experimental part of 5.2.2. 
Besides voltage, the signal quality is also greatly dependent on AGC target value. 
With LTQ Velos, the AGC value refers to the maximum quantity of total ions injected into 
the first ion trap during the defined maximum ion injection time of 500 ms. With an improper 
AGC value, the collected analyte ions are either not abundant enough or suppressed by 
coexisting background ions, resulting in a low S/N. Different AGC values were set for the 
analyses of 0.15 nM Ang I at a flow rate of 100 nL/min and with a voltage of 3 kV. In Figure 
5.5, the AGC value of 10’000 gave the best S/N and was applied for all the following MS 
analyses. 
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Figure 5.5. Analyses of 0.15 nM Ang I in ESI buffer by spyhole-nanoESI MS with AGC values of: 
(a) 5’000, (b) 10’000 and (c) 50’000. Voltage: 3 kV. The other detection conditions were the same as 
those given in experimental part of 5.2.2. 
It is worth mentioning that the spyhole distance to the “L-shaped” ion transfer 
capillary inlet should be adjusted to obtain an optimal signal. The improper distance of either 
being too small or too big will hinder the continuous formation of a small and stable Taylor 
cone. In the present work, the optimal distance was found to be around 1 mm with the voltage 
of 3 kV. When the distance was smaller than 1 mm, the sample solution would be sucked into 
the ion transfer capillary under vacuum. On the contrary, with the distance larger than 1 mm, 
a higher voltage than 3 kV would be required to prevent the sample solution aggregation at 
the spyhole. However, the efficient ion transmission could be deteriorated by the enlarged 
distance and a higher voltage would also be a problem for the safety consideration. Therefore, 
a stable electrospray process could be obtained by applying a voltage of 3 kV with the 
distance of 1 mm between the spyhole and the ion transfer capillary. 
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In summary, the optimized conditions are: ESI buffer: 50% MeOH, 49% H2O, 1% 
Acetic acid; flow rate: 100 nL/min; ESI voltage: 3 kV, the AGC value: 10’000; vertical 
distance: 1 mm.  
5.3.2. Sensitivity of spyhole-nanoESI MS 
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Equation 5.1: PE, electrostatic pressure; PL, Laplace pressure; σ, surface charge density; ε0, vacuum 
permittivity; r, the radius of the initial charged droplet; γ, the surface tension of the liquid; SSC, 
specific surface charge; C, the analyte concentration. 
According to the Equation 5.1, the ionization efficiency can be generally determined 
by the specific surface charge (SSC), which means the surface charge number per unit 
amount of analytes obtained when the Rayleigh limit is reached for every initial droplet 
emitted from the Taylor Cone. The charge number per sample molecule is mainly determined 
by the radius of the charged droplet for a certain concentration of analyte and could be used 
to theoretically evaluate the overall ionization efficiency of an electrospray emitter. A larger 
proportion of analyte molecules could be ionized for MS detection when the initial droplets 
are smaller.  
Table 5.1. LODs of Ang I in ESI buffer (50% MeOH, 49% H2O, 1% Acetic acid) with various 
devices. The detection conditions for the four different devices were described in experimental parts 
of 5.2.2 and 5.2.3. i.d: internal diameter. 
 
Based on Equation 5.1, the sensitivity of spyhole-nanoESI was measured and 
compared to standard ESI from commercial ion source, chiptip-ESI and spyhole-
nanoESTASI, under optimized analysis conditions. For chiptip-ESI, the tip of the sample 
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channel (110 μm × 50 μm) was cut into a V-shape as spray emitter. Ionization with spyhole-
nanoESTASI was achieved using a recently developed method of electrostatic spray 
ionization (ESTASI).29 The sample channel and the spyhole on the spyhole-nanoESTASI 
were the same as those of spyhole-nanoESI but no on-chip electrode was used. Instead, a disk 
metallic electrode (Ø, 1 mm) was placed below the microchip and in line with the spyhole 
and the “L-shaped” ion transfer capillary to induce the ESTASI by applying a pulsed high 
voltage of 10 kV.  
 
Figure 5.6. Detection of different molecules in ESI buffer (50% MeOH, 49% H2O and 1% acetic 
acid) by the spyhole-nanoESI MS: (a) 0.1 nM reserpine, (b) 0.05 nM Ang I. The detection conditions 
were the same as the optimized one given in experimental part of 5.2.2. 
Ang I in ESI buffer was analyzed with spyhole-nanoESI, chiptip-ESI and spyhole-
nanoESTASI and standard ESI, respectively. The LODs of Ang I from its triply protonated 
ions (m/z =433) were listed in Table 5.1. From the results, the spyhole-nanoESI demonstrated 
the best sensitivity with the S/N of 4 for 0.05 nM Ang I, as shown in Figure 5.6 (b). In 
contrast, the LODs with chiptip-ESI, spyhole-nanoESTASI and standard ESI were 
determined to be 5 nM, 15 nM and 30 nM, respectively, for Ang I with S/N ≥3. It is worth 
mentioning that different flow rates were used for different setups. For the spyhole-nanoESI, 
the optimized flow rate was 100 nL/min; for spyhole-nanoESTASI, the optimized flow rate 
was 200 nL/min; for chiptip-ESI, the optimized flow rate was 1 μL/min; for standard ESI, the 
optimized flow rate was 3 μL/min. Therefore, the spyhole-nanoESI showed a LODs 600 
times lower than standard ESI and 100 times than the previously developed chiptip-ESI.25 
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The sample consumption is decreased by ~1,000 times lower than chiptip-ESI, and ~20,000 
time lower than the standard ESI considering the difference in flow rate. With such a high 
performance, the spyhole-nanoESI can bring additional value to the coupling of microfluidics 
with MS. Considering that the ion injection time was around 1 ms to generate a mass 
spectrum for 0.15 nM Ang I, the infused Ang I at 100 nL/min was ~150 molecules to 
generate a mass spectrum, which was comparable with other reported nanospray devices for 
peptide detection.8,30,31 
The high sensitivity of the spyhole-nanoESI was also demonstrated with reserpine, a 
small drug molecule, with LOD as 0.1 nM, Figure 5.6(a). The good performance of spyhole-
nanoESI stems from the advantages of nanoESI,8 the well-controlled emitter geometry and 
the surface hydrophobic modification of microfluidic chips. 
5.3.3. Detection of cancer biomarker with the spyhole-nanoESI MS/MS 
With the high sensitivity, the spyhole-nanoESI MS could be applied to detect cancer 
biomarkers directly from body fluids. As a proof-of-concept, a lung cancer biomarker 
protein, neuron-specific enolase (NSE), at low abundance was detected by monitoring the 
transition of its unique peptide with spyhole-nanoESI MS/MS.  
Signature peptide candidates were obtained by analysing 1 μg/mL NSE tryptic digest 
with spyhole-nanoESI MS. 9 peaks were found possibly originating from NSE by matching 
the experimental data to the peptide list from in silico proteolysis, as shown in Figure 5.7(b) 
in bold. The mass tolerance was less than 1 Da. Peptides with missed cleavage or any 
modification were not considered to ensure the quality of signature peptide candidates, for 
example the reproducibility or chemical stability. Uniqueness of these potential peptides was 
checked with the peptide search in UniprotKB and 8 of them were found specific for NSE, as 
the italic and bold parts in Figure 5.7(b). Finally, four highly detectable and unique peptides 
were selected and further identified by spyhole-nanoESI MS/MS, as the italic, bold and 
underlined parts in Figure 5.7(b).  
CID-induced fragmentations of the four candidate signature peptides were performed 
individually and the optimal transition of each peptide was obtained through SRM by 
adjusting the collision energy. The fragments with m/z values too close to the precursor ions 
were not considered, as such transitions are usually noisy especially when analysing the 
rather complicated sample. The fragments with m/z values smaller than the precursors were 
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also avoided even though they are usually the predominant product ions, because they 
generally display worse selectivity and may come from the singly charged chemical 
background. Considering these factors and comparing the efficiency of the optimal transition 
for each candidate signature peptide, the peptide of IVIGMDVAASEFYR namely SP-14 was 
selected as the signature peptide of NSE and the transition of 785.82+ → 843.4+ with the 
optimal normalized collision energy of 20 and the isolated width of 1 m/z was monitored for 
the following NSE detection, as shown in Figure 5.7(c). The product ion at m/z 843.4 was 
further identified by spyhole-nanoESI MS3 to ensure it actually came from the signature 
peptide instead of any other chemical background, in Figure 5.7(d). 
 
Figure 5.7. (a) Mass spectrum of 1 μg/mL NSE tryptic digests in ESI buffer (50% MeOH, 49% H2O 
and 1% acetic acid) by spyhole-nanoESI MS. The peaks marked with stars were peptides potentially 
from NSE. The peaks marked with stars and circles were selected as candidate signature peptides. (b) 
NSE sequence. Bold parts: potential peptides of NSE observed by spyhole-nanoESI MS. Bold and 
italic parts: potential peptides specific for NSE. Bold, italic and underlined parts: signature peptides 
candidates. (c) Mass spectrum from the CID-induced fragmentation of the signature peptide SP-14 at 
m/z 785.8 in 100 ng/mL NSE digests with a normalized energy of 20 and the isolated width of 1 m/z 
by spyhole-nanoESI MS/MS. (d) Mass spectrum from the CID-induced fragmentation of the product 
ion at m/z 843.4 by spyhole-nanoESI MS3. The product ion at m/z 843.4 was selected from the 
fragmentation of the signature peptide SP-14 at m/z 785.8 by spyhole-nanoESI MS/MS. The detection 
conditions were described in experimental part of 5.2.2. 
Under these conditions, the spyhole-nanoESI MS/MS was firstly used to detect NSE 
in water. With 10 ng/mL (0.2 nM) NSE tryptic digest, the fragment ion at m/z = 834.4 could 
be observed with good S/N of 50, as shown in Figure 5.8(a). In contrast, chiptip-ESI and 
standard ESI gave the S/N of 6 and 3 for 10 ng/mL NSE, respectively, as shown in Figure 
5.8(b) and (c). As shown in Figure 5.8(d), the ESI buffer did not give any signal at m/z 834.4, 
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confirming that the fragment ion solely originating from NSE instead of contaminates in the 
microchip or MS instrument.  
The LOD of NSE with the S/N of 3 by spyhole-nanoESI was then estimated as around 
0.6 ng/mL (12 pM) and was comparable to that (0.4 ng/mL) reported with liquid 
chromatography (LC)-MS/MS based method.32 In the literature, specific capture was firstly 
performed to collect the low abundant NSE (5-500 ng/mL, 1 mL), and then LC was applied 
to desalt and fractionate the 100 μL 10 times concentrated tryptic peptides before MS/MS 
analysis. In contrast, the spyhole-nanoESI MS/MS requires no additional sample pretreatment 
prior to analysis and provides good sensitivity even without any concentration step.  
 
Figure 5.8. NSE detection by single reaction monitoring (SRM) of its signature peptide SP-14. 10 
ng/mL NSE tryptic digest in ESI buffer (50% MeOH, 49% H2O and 1% acetic acid) was used for the 
following tests. Mass spectra of the signature fragment ion of SP-14 at m/z 843.4 obtained by (a) 
spyhole-nanoESI MS/MS; (b) chiptip-ESI MS/MS; (c) standard ESI MS/MS. (d) Mass spectrum of 
the ESI buffer obtained by spyhole-nanoESI MS/MS.  
The spyhole-nanoESI MS/MS was further applied to detect the biomarker directly 
from human serum to demonstrate its potential application in clinical diagnosis. Human 
serum from healthy individuals was spiked with 0, 100, or 200 ng/mL of NSE for test. To 
reduce the complexity of the human serum, the top 12 abundant proteins in the serum sample 
were first depleted with immune spin columns and then digested by trypsin. The tryptic 
digests were directly analyzed with spyhole-nanoESI MS/MS after being diluted 10 times 
with ESI buffer (50% MeOH, 49% H2O and 1% acetic acid). For the 10 times diluted human 
serum without spiked NSE, there was no obvious signal of the signature fragment ion of SP-
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14 at m/z = 834.4 observed in Figure 5.9(c), while the ion could be found from the serum 
spiked with 200 ng/mL NSE (S/N = 10) or 100 ng/mL NSE (S/N =3), Figure 5.9(a) and (b). 
Therefore, the elevated NSE at 100 ng/mL (2 nM) in 1 μL human serum could be detected 
with the spyhole-nanoESI MS/MS, which could be valuable for the fast and simple diagnosis 
of SCLC at the extensive stage (94.5+/-13.8 ng/mL)27 and could also be used as the early 
indicator of the response rate to chemotherapy. In contrast, with the chiptip-ESI and standard 
ESI, no obvious signal of the fragment ion of SP-14 could be detected either from normal 
human serum or the serum spiked with 100 ng/mL NSE. 
 
Figure 5.9. Detection of NSE in human serum with spyhole-nanoESI MS/MS. 1 μL of tryptic digests 
of human serum spiked with NSE was diluted by 10 times with ESI buffer (50% MeOH, 49% H2O 
and 1% acetic acid) for spyhole-nanoESI MS/MS analysis. Mass spectra of the signature fragment ion 
of SP-14 at m/z 843.4 from serum sample spiked with (a) 200 ng/mL NSE; (b) 100 ng/mL NSE; (c) 
without NSE. The detection conditions were the same as those given in experimental part of 5.2.2. 
Compared with the routine immunometric method for NSE determination, the present 
method requires no usage of expensive labelled antibodies and provides exact identification, 
avoiding possible false positive diagnosis from antibody cross reaction. Using LC-MS/MS 
based methods for NSE detection, numerous cleanup processes before analysis are rather 
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complicated, labour-extensive, time-consuming and can cause sample loss. A large volume of 
serum from several hundred microliters to millilitres was usually required for specific 
separation and concentration. In contrast, the spyhole-nanoESI MS/MS could offer direct and 
sensitive diagnosis of the low abundant biomarker in human serum and requires only one 
cleanup procedure of high abundant protein depletion. Owing to the simplified procedure and 
great sensitivity, only 1 μL of serum was consumed for a single diagnosis.  
In addition, the laser ablation method for microchip fabrication offers a precise 
process control, wherein the spyhole-nanoESI devices were reproducible. Its easy fabrication, 
low cost and disposable nature make washing avoided and eliminate cross contamination 
between samples, which is highly suitable for clinical diagnosis application. Moreover, the 
spyhole-nanoESI device could be coupled with various MS instruments, such as high-
resolution mass spectrometers for improved accuracy of the analyte identification, which are 
intensively required in clinical diagnosis from complex matrices. 
5.4. Conclusions 
In the present work, a microchip device was coupled with MS by drilling a spyhole 
with a diameter of 10-12 μm on top of the chip to form a nanoESI emitter for ultrasensitive 
analysis. The sample was infused at a nanoscale flow rate and emitted from the hydrophobic-
treated spyhole into MS by a nanoelectrospray ionization. With the optimized detection 
conditions, peptides were detected with ultrahigh sensitivities. The LOD of Ang I was as low 
as 50 pM, which was 600 times lower comparing to standard ESI. The sample consumption 
for MS detection can be lowered 20,000 times compared to standard ESI. With the spyhole-
nanoESI MS/MS, a lung cancer biomarker protein of NSE could be detected sensitively with 
a LOD of 12 pM by monitoring the transition of its signature peptide. The biomarker can also 
be detected from human serum with concentrations as low as 2 nM. Only 1 μL of serum 
digests was sufficient for a single diagnosis. The great sensitivity, low cost, disposal nature, 
compatible with various MS instruments, together with the overall simplicity of the direct 
analysis with few cleanup processes make spyhole-nanoESI MS/MS suitable for clinical 
diagnosis with a limited amount of samples.  
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CHAPTER VI. 
Summary & perspective 
The main purpose of this thesis is to develop bioanalytical tools based on mass 
spectrometry. The first objective is to expand the application fields of ESTASI-MS exploiting 
the advantages of this ambient technique. Therefore, Chapter II & III describe the 
combination of ESTASI-MS or ESTASI-MSI with two classical analytical tools of TLC 
plates and 384-well plates. Coupling ESTASI-MS with 384-well plates, liquid samples could 
be sprayed directly from the unmodified wells, which acted as both containers and emitters 
for ionization without any liquid delivery interface. With both the qualification and 
quantification abilities, the integrated device is suitable for enzyme assay and drug 
metabolism studies, providing great potential value for drug development. In ESTASI-TLC-
MS, dye spots separated on a high performance reverse phase C18 silica plate were profiled 
by ESTASI-MSI, which revealed the accurate sample location and is especially of great value 
when the samples are colorless and do not give a clear image under UV illumination. To 
analyze the normal phase silica TLC plates with ESTASI-MS, the surface modification with 
chlorotrimethylsilane was performed to render the normal phase TLC plates hydrophobic, 
which alleviated the strong adsorption of ESI buffer into the TLC plates and benefited the 
ESTASI-MS analyses with efficient sample extraction, reduced tailing effect and even the 
abilities of sample desalting, thus leading to an enhanced sensitivity. 
Similarly, ambient surface analyses with ESTASI-MS could be extended to lateral 
flow tests, also known as lateral flow immunochromatographic assays, which is a rather 
inexpensive, simple and rapid device for clinical and point-of-care testing.1 Typically, the 
analytes in biofluids were passing through a series of capillary beds spontaneously by a 
capillary pumping, binding with particle-labeled antibodies (Abs) or mixing with particle-
labeled target analytes, and then finally captured in a format of sandwich assay or 
competitive assay. As mediums for signal reading out, latex or nanoparticles, including gold, 
fluorescent or magnetic particles, are often employed. 
CHAPTER Ⅵ: Summary & perspective 
 
122 
 
Figure 6.1. Direct coupling of ESTASI-MS with lateral flow tests. (a) High throughput analyses of 
multiple target analytes from biofluids captured and separated on a lateral flow strip. (b) Amplified 
ESTASI-MS signals with various mass barcoded particles for multiplex analyses of biofluids.  
Compared to spectroscopic, magnetic or electronic detection methods, ESTASI-MS as 
a signal read out tool could provide accurate identification of analytes, as well as structural 
elucidation with tandem MS, avoiding false positive results often happened in reporter-
labeled immunoassay. Moreover, high throughput and fast analysis could be easily realized 
within a single lateral flow strip, no requiring multiplex labels and expensive Abs, as shown 
in Figure 6.1(a). Coupling ESTASI-MS with lateral flow strips holds a wide range of 
applications in biochemical analyses, particularly for biofluid-based clinical tests, such as the 
allergy and allergen, biomarker, or pregnancy diagnosis in a component-resolved diagnosis 
way. Furthermore, mass barcode-based MS signal amplification strategy, described in 
Chapter II, could also be implanted into lateral flow strip ESTASI-MS to achieve 
ultrasensitive testing, which is very important for disease-related early diagnosis. Based on 
the sandwich or competitive assay, the mass barcodes could be grafted onto particles in a 
covalent or noncovalent way, and then desorbed for ESTASI-MS analysis, as shown in 
Figure 6.1(b). 
Taking advantage of ESTASI-MS as an ambient surface analysis method, studies of 
solid-liquid reaction kinetics could also be performed to monitor intermediate products with 
short half-life time in real time.2 Besides, large quantities of metabolic profiles of normal 
cells and cancerous cells at different stages could be differentiated with the 384-well plate 
ESTASI-MS in a high throughput way. Based on the differences of mass spectra profiles, the 
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potential metabolic biomarkers could be determined and their distributions of over normal 
and cancerous tissues would further be imaged with ESTASI-MSI to reveal the tumor 
margin, which should be helpful for the rapid intra-operative detection of residual cancer 
tissue during organ-conserving surgery.3 
Chapter IV and V presented two strategies to enhance the MALDI-MS and ESI-MS 
signals, respectively. Combined with immunomagnetic separation, multiplex allergenic 
proteins in cow’s milk were conjugated onto mass barcoded gold nanoparticles (Mb-AuNPs), 
captured by specific IgE Abs in only 1 μL of patient’s blood serum, and then reported by 
simultaneous detection of corresponding mass barcodes from AuNPs in a highly sensitive 
manner for component resolved allergy diagnosis. This signal amplification strategy could 
also be applied for biomarker probing in cells or tissues, such as the melanoma cell diagnosis 
by labeling the biomarker of tyrosinase with Mb-AuNPs for sensitive MALDI-MS detection 
of the mass barcodes. 
In Chapter V, an on-chip spyhole with a diameter around 10 μm was created by laser 
ablation method to work as an emitter for nanoESI, which acted as an efficient interface for 
coupling microfluidics with MS. With the spyhole-nanoESI-MS/MS, sensitive detection of 
lung cancer biomarker in small volumes of human serum was realized by monitoring the 
characteristic transition of a signature peptide without complicated sample pretreatments. 
Moreover, with the producible and precise control of the fabrication process by laser ablation, 
various functions could be easily integrated for different purposes. In proteomics, several on-
chip sample treatments, such as proteolysis, purification, and fractionation, could be 
performed, following with sensitive spyhole-nanoESI-MS/MS analysis.  
To develop novel emitters and improve the spray flux, macroporous ordered silica 
foams (MOSF) would be deposited on a substrate or modified onto capillary tips, and then act 
as multiplex emitters for nanoESTASI-MS analysis.4  
All in all, as this thesis has shown, it is clear that mass spectrometry will become 
more and more an instrument of choice of bioanalytical chemistry, and will play a greater 
role in automated medical diagnostic laboratories. 
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